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Summary	  	  Pol	  II	   is	   the	   conserved	  12-­‐subunit	   enzyme	   that	   transcribes	  mRNA	   from	  protein-­‐coding	  genes	  in	  the	  nucleus	  of	  eukaryotic	  cells.	  Whereas	  the	  structure	  and	  function	  of	  Pol	  II	  have	  been	  extensively	   studied,	   its	   biogenesis	   is	   not	   well	   understood	   and	   the	  mechanism	   of	   how	   Pol	  II	   is	  imported	  into	  the	  nucleus	  remains	  elusive.	  This	  work	  establishes	  that	  the	  conserved	  protein	  Iwr1	  specifically	  binds	  Pol	  II	  between	  its	  two	  largest	  subunits	  Rpb1	  and	  Rpb2,	  and	  directs	  its	  nuclear	  import.	   Iwr1	  was	  previously	  identified	  in	  co-­‐purifications	  with	  Pol	  II	  subunits	  and	  deletion	  of	  its	  gene	  resulted	  in	  a	  pleiotropic	  phenotype,	  suggesting	  a	  general	  cellular	  function.	  Moreover,	  from	  proteome-­‐wide	   localization	   data	   Iwr1	   was	   known	   to	   reside	   both	   in	   the	   nucleus	   and	   in	   the	  cytoplasm.	  While	  this	  work	  was	  ongoing,	   Iwr1	  was	  reported	  to	  bear	  a	  nuclear	  export	  sequence	  (NES),	  further	  supporting	  nucleo-­‐cytoplasmic	  shuttling	  of	  the	  protein.	  Analysis	   of	   the	   Iwr1	   sequence	   revealed	   an	   N-­‐terminally	   located	   classical	   bipartite	  nuclear	  localization	  sequence	  (NLS)	  that	  was	  confirmed	  to	  be	  functional	  in	  vivo	  and	  required	  for	  nuclear	  import	  of	  Iwr1.	  Based	  on	  these	  results	  the	  hypothesis	  was	  proposed	  that	  Iwr1	  is	  involved	  in	  nuclear	  import	  of	  Pol	  II.	  To	  validate	  this,	  IWR1	  was	  deleted	  in	  yeast	  strains	  carrying	  an	  EGFP-­‐fusion	  with	  Rpb1,	  Rpb3	  and	  Rpb4,	  respectively.	  Cytoplasmic	  accumulation	  of	  Pol	  II	  subunits	  was	  observed,	  while	  localization	  of	  the	  Pol	  I	  and	  Pol	  III	  largest	  subunits	  was	  unaffected	  in	  the	  absence	  of	   Iwr1.	   Pol	  II	   nuclear	   localization	   could	   be	   re-­‐established	   upon	   expression	   of	   the	   full-­‐length	  protein	   or	   of	   a	   region	   of	   Iwr1	   that	   was	   sufficient	   to	   bind	   Pol	  II	   in	   vitro,	   while	   variants	   with	  mutations	  in	  the	  bipartite	  NLS	  were	  not	  functional.	  The	  mechanism	  seems	  to	  be	  conserved	  from	  yeast	  to	  humans,	  as	  a	  partial	  rescue	  of	  the	  Pol	  II	  delocalization	  was	  also	  possible	  with	  the	  human	  homologue	  of	  Iwr1.	  According	   to	   a	   cryo-­‐electron	   microscopy	   (EM)	   map	   of	   the	   Pol	  II-­‐Iwr1	   complex,	   Iwr1	  binds	  Pol	  II	  in	  the	  active	  centre	  cleft	  between	  Rpb1	  and	  Rpb2,	  thereby	  possibly	  sensing	  complete	  assembly	  of	   the	  enzyme	  and	  thus	  restricting	  nuclear	   import	   to	   functional	  complexes.	  The	  cryo-­‐EM	  map	  was	  validated	  by	  competition	  experiments	  with	  nucleic	  acids	  and	  general	  transcription	  factors,	  which	  also	   led	   to	  a	  proposed	  mechanism	  of	   Iwr1	  eviction	   from	  the	  complex	  as	  Pol	  II	   is	  recruited	  to	  gene	  promoters	  in	  the	  nucleus.	  In	  agreement	  with	  the	  nucleic	  acid	  competition,	  Iwr1	  could	  not	  be	  detected	  at	  chromatin	  in	  immunoprecipitation	  (ChIP)	  experiments.	  Nuclear	  extracts	  from	  Δiwr1	  cells	  fully	  supported	  in	  
vitro	  transcriptional	  initiation,	  which	  was	  decreased	  by	  addition	  of	  recombinant	  Iwr1.	  Together	  with	   these	   results	   a	   comparison	   of	   the	  Δiwr1	   gene	   expression	   profile	  with	   the	   profiles	   of	   263	  transcription	  factor	  deletions	  argues	  against	  the	  notion	  of	  Iwr1	  being	  a	  transcription	  factor.	  Finally,	  an	  increase	  of	  Rpb1	  levels	  and	  half-­‐life	  in	  Δiwr1	  as	  compared	  to	  wild-­‐type	  cells	  is	  described,	  possibly	  reflecting	  an	  involvement	  of	  Iwr1	  in	  Pol	  II	  biogenesis	  as	  a	  second	  function	  of	  the	  protein.	  In	  conclusion,	  a	  cyclic	  model	  for	  Iwr1-­‐directed	  Pol	  II	  nuclear	  import	  is	  presented.	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1.1 Eukaryotic	  RNA	  polymerases	  	   In	  bacteria	  and	  archaea,	  a	  single	  DNA-­‐dependent	  RNA	  polymerase	  suffices	  to	  synthesize	  all	  of	  a	  cell’s	  transcriptional	  RNA.	  Eukaryotes,	  however,	  diversified	  this	   task	   and	   generally	   possess	   three	   different	   nuclear	  RNA	  polymerases,	   each	  responsible	  for	  synthesis	  of	  different	  classes	  of	  RNAs.	  RNA	  polymerase	  I	  (Pol	  I)	  is	  located	  in	  nucleoli	  and	  synthesizes	  precursors	  of	  most	  ribosomal	  RNAs.	  RNA	  polymerase	  II	  (Pol	  II)	  acts	  in	  the	  nucleoplasm	  and	  synthesizes	   messenger	   RNA	   (mRNA)	   precursors,	   small	   nuclear	   and	   nucleolar	  RNAs	  and	  other	  non-­‐coding	  RNAs.	  RNA	  polymerase	  III	  (Pol	  III)	  also	  resides	  in	  the	  nucleoplasm	  and	  synthesizes	  the	  precursors	  of	  5S	  ribosomal	  RNA,	  transfer	  RNAs,	  and	  other	  small	  RNAs.	  In	  plants,	  two	  additional	  closely	  related	  RNA	  polymerases,	  Pol	  IV	  and	  Pol	  V,	  exist	  that	  are	  involved	  in	  RNA-­‐dependant	  DNA	  methylation	  and	  heterochromatin	  formation	  (Dalmay	  et	  al,	  2000;	  Herr	  et	  al,	  2005).	  Eukaryotic	  RNA	  polymerases	  vary	  in	  their	  subunit	  composition	  and	  their	  molecular	  weights	   (Table	   1).	   The	  RNA	  polymerase	   core	   structure	   is	   conserved	  among	   all	   three	   domains	   of	   life	   (Hirata	   &	  Murakami,	   2009).	   Five	   subunits	   are	  shared	   among	   all	   RNA	   polymerases	   (Rpb5,	   6,	   8,	   10	   and	   12)	   and	   two	   between	  Pol	  I	  and	  Pol	  III	  (AC40	  and	  19),	  whereas	  all	  others	  are	  specific.	  Not	  all	  subunits	  are	  essential	  for	  transcriptional	  elongation,	  such	  as	  Rpb4,	  7	  and	  9	  in	  the	  case	  of	  Pol	  II.	   Although	   a	   plethora	   of	  mechanistic	   and	   structural	   details	   on	   eukaryotic	  RNA	  polymerases	   is	  described	  (Cramer	  et	  al,	  2008),	   the	  understanding	  of	   their	  “life	  cycle”	  beyond	  transcription,	  namely	  their	  biogenesis,	  nuclear	  translocation	  and	  degradation	  is	  only	  about	  to	  be	  developed	  (Cloutier	  &	  Coulombe,	  2010).	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Table	  1	  ⋅ 	  Subunits	  of	  RNA	  polymerases	  
RNA	  polymerase	   Pol	  I	   Pol	  II	   Pol	  III	   bacterial	  core	  subunits	  –	  largest/specific	   A190	   Rpb1	   C160	   β’	  	   A135	   Rpb2	   C128	   β	  –	  partially	  shared/α-­‐motif	  containing	   AC40	   Rpb3	   AC40	   α	  	   AC19	   Rpb11	   AC19	   α	  –	  specific	   A12.2*	   Rpb9*	   C11	   	  –	  shared	   ABC27	   ABC27	  (Rpb5)	   ABC27	   	  	   ABC23	   ABC23	  (Rpb6)	   ABC23	   ω*	  	   ABC14.5	   ABC14.5	  (Rpb8)	   ABC14.5	   	  	   ABC10β	   ABC10β	  (Rpb10)	   ABC10β	   	  	   ABC10α	   ABC10α	  (Rpb12)	   ABC10α	   	  Rpb4/7	  subcomplex	   A14*	   Rpb4*	   C17	   	  	   A43	   Rpb7	   C25	   	  TFIIF-­‐like	  subcomplex1	   A49*	   Tfg1	   C37	   	  	   A34.5*	   Tfg2	   C53	   	  Pol	  III-­‐specific	  subcomplex	   	   	   C82	   	  	   	   	   C34	   	  	   	   	   C31	   	  Number	  of	  subunits	   14	   12	   17	   5	  Molecular	  weight	  [kDa]	   589	   514	   693	   ~400	  	  
1(Geiger	  et	  al,	  2010),	  *subunit	  is	  not	  essential	  in	  YPD/LB	  medium	  in	  Saccharomyces	  cerevisiae/Escherichia	  coli	  	  	  
1.2 RNA	  polymerase	  II	  associated	  factors	  	   The	  central	  enzyme	  in	  eukaryotic	  transcription	  of	  protein-­‐coding	  genes	  is	  Pol	  II.	   To	   act	   in	   a	   regulated	  manner,	   Pol	  II	   is	   dependent	   on	   a	   series	   of	   factors.	  Most	  prominent	  are	  the	  general	  transcription	  factors	  (GTFs,	  TFIIA,	  B,	  D,	  E,	  F,	  H)	  that	   form	  the	  pre-­‐initiation	  complex	   together	  with	  Pol	  II	  and	   that	  are	  sufficient	  for	   basal	   transcription	   (Hahn,	   2004;	   Thomas	   &	   Chiang,	   2006).	   For	   activator-­‐dependent	   transcription	   additional	   cofactors	   such	   as	   the	  Mediator	   complex	   or	  TBP-­‐associated	   factors	   (TAFs)	   are	   required.	   Furthermore,	   while	   transcription	  proceeds	   Pol	  II	   is	   bound	   by	   factors	   involved	   in	   elongation,	   co-­‐transcriptional	  RNA	  processing,	  DNA	  repair	  and	  termination.	  Pol	  II	  in	  association	  with	  TFIIF	  is	  one	  of	  the	  major	  stable	  Pol	  II	  complexes	  in	  yeast	  (Rani	  et	  al,	  2004).	  About	  half	  of	  the	  polymerase	  is	  present	  in	  this	  form.	  Yeast	   TFIIF	   is	   made	   up	   of	   three	   subunits	   (Tfg1,	   2	   and	   3)	   and	   is	   involved	   at	  multiple	  steps	  in	  initiation	  such	  as	  recruiting	  Pol	  II	  to	  the	  promoter	  (Flores	  et	  al,	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1991),	   selection	   of	   the	   transcription	   start	   site	   together	   with	   TFIIB	   (Sun	   &	  Hampsey,	  1995),	  entry	  of	  TFIIE	  and	  TFIIH	  into	  the	  PIC	  (Flores	  et	  al,	  1992),	  DNA	  strand	  separation	  together	  with	  TFIIE	  (Coulombe	  &	  Burton,	  1999)	  and	  promoter	  escape	   (Yan	   et	   al,	   1999).	   Also	   several	   functions	   of	   TFIIF	   in	   elongation	   are	  described	  (Thomas	  &	  Chiang,	  2006).	  Only	  recently,	  mechanistic	  insight	  into	  transcriptional	  initiation	  has	  been	  gained	   with	   an	   atomic	   structure	   of	   TFIIB	   in	   complex	   with	   the	   polymerase	  (Kostrewa	  et	  al,	  2009).	  The	  structure	  rationalizes	  DNA	  opening,	  scanning	  for	  the	  transcription	  start	  site	  with	  a	  TFIIB	  region	  called	  the	  B-­‐reader,	  transition	  to	  RNA	  elongation,	  release	  of	  TFIIB	  from	  Pol	  II	  and	  finally	  elongation	  complex	  formation.	  Structurally,	  TFIIB	  extends	  from	  the	  Pol	  II	  dock	  domain	  via	  the	  RNA	  exit	  tunnel	  to	  the	  hybrid-­‐binding	  site	  and	  active	  centre,	  where	  the	  B-­‐reader	  is	  located,	  to	  the	  rudder	  and	  clamp	  coiled-­‐coil,	  and	  to	  the	  Pol	  II	  wall.	  Thus,	  Pol	  II	  binding	  factors	  are	  key	  to	  understand	  transcription.	  To	  better	  understand	   polymerase	   biology	   away	   from	   DNA,	   factors	   involved	   in	   these	  processes	  need	  to	  be	  identified	  and	  investigated.	  	  	  
1.3 Iwr1	  –	  Interact	  with	  RNA	  polymerase	  II	  
1.3.1 Iwr1	  in	  Saccharomyces	  cerevisiae	  	  In	   an	   attempt	   to	   comprehensively	   describe	   protein	   complexes	   in	  
Saccharomyces	   cerevisiae	   by	   a	   genome-­‐wide	   tandem-­‐affinity	   purification	   (TAP)	  and	  mass	  spectrometry	  (MS)	  identification	  approach	  an	  uncharacterized	  protein	  encoded	  by	  the	  ORF	  YDL115c	  was	  found	  to	  be	  co-­‐purified	  with	  TAP-­‐tagged	  Rpb3	  (Gavin	  et	  al,	  2002).	  Most	  other	  Pol	  II	  subunits	  as	  well	  as	  the	  TFIIF	  subunits	  Tfg1	  and	   Tfg2	   were	   identified	   in	   the	   same	   co-­‐purification.	   Accordingly,	   the	   protein	  was	   later	   named	   Interact	  With	   RNA	   polymerase	   II	   1	   (Iwr1).	   The	   association	   of	  Iwr1	  with	   Pol	  II	   and	   TFIIF	  was	   confirmed	   by	   a	   second	   genome-­‐wide	   TAP/MS-­‐study	  (Krogan	  et	  al,	  2006).	  In	   an	   earlier	   screen	   the	   deletion	   of	   YDL115c	   was	   found	   to	   cause	   a	  pleiotropic	  phenotype,	   suggesting	  a	  general	   function	  of	   the	  gene	   (Bianchi	   et	   al,	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2001).	   Moreover,	   the	   deletion	   strain	   showed	   an	   increased	   sensitivity	   to	   the	  antifungal	  protein	  K1	  killer	   toxin	   (Page	  et	   al,	   2003).	   In	   a	   study	  using	   synthetic	  genetic	   arrays	   (SGA)	   that	   concentrated	   on	   around	   800	   genes	   involved	   in	  chromatin	  biology,	  profiles	  were	  assigned	  to	  a	  certain	  gene	  that	  were	  made	  up	  of	  measured	   colony	   sizes	   of	   all	   double	   knock-­‐outs	   of	   that	   gene	   with	   each	   of	   the	  other	  genes	  under	   investigation.	  Based	   thereon,	   the	   IWR1	  profile	  was	   found	   to	  be	  most	  similar	  to	  the	  profiles	  of	  the	  Mediator	  components	  MED20	  and	  MED31,	  suggesting	  a	  critical	  role	  for	  properly	  regulated	  Pol	  II	  transcription	  (Collins	  et	  al,	  2007).	  Due	  to	  an	  unannotated	  intron	  in	  the	  IWR1	  gene	  the	  start	  of	   the	  protein-­‐coding	   region	   in	   the	  databases	  was	   initially	   incorrect.	  Although	   the	   intron	  was	  predicted	  bioinformatically	   (Brachat	   et	   al,	   2003)	   the	   annotation	  was	   corrected	  only	  after	  experimental	  prove	  became	  available	  (Juneau	  et	  al,	  2007).	  Recently,	   IWR1	   was	   found	   in	   a	   screen	   for	   suppressors	   of	   negative	   co-­‐factor	   2	   (NC2)	   requirement	   (Peiro-­‐Chova	  &	  Estruch,	   2009).	   In	   the	   same	   study,	  the	   fusion	   protein	   LexA-­‐Iwr1	   was	   shown	   to	   be	   competent	   in	   transcriptional	  activation	   in	  a	  strain	  carrying	   the	  HIS3	  and	   lacZ	  reporters	   that	  both	   included	  a	  LexA	  binding	  site	  in	  their	  promoter.	  Also,	  ChIP/RT-­‐PCR	  experiments	  with	  a	  TAP-­‐,	  HA-­‐	   and	   myc-­‐tagged	   version	   of	   Iwr1	   were	   performed	   on	   promoters	   of	   genes	  (ARG1,	  PHO5,	  SUC2)	   that	   showed	   the	  highest	   fold-­‐change	   in	  a	  gene	  expression	  profile	   of	   the	  Δiwr1	   strain	   (compared	   to	  wild	   type).	   Although	   the	   presence	   of	  Iwr1	   at	   the	   promoter	   remained	   unconfirmed,	   Iwr1	   was	   suggested	   to	   be	   a	  transcription	  factor.	  Iwr1	   possesses	   a	   leucine-­‐rich	   nuclear	   export	   sequence	   (NES)	   (Peiro-­‐Chova	  &	  Estruch,	  2009).	  Upon	  deletion	  of	  the	  NES	  or	  in	  a	  temperature	  sensitive	  Xpo1	   nuclear	   export	   factor	   strain	   under	   non-­‐permissive	   conditions,	   Iwr1-­‐GFP	  shows	  an	  altered	  localization	  that	  changes	  from	  pan-­‐cellular	  in	  wild	  type	  cells	  to	  nuclear	  in	  the	  mutants.	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1.3.2 Iwr1	  homologues	  in	  plants	  	  In	  Arabidopsis	  thaliana	  DMS4,	  the	  homologue	  to	  yeast	  IWR1,	  was	  found	  in	  a	   screen	   for	   factors	   involved	   in	   RNA-­‐directed	   DNA	   methylation	   (RdDM)	   in	   a	  developmental	   context	   (Kanno	   et	   al,	   2010).	   Unlike	   other	   mutants	   defective	   in	  RdDM,	  dms4	  mutants	  have	  a	  pleiotropic	  developmental	  phenotype.	  DMS4	  cDNA	  partially	   complements	   the	   K1	   killer	   toxin	   hypersensitivity	   of	   the	   yeast	   Δiwr1	  strain,	   suggesting	   some	   functional	   conservation.	  Mutations	   in	  DMS4	  directly	  or	  indirectly	   affect	   Pol	  IV-­‐dependent	   secondary	   siRNAs,	   Pol	  V-­‐mediated	   RdDM,	  Pol	  V-­‐dependent	  synthesis	  of	   intergenic	  noncoding	  RNA	  and	  altered	  expression	  of	  many	  Pol	  II	  driven	  genes.	  A	  second	  study	  in	  Arabidopsis	  thaliana	  made	  similar	  observations.	   There,	   RDM4,	   identical	   with	   DMS4,	   is	   additionally	   shown	   to	  physically	   interact	   with	   Pol	  V	   (He	   et	   al,	   2009).	   Therefore,	   DMS4	   may	   be	   a	  regulatory	  factor	  for	  multiple	  RNA	  polymerases	  in	  plants.	  However,	  Pol	  IV/V	  are	  more	  similar	  to	  Pol	  II,	  than	  to	  Pol	  I	  or	  Pol	  III	  (Herr	  et	  al,	  2005;	  Kanno	  et	  al,	  2005).	  	  	  
1.4 The	  “life	  cycle”	  of	  RNA	  polymerases	  	  Although	   a	   detailed	   understanding	   about	   the	   structural	   and	   functional	  aspects	  of	  RNA	  polymerases	  in	  general	  and	  Pol	  II	  in	  particular	  has	  been	  reached	  (Cramer	   et	   al,	   2008),	  much	   remains	   to	  be	   learnt	   about	   the	   “life	   cycle”	   of	   these	  intricate	   cellular	   machines.	   Their	   biogenesis,	   nuclear	   translocation	   and	  degradation	   are	   poorly	   or	   at	   best	   fragmentarily	   investigated.	   Here,	   a	  comprehensive	  review	  is	  attempted,	  summing	  up	  the	  current	  knowledge	  on	  RNA	  polymerase	  biogenesis	  and	  degradation.	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1.4.1 Biogenesis	  	  Already	   in	   the	   early	   seventies	   the	   first	   studies	   on	   Escherichia	   coli	   RNA	  polymerase	   assembly	   were	   performed	   (Ishihama	   &	   Ito,	   1972).	   After	   complete	  dissociation	  of	  bacterial	  RNA	  polymerase	   in	  6	  M	  urea,	   subunits	  were	  separated	  by	  successive	  column	  chromatography	  and	  binary	  combinations	  for	  reassembly	  were	   tested.	   A	   significant	   interaction	  was	   observed	   only	   between	   the	  α	   and	  β	  subunits,	   and	   the	   complex	   formed	   was	   found	   to	   have	   the	   composition	   α2β.	  Addition	   of	   the	   dialysed	   β’	   subunit	   converted	   this	   complex	   into	   the	   complete	  enzyme,	   suggesting	   that	   the	   assembly	   of	   bacterial	   RNA	   polymerase	   is	   a	  sequential	  process:	  	  	   	   	   	   +β	   	   +β’	   	  2	  α	   →	   α2	   →	   α2β	   →	   α2ββ’	  	  Later	   on,	   the	   in	   vitro	   assembly	   pathway	  was	   confirmed	   in	   vivo	  with	   the	  use	  of	  pulse-­‐labelling	  experiments,	   temperature	  sensitive	  core	  subunit	  mutants	  and	   the	   identification	   of	   assembly	   intermediates	   in	   cell	   extracts	   (Ishihama,	  1981).	  Due	  to	  the	  high	  structural	  conservation	  between	  eukaryotic	  and	  bacterial	  RNA	  polymerases	   (Cramer	   et	   al,	   2001),	   these	   findings	   later	   turned	   out	   to	   be	   a	  valid	   starting	   point	   for	   eukaryotic	   RNA	   polymerase	   assembly.	   Dissociation	  experiments	  with	  yeast	  Pol	  II	  yielded	  an	  Rpb2/3/11	  subassembly	  that	  was	  stable	  at	   6	  M	   urea	   (Kimura	   et	   al,	   1997).	   At	   a	   lower	   concentration	   of	   4	  M	   urea	   a	  substoichiometric	   level	   of	   Rpb10	   was	   bound	   to	   the	   Rpb2/3/11	   subassembly,	  while	   substoichiometric	   levels	   of	   Rpb8	   were	   bound	   to	   Rpb1.	   The	   use	   of	  temperature	   sensitive	   assembly	   mutants	   of	   Rpb1,	   Rpb2	   and	   Rpb3	   led	   to	   the	  identification	  of	  Rpb2/3	  as	  an	  early	  subcomplex	   in	  pulse-­‐labelling	  experiments	  (Kolodziej	   &	   Young,	   1991).	   A	   western	   blot	   based	   quantification	   of	   all	   Pol	  II	  subunits	  in	  Schizosaccharomyces	  pombe	  revealed	  that	  Rpb3	  is	  least	  abundant	  and	  limiting	   for	   complex	   formation	   (Kimura	   et	   al,	   2001).	   The	   two	   largest	   subunits	  and	  Rpb7	  were	  present	  at	  up	  to	  two-­‐fold	  higher	   levels.	  Rpb4	  was	  eleven	  times,	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Rpb9	  and	  Rpb11	  were	  four	  times,	  and	  the	  common	  subunits	  (Rpb5,	  6,	  8,	  10	  and	  12)	   were	   seven	   to	   fifteen	   times	   more	   abundant	   than	   Rpb3.	   Again,	   the	   tight	  association	  of	  Rpb3	  and	  Rpb2	  could	  be	  confirmed,	  as	  overexpressed	  Rpb3	  ended	  up	  in	  complex	  with	  Rpb2.	  Smaller	  subunits	  (Rpb4	  to	  Rpb12)	  were	  also	  identified	  in	  unassembled	  form	  by	  glycerol	  gradient	  centrifugation,	  meaning	  that	  they	  can	  exist	  at	  least	  temporarily	  in	  free	  form	  in	  the	  cell.	  With	  Rpb1,	  Rpb2	  and	  Rpb3/11	  being	  the	  homologues	  of	  the	  bacterial	  β’,	  β	  and	  α	  subunits,	  respectively,	  the	  yeast	  subcomplexes	  are	  in	  agreement	  with	  the	  assembly	  pathway	  derived	  for	  bacteria.	  	  The	  common	  subunits	  of	  Pol	  I	  and	  Pol	  III,	  AC40	  and	  AC19,	  which	  share	  the	  bacterial	   α	   motif	   with	   Rpb3	   and	   Rpb11	   were	   found	   upon	   mutation	   to	   be	  extragenetically	  suppressed	  by	  the	  shared	  subunit	  ABC10β	   (Rpb10)	  (Lalo	  et	  al,	  1993).	  This	  is	  in	  agreement	  with	  Rpb10	  binding	  to	  the	  Rpb2/3/11	  subassembly	  and	  could	  be	  an	  indication	  of	  a	  conserved	  assembly	  pathway	  among	  eukaryotic	  RNA	  polymerases.	  Another	   shared	   subunit,	  ABC10α	   (Rpb12),	   is	  unique	   in	   the	   respect,	   that	  diploid	   cells	   containing	   only	   one	   functional	   gene	   copy	   have	   a	   partial	   growth	  defect	  (Rubbi	  et	  al,	  1999).	  Preventing	  de	  novo	  expression	  of	  ABC10α	   leads	   to	  a	  parallel	   decrease	   in	   all	   RNA	   polymerase	   transcription	   followed	   by	   complete	  growth	  arrest.	  A	  certain	  ABC10α	  double	  mutant	  exhibits	  a	  temperature	  sensitive	  phenotype	   at	   37	  °C	   which	   is	   characterized	   by	   declining	   Pol	  III	   levels	   and	  impaired	  Pol	  III	  transcription	  of	  tRNAs.	  As	  the	  specific	  activity	  and	  heat	  stability	  of	  Pol	  III	  with	  wild-­‐type	  and	  mutated	  ABC10α	  are	  identical	  and	  considering	  the	  ABC10α	  requirement	  for	  Pol	  II,	  and	  I	  a	  critical	  role	  of	  ABC10α	  in	  the	  assembly	  of	  all	  three	  RNA	  polymerases	  has	  been	  proposed.	  The	   common	   subunit	   Rpb6	   and	   its	   bacterial	   homologue	   ω	   have	   been	  implicated	   in	  RNA	  polymerase	  assembly	  and	  stability	   (Minakhin	  et	  al,	  2001).	  A	  “latching	  mechanism”	  has	  been	  proposed	  in	  which	  Rpb6/ω	  stabilizes	  the	  N-­‐	  and	  C-­‐terminus	  of	  the	  largest	  subunit,	  facilitating	  its	  association	  with	  the	  Rpb2/3/11	  or	  α2β	  assembly	  intermediate,	  respectively.	  Overexpression	  of	  Rpb6	  suppresses	  the	  phenotype	  of	   the	   temperature	  sensitive	  Rpb1-­‐1	  mutant	   (Nonet	  et	  al,	  1987)	  that	   is	   characterized	   by	   immediate	   transcriptional	   shutdown	   at	   elevated	  temperatures,	  underpinning	  the	  relevance	  of	  Rpb6	  for	  the	  stability	  of	  the	  formed	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complex.	   A	   comparison	   of	   protein	   levels	   between	   different	   growth	   phases	  uncovered	  that	  absolute	  Rpb6	  levels	  decreased	  to	  only	  about	  60%	  in	  stationary	  phase	   as	   compared	   to	   exponential	   phase,	   while	   all	   other	   Pol	  II	   subunits	  decreased	   to	   40	   to	   50%,	   which	   was	   interpreted	   in	   light	   of	   its	   alleged	   role	   in	  assembly	  (Sakurai	  &	  Ishihama,	  2002).	  In	   earlier	   studies	   dedicated	   to	   the	   assembly	   of	   Pol	  II,	   the	   distinction	  between	  the	  structure,	   i.e.	  the	  final	  spatial	  configuration	  of	  the	  complex,	  and	  its	  biogenesis,	  i.e.	  the	  process	  of	  building	  the	  complex	  over	  time,	  was	  blurred.	  Pair-­‐wise	   interactions	   between	   Rpb	   subunits	   were	   probed	   with	   far-­‐western	   and	  cross-­‐linking	   experiments,	   that	   led	   to	   structural	   insight	   but	   left	   question	   of	  biogenesis	   unanswered	   (Ishiguro	   et	   al,	   1998).	   By	   these	   means,	   the	   Rpb3/11	  
heterodimer	  of	   the	  core	  polymerase	  was	   identified	  which	  was	  distinct	   from	  the	  homologous	  α2	  homodimer	   in	   bacterial	   RNA	   polymerase	   (Yasui	   et	   al,	   1998).	   A	  core	  Pol	  II	  backbone	  model	   finally	  answered	  all	   remaining	  structural	  questions	  and	  provided	  a	  framework	  to	  validate	  subunit	   interaction	  data	  available	  at	  that	  time	   (Cramer	   et	   al,	   2000).	   Importantly,	   the	   possibility	   of	   an	   Rpb3/11/10	  assembly	   intermediate	   that	   was	   tightly	   associated	   with	   the	   second	   largest	  subunit	   Rpb2	   was	   structurally	   confirmed.	   Also,	   the	   critical	   role	   of	   the	   shared	  subunit	  ABC10α	  (Rpb12)	  (Rubbi	  et	  al,	  1999)	  was	  rationalized	  by	  the	  core	  Pol	  II	  backbone	   model,	   as	   Rpb12	   bridges	   between	   Rpb2	   and	   the	   Rpb3/11/10	  subassembly.	   By	   stabilizing	   the	   interaction	   between	   the	   second	   largest	   and	  α-­‐motif-­‐containing	   subunits,	   ABC10α	   appears	   to	   play	   an	   essential	   role	   in	   the	  assembly	  or	  maintenance	  of	  all	  eukaryotic	  RNA	  polymerases.	  Biogenesis	   of	   eukaryotic	   RNA	   polymerases	   probably	   involves	   more	  players	   than	   the	   subunits	   making	   up	   the	   final	   enzyme.	   Attempts	   to	  recombinantly	  express	  Pol	  II	  failed	  (Kimura	  &	  Ishihama,	  2000).	  Expression	  trials	  in	   insect	   cells	   did	   not	   yield	   functional	   Pol	  II,	   little,	   if	   any,	   complete	   complexes	  could	   be	   obtained	   and	  mostly	   subcomplexes	   without	   the	   two	   largest	   subunits	  were	   purified.	   The	   reason	   seems	   to	   lie	   in	   the	   requirement	   for	   chaperone	  assistance	   during	   the	   folding	   of	   the	   largest	   subunits.	   As	   published	   during	   the	  course	  of	   this	  work	  and	   inferred	   from	  a	  mass	   spectrometry-­‐based	  quantitative	  proteomic	   approach	  HSP90	   activity	   stabilizes	   incompletely	   assembled	   Rpb1	   in	  the	   cytoplasm	   of	   human	   cells	   (Boulon	   et	   al,	   2010).	   Further,	   the	   HSP90	   co-­‐
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chaperone	  hSpagh	  (RPAP3)	  as	  well	  as	  the	  R2TP/prefoldin-­‐like	  complex	  bind	  to	  a	  cytoplasmic	  complex	  of	  Rpb1	  and	  Rpb8,	  confirming	  this	  assembly	   intermediate	  (Kimura	   et	   al,	   1997).	   hSpagh	   (RPAP3)	  was	   also	   found	   to	   bind	   free	   Rpa194	   of	  Pol	  I,	   suggesting	   a	   general	   role	   in	   assembling	   RNA	   polymerases.	   In	   agreement	  with	   previous	   data	   (Cramer	   et	   al,	   2000;	   Kimura	   et	   al,	   1997),	   a	   cytoplasmic	  Rpb2/3/11/10/12	   subcomplex	   was	   identified.	   Importantly,	   the	   site	   of	   Pol	  II	  assembly	   was	   described	   to	   be	   the	   cytoplasm.	   Depletion	   of	   any	   Pol	  II	   subunit	  resulted	  in	  cytoplasmic	  accumulation	  of	  Rpb1,	  which	  was	  resistant	  to	  proteolytic	  degradation	   after	   addition	   of	   α-­‐amanitin.	   As	   α-­‐amanitin	   specifically	   promotes	  degradation	  of	  the	  elongating	  form	  of	  Pol	  II	  (Nguyen	  et	  al,	  1996),	  Rpb1	  needs	  to	  correspond	  to	  newly	  synthesized	  protein	  and	  therefore	  Pol	  II	  assembly	  entirely	  has	   to	   take	  place	   in	   the	  cytoplasm	  and	  requires	   the	  presence	  of	  all	  polymerase	  subunits.	  In	   summary,	   there	   seems	   to	  be	   a	   consistent	   understanding	  on	   the	   step-­‐wise	  association	  of	  polymerase	  subunits	  and	  the	  assembly	  intermediates	  formed.	  However,	  to	  which	  extent	  these	  associations	  are	  regulated	  by	  additional	  factors	  and	   at	   which	   steps	   the	   assistance	   of	   chaperones	   is	   needed	   remains	   elusive.	  Ultimately,	   a	   structural	   understanding	   of	   defined	   assembly	   intermediates	   in	  complex	  with	  auxiliary	  factors	  is	  needed.	  	  	  
1.4.2 Degradation	  	  Pol	  II	   subunits	   have	   individual	   half-­‐lives,	   with	   estimates	   ranging	   from	  22	  min	  for	  Rpb1	  to	  87	  min	  for	  Rpb9,	  while	  the	  shared	  subunits	  Rpb6,	  Rpb8	  and	  Rpb12	  were	  described	  as	  stable	  (within	  the	  course	  of	  the	  measurement)	  (Belle	  et	  al,	  2006).	  In	  terms	  of	  protein	  degradation,	  these	  individual	  half-­‐lives	  suggest	  an	  individual	  fate	  of	  each	  subunit	  as	  opposed	  to	  proteolysis	  of	  the	  Pol	  II	  complex	  as	  a	  whole.	  How	  this	  basal	  turnover	  of	  Pol	  II	  subunits	  is	  achieved	  and	  regulated	  has	  not	   been	   investigated	   in	   detail.	   Most	   studies	   focused	   on	   targeted	   Pol	  II	  degradation	   after	   DNA	   damage	   or	   treatment	   of	   cells	   with	   transcriptional	  inhibitors	   such	   as	  α-­‐amanitin,	   actinomycin	   D	   or	   6-­‐azauracil	   (Beaudenon	   et	   al,	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1999;	  Harreman	  et	  al,	  2009;	  Nguyen	  et	  al,	  1996;	  Ribar	  et	  al,	  2007;	  Somesh	  et	  al,	  2005;	  Somesh	  et	  al,	  2007;	  Woudstra	  et	  al,	  2002).	  Treatment	   of	   cells	  with	  α-­‐amanitin	   led	   to	   specific	   degradation	   of	   Rpb1,	  while	  the	  shared	  subunits	  Rpb5	  and	  Rpb8	  were	  almost	  unaffected	  (Nguyen	  et	  al,	  1996).	   The	   dependence	   of	   degradation	   on	   elongation	   was	   inconclusive	   as	   the	  transcriptional	   inhibitor	   actinomycin	  D	   abolished	   α-­‐amanitin	   induced	   Rpb1	  degradation	   as	   opposed	   to	   another	   inhibitor,	   5,6-­‐dichloro-­‐1-­‐β-­‐D-­‐ribofuranosyl-­‐benzimidazole	  (DRB),	  that	  did	  not.	  When	  Pol	  II	   encounters	   a	  DNA	   lesion,	   the	  damage	   is	   either	   immediately	  repaired	   by	   transcription-­‐coupled	   nucleotide	   excision	   repair	   (TCR)	   or	   Pol	  II	  (Rpb1)	  is	  degraded	  to	  allow	  for	  other	  repair	  pathways,	  such	  as	  general	  (global)	  genome	   repair	   to	   take	   place	   (Selth	   et	   al,	   2010).	   In	  mammalian	   cells,	   defective	  TCR	  gives	   rise	   to	   the	  severe	  human	  disorder	  Cockayne’s	   syndrome	  (CS).	  A	   link	  between	   TCR	   and	   DNA	   damage-­‐induced	   Pol	  II	   degradation	   is	   provided	   by	   the	  factor	  Def1	  that	   forms	  a	  complex	  with	  the	  TCR	  factor	  Rad26/CSB	  (Woudstra	  et	  al,	  2002).	  Rad26	  promotes	  TCR	  in	  conjunction	  with	  CSA	  and	  delays	  Def1	  induced	  Pol	  II	   degradation.	   Deletion	   of	   Def1	   in	   yeast	   leads	   to	   impaired	   DNA	   damage-­‐induced	   Pol	  II	   degradation	   and	   to	   increased	   6-­‐azauracil	   sensitivity	   that	   is	  comparable	  to	  DST1	  (TFIIS)	  deletion	  cells.	  In	  an	  in	  vitro	  reconstituted	  system	  it	  was	   shown	   that	  Def1	   binds	   to	   Pol	  II	   in	   a	  DNA	   damage-­‐dependent	  manner	   and	  that	  it	  is	  directly	  involved	  in	  ubiquitination	  of	  Pol	  II	  (Reid	  &	  Svejstrup,	  2004).	  Two	   ubiquitin	   ligases	   have	   been	   found	   to	   be	   responsible	   for	  ubiquitination	  of	  Pol	  II.	  The	  first,	  Rsp5,	  is	  an	  essential	  HECT	  domain	  E3	  ubiquitin	  ligase	   that	   was	   shown	   to	   bind	   the	   Rpb1	   CTD	   from	   35S-­‐labeled	   yeast	   extracts	  (Huibregtse	  et	  al,	  1997)	  and	  to	  ubiquitinate	  Rpb1	  upon	  UV-­‐induced	  DNA	  damage	  (Beaudenon	   et	   al,	   1999).	   Basal	   levels	   of	   Rpb1	   ubiquitination	   were	   found	   in	  normally	  growing	  cells,	  suggesting	  that	  this	  specific	  degradation	  pathway	  might	  also	  play	  a	  role	   in	  constitutive	  turnover	  of	   the	   largest	  subunit.	  In	  vitro	  arrested	  Pol	  II	  elongation	  complexes	  were	  shown	  to	  be	  the	  preferred	  substrates	  for	  Rpb1	  ubiquitination	   by	  Rsp5	  with	   further	   stimulation	   by	  Def1	   (Somesh	   et	   al,	   2005).	  Serine	   5	   phosphorylation	   of	   the	   Pol	  II	   CTD,	   that	   is	   typical	   for	   initiating	   Pol	  II,	  inhibited	   ubiquitination,	  while	   Serine	   2	   phosphorylation,	   providing	   a	  mark	   for	  elongating	   Pol	  II,	   did	   not.	   Even	   deceleration	   of	   elongation	   by	   6-­‐azauracil	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augmented	   Rpb1	   labelling	   with	   ubiquitin.	   This	   led	   to	   the	   general	   view,	   that	  arrested	   or	   paused	   Pol	  II	   is	   preferentially	   targeted	   for	   ubiquitination	   and	   that	  immobile	   polymerases	   at	   the	   promoter	   are	   protected	   by	   a	   serine	   5	  phosphorylation	  mark	  on	   the	  Rpb1	  CTD.	  Mechanistically,	  each	  of	   the	   two	  Pol	  II	  ubiquitination	  sites	  on	  Rpb1	  (K330	  and	  K695)	  is	  bound	  by	  one	  Ubc5	  protein	  (a	  ubiquitin	  conjugating	  enzyme,	  E2)	  until	  ubiquitin	  transfer	  is	  triggered	  when	  both	  Ubc5	  proteins	  simultaneously	  form	  a	  complex	  with	  an	  Rsp5	  dimer	  bound	  to	  the	  Rpb1	  CTD	  (Somesh	  et	  al,	  2007).	  The	   second	   E3	   ubiquitin	   ligase	   acting	   on	   Pol	  II	   is	   the	   elongin-­‐cullin	  complex	   (Elc1,	   Ela1,	   Cul3,	   Roc1	   in	   yeast),	   which	   has	   been	   shown	   to	   promote	  Rpb1	  lysine	  48-­‐linked	  polyubiquitination	  (Ribar	  et	  al,	  2007)	  –	  the	  mark	  for	  26S	  proteasomal	   degradation.	   The	   distinct	   roles	   of	   the	   two	   Pol	  II	   ubiquitin	   ligases,	  Rsp5	  and	   the	  elongin-­‐cullin	  complex	  have	  been	  unravelled	   lately	   (Harreman	  et	  al,	  2009).	  Rsp5	  either	  leads	  to	  mono-­‐	  or	  lysine	  63-­‐linked	  polyubiquitination	  that	  is	  trimmed	  to	  mono-­‐ubiquitination	  by	  the	  ubiquitin	  protease	  Ubp2.	  Based	  on	  this	  mono-­‐ubiquitin	   moiety	   the	   elongin-­‐cullin	   complex	   catalyzes	   formation	   of	   an	  ubiquitin	  chain	  linked	  via	  lysine	  48,	  which	  triggers	  proteolysis.	  This	  cooperation	  of	  two	  sequentially	  acting	  ubiquitin	  ligases	  possibly	  forms	  a	  checkpoint	  to	  ensure	  Rpb1	  degradation	  only	  when	  it	  is	  indeed	  required.	  	  Although	   intricate	   mechanistic	   insights	   have	   been	   obtained	   about	  scheduled	   proteolysis	   of	   Rpb1,	   open	   questions	   remain.	   Does	   targeting	   for	  degradation	   also	   take	   place	   away	   from	   DNA?	   Are	   non-­‐degraded	   subunits	  recycled	  and	  re-­‐assembled	  into	  new	  complexes	  in	  the	  cytoplasm,	  as	  has	  recently	  been	  suggested	  (Boulon	  et	  al,	  2010)?	  To	  put	  it	  more	  broadly,	  in	  which	  ways	  and	  via	   which	   nuclear	   import	   and	   export	   pathways	   are	   Pol	  II	   biogenesis	   and	  degradation	  intertwined?	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1.5 Nuclear	  traffic,	  karyopherins	  and	  transcription	  
1.5.1 Nuclear	  traffic	  and	  karyopherins	  	   All	   traffic	   into	   and	   out	   of	   the	   nucleus	   passes	   through	   nuclear	   pore	  complexes	  (NPCs)	  (Chook	  &	  Blobel,	  2001;	  Mosammaparast	  &	  Pemberton,	  2004;	  Pemberton	   &	   Paschal,	   2005).	   These	   large	   multiprotein	   assemblies	   with	   an	  approximate	  molecular	  weight	  of	  60	  MDa	   in	  yeast	  and	  125	  MDa	   in	  mammalian	  cells	   restrict	   the	   size	   of	   macromolecules	   that	   can	   freely	   diffuse	   between	   the	  nucleus	  and	  the	  cytoplasm.	  Above	  a	  molecular	  weight	  of	  around	  40	  kDa	  proteins	  need	  to	  be	  recognized	  as	  cargo	  by	  karyopherins	  that	  mediate	  transport	  through	  the	   NPC	   by	   interacting	   with	   its	   nucleoporins.	   While	   yeast	   cells	   contain	   14	  karyopherins,	   in	   human	   cells	   this	   family	   comprises	   at	   least	   20	  members.	  Most	  karyopherins	  are	  either	  importins	  or	  exportins,	  the	  name	  reflecting	  the	  direction	  in	  which	  cargo	  is	  translocated	  relative	  to	  the	  nucleus.	  The	   best	   characterized	   adaptor	   protein	   is	   importin-­‐α/importin-­‐β	  (Kap60/Kap95	  in	  yeast),	  which	  is	  special	  in	  the	  respect	  that	  importin-­‐β	  does	  not	  bind	   its	   cargo	   directly,	   like	   other	   karyopherin-­‐β	   family	   members,	   but	   rather	  needs	  importin-­‐α	  as	  an	  adaptor	  protein.	  Importin-­‐α	  recognizes	  and	  binds	  to	  the	  so-­‐called	  basic	  or	  classical	  nuclear	  localization	  sequence	  (NLS)	  that	  has	  initially	  been	  characterized	  from	  the	  SV40	  large	  T	  antigen	  and	  from	  nucleoplasmin.	  This	  NLS	   is	   either	  mono-­‐	   or	   bipartite,	  meaning	   that	   it	   consists	   of	   either	   one	   or	   two	  clusters	  of	  basic	  amino	  acids	  separated	  by	  a	  linker.	  The	  classical	  NLS	  has	  recently	  been	   characterized	  by	   systematic	  mutations	   and	  measurement	  of	   the	   resultant	  signal	  strength	  in	  import	  assays	  (Kosugi	  et	  al,	  2009a)	  providing	  quantitative	  data	  for	   a	   bioinformatic	   NLS	   identification	   program	   that	   goes	   beyond	   simple	  motif	  search	   (Kosugi	   et	   al,	   2009b).	   The	  NLS	   recognized	   by	   other	   karyopherin-­‐βs	   are	  harder	   to	   define,	   like	   the	   relatively	   large	  M9	  NLS,	  which	   consists	   of	   38	   a.	  a.,	   is	  glycine-­‐rich	   and	   deficient	   in	   basic	   amino	   acids	   (Pollard	   et	   al,	   1996).	   In	   other	  cases,	   the	   three-­‐dimensional	   structure	   of	   the	   protein	   seemed	   to	   be	   critical	  (Rosenblum	  et	  al,	  1998).	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The	  best	  characterized	  exportin	  is	  CrmI	  (Xpo1	  in	  yeast),	  which	  recognizes	  leucine	   rich	  nuclear	  export	   sequences	   (NES)	   that	  are	  utilized	  by	  all	   eukaryotes	  (Fornerod	  et	  al,	  1997;	  Stade	  et	  al,	  1997).	  These	  hydrophobic	  NES	  sequences	  are	  loosely	   conserved	   containing	   three	   to	   four	   hydrophobic	   residues	   in	   close	  proximity.	  Like	  the	  classical	  NLS	  they	  can	  be	  identified	  by	  bioinformatic	  means,	  though	  are	  harder	  to	  predict	  (la	  Cour	  et	  al,	  2004).	  Directionality	  of	  nuclear	  transport	  depends	  on	  a	  RanGTP	  gradient	  that	  is	  characterized	  by	  a	  high	  concentration	  in	  the	  nucleus	  and	  a	  low	  concentration	  in	  the	   cytoplasm	   (Chook	   &	   Blobel,	   2001;	   Mosammaparast	   &	   Pemberton,	   2004;	  Pemberton	  &	  Paschal,	  2005).	  Importins	  release	  their	  cargo	  upon	  RanGTP	  binding	  in	  the	  nucleus,	   leading	  to	  recycling	  of	  the	  importin	  to	  the	  cytoplasm.	  There,	  the	  intrinsic	  GTPase	  activity	  of	  Ran	   is	   stimulated	  by	  Ran	  GTPase	  activating	  protein	  (RanGAP),	  leading	  to	  hydrolysis	  of	  GTP	  to	  GDP	  and	  release	  of	  RanGDP	  from	  the	  importin.	  RanGDP	  is	   then	  transported	  back	  to	  the	  nucleus	  by	   its	  proper	   import	  factor	   NTF2.	   GDP	   is	   exchanged	   for	   GTP	   by	   Ran	   guanine	   nucleotide	   exchange	  factor	   (RanGEF),	   which	   is	   bound	   to	   chromatin,	   maintaining	   a	   high	   RanGTP	  concentration	  in	  the	  nucleus.	  Contrarily	  to	  importins,	  exportins	  need	  RanGTP	  to	  bind	  their	  cargo	  in	  a	  ternary	  complex.	  In	  the	  cytoplasm	  they	  release	  their	  cargo	  upon	  Ran	  GTP	  hydrolysis.	  	  	  
1.5.2 Nuclear	  import	  of	  transcriptional	  factors	  	  Research	   on	   nuclear	   transport	   already	   identified	   routes	   of	   several	  transcriptional	  factors	  into	  the	  nucleus.	  TFIIA	  has	  been	  shown	  to	  be	  imported	  by	  Kap122	   (Titov	  &	   Blobel,	   1999),	   TFIIS	   by	   Kap119	   (Albertini	   et	   al,	   1998),	   TFIIB	  and	  TBP	  by	  Kap114	   (Hodges	   et	   al,	   2005;	  Morehouse	   et	   al,	   1999)	   and	  TFIIF	  by	  Kap104	  (Suel	  &	  Chook,	  2009).	  None	  of	   these	  karyopherins	   is	  essential	   in	  yeast,	  although	   all	   of	   their	   cargoes	   listed	   here,	   with	   the	   exception	   of	   TFIIS,	   are,	  implicating	   a	   network	  of	   redundancy	   in	   import.	   Partly,	   this	   redundancy	   comes	  from	   promiscuous	   binding	   of	   karyopherins	   to	   different	   NLS	   sequences.	   In	  addition,	  a	  second	  level	  of	  redundancy	  is	  imaginable	  at	  the	  level	  of	  cargo,	  where	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proteins	   undergo	   transient	   interactions	   with	   each	   other	   and	   thereby	   are	   co-­‐imported	  into	  the	  nucleus.	  Interestingly,	  no	  NLS	  has	  been	  identified	  in	  any	  of	  the	  Pol	  II	  core	  subunits.	  Neither	   was	   a	   localisation	   signal	   or	   a	   karyopherin	   described	   for	   the	   Rpb4/7	  heterodimer	   that	  was	   reported	   to	  undergo	  nucleo-­‐cytoplasmic	   shuttling	   linked	  to	  a	  role	   in	  mRNA	  decay	   in	  the	  cytoplasm	  (Goler-­‐Baron	  et	  al,	  2008;	  Lotan	  et	  al,	  2005).	  Recently,	   a	   model	   was	   proposed	   in	   which	   the	   two	   largest	   subunits	   of	  Pol	  II	  are	  supposed	  to	  be	  imported	  separately	  from	  the	  smaller	  ones	  (Forget	  et	  al,	  2010).	  Based	  on	  a	  systematic	  protein	  affinity	  purification	  and	  mass	  spectrometry	  identification	   approach	   a	   protein	   interaction	   network	   for	   Pol	  II	   in	   the	   soluble	  fraction	  of	   human	  extracts	  was	   generated.	  One	  of	   the	  Pol	  II	   interacting	   factors,	  the	   GTPase	   RPAP4/GPN1	   was	   shown	   to	   shuttle	   between	   the	   nucleus	   and	   the	  cytoplasm.	   Depletion	   of	   the	   factor	   by	   siRNA	   resulted	   in	   cytoplasmic	  accumulation	   of	   Rpb1	   and	   Rpb2,	   while	   the	   smaller	   subunits	   were	   unaffected.	  Treatment	   of	   the	   cells	  with	   the	   CRM1	   exportin	   specific	   inhibitor	   leptomycin	   B	  trapped	  RPAP4/GPN1	  in	  the	  nucleus	  and	  also	  led	  to	  cytoplasmic	  accumulation	  of	  the	  two	  largest	  subunits.	  The	  essential	  RPAP4/GPN1	  homologue	  in	  yeast,	  Npa3,	  also	   bound	   Pol	  II	   and	  mutation	   of	   its	   3	   a.	  a.	   loop	   resulted	   in	   either	   lethality	   or	  slow	   growth	   and	   cytoplasmic	  mislocalization	   of	   Rpb1	   and	   Rpb2.	   Further,	   NP3	  mutants	  were	  hypersensitive	  to	  benomyl,	  an	  inhibitor	  of	  microtubule	  assembly.	  This	   finding	   might	   indicate	   the	   involvement	   of	   microtubules	   in	   Pol	  II	   nuclear	  import	  as	  it	  has	  been	  shown	  for	  other	  nuclear	  proteins	  (Pouton	  et	  al,	  2007).	  However,	   RPAP4/GPN1	   was	   reported	   to	   bind	   both	   Rpb1	   and	   the	  Rpb2/3/10/11/12	   assembly	   intermediate	   (Boulon	   et	   al,	   2010),	   making	   an	  earlier	   involvement	   in	   Pol	  II	   biogenesis	   and	   before	   nuclear	   import	   likely.	  Moreover,	   a	   separate	   import	  mechanism	   for	   the	   two	   largest	   subunits	   is	   not	   in	  good	  agreement	  with	  the	  well	  established	  Pol	  II	  assembly	  intermediates	  (Boulon	  et	   al,	   2010;	   Kimura	   et	   al,	   1997;	   Kimura	   et	   al,	   2001;	   Kolodziej	   &	   Young,	   1991;	  Minakhin	  et	  al,	  2001).	  Import	  of	  subcomplexes	  also	  contradicts	  the	  requirement	  for	  every	  single	  Pol	  II	  subunit	  to	  be	  present	  in	  the	  cytoplasm	  for	  Rpb1	  import	  in	  the	  context	  of	  the	  Pol	  II	  complex	  to	  occur	  (Boulon	  et	  al,	  2010).	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1.6 Aims	  of	  this	  study	  	  The	   identification	   of	   novel	   Pol	  II-­‐interacting	   factors	   always	   bears	   the	  promise	  to	  obtain	  new	  insights	  into	  RNA	  polymerase	  biology.	  In	  this	  respect,	  the	  
Saccharomyces	  cerevisiae	  protein	  encoded	  by	  the	  ORF	  YDL115c	  deserved	  special	  attention	   for	   two	   reasons.	   Firstly,	   as	   compared	   to	   most	   of	   the	   general	  transcription	  factors	  that	  on	  their	  own	  only	  weakly	  interact	  with	  Pol	  II,	  it	  forms	  a	  stable	   complex	   with	   the	   enzyme	   (Gavin	   et	   al,	   2002;	   Krogan	   et	   al,	   2006).	  Nevertheless	  Interact	  With	  RNA	  polymerase	  II	  1	  (Iwr1),	  as	  the	  protein	  encoded	  by	  YDL115c	   is	   named	   today,	   was	   described	   rather	   late	   in	   the	   history	   of	   RNA	  polymerase	  research.	  Secondly,	  deletion	  of	  the	  IWR1	  gene	  resulted	  in	  pleiotropic	  effects,	  implying	  a	  basic	  cellular	  function	  (Bianchi	  et	  al,	  2001;	  Page	  et	  al,	  2003).	  In	   this	   study,	   a	   both	   structural	   and	   functional	   approach	   was	   chosen	   to	  investigate	   Iwr1.	  Starting	  with	  a	  bioinformatic	  analysis	  of	   the	   Iwr1	  sequence,	  a	  potential	   N-­‐terminal	   nuclear	   localisation	   sequence	   (NLS)	   was	   identified	   (see	  3.1.1),	   which	   together	   with	   a	   published	   Iwr1	   nuclear	   export	   sequence	   (NES)	  (Peiro-­‐Chova	  &	  Estruch,	  2009)	  and	  Iwr1	  localization	  data	  from	  a	  proteome-­‐wide	  approach	   (Huh	   et	   al,	   2003)	   suggested	   nucleo-­‐cytoplasmic	   shuttling	   of	   the	  protein.	   Given	   this	   shuttling	   and	   tight	   binding	   of	   Iwr1	   to	   Pol	  II	   (see	   3.2.1),	   a	  hypothesis	   was	   drafted,	   in	   which	   Iwr1	   was	   proposed	   to	   be	   the	   central	   and	  specific	   factor	   for	  nuclear	   import	  of	  Pol	  II.	   Therefore,	   the	  dependency	  of	   the	   in	  
vivo	   localization	  of	  all	   three	  eukaryotic	  RNA	  polymerases	  on	   Iwr1	  and	  variants	  had	   to	   be	   assessed,	   both	   qualitatively	   and	   quantitatively	   in	   correlation	   with	  cellular	  growth	  rates	  (see	  3.1).	  Functional	  in	  vivo	  data	  was	  integrated	  with	  the	  in	  
vitro	   delineation	   of	   an	   Iwr1	   region	   sufficient	   for	   Pol	  II	   binding	   (see	   3.2.2).	  Structurally,	  the	  architecture	  of	  the	  Pol	  II-­‐Iwr1	  complex	  had	  to	  be	  elucidated	  by	  cryo-­‐EM	   (see	   3.3.1)	   and	   was	   supposed	   to	   be	   confirmed	   by	   competition	  experiments	  with	  nucleic	  acids	  (see	  3.3.2)	  and	  general	  transcription	  factors	  (see	  3.3.3).	  The	  notion	  of	   Iwr1	  being	   a	   transcription	   factor	   (Peiro-­‐Chova	  &	  Estruch,	  2009)	   had	   to	   be	   challenged	   and	   repudiated	   by	   in	   vitro	   transcription	   initiation	  assays	   (see	   3.4.1)	   and	   by	   gene	   expression	   analysis	   and	   extensive	   profile	  comparison	  (see	  3.4.3).	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2 Materials	  and	  Methods	  
2.1 Materials	  
2.1.1 Bacterial	  strains	  	  Bacterial	   strains	  used	   in	   this	   study	  are	   listed	   in	  Table	  2.	  XL-­‐1	  Blue	   cells	  were	   used	   for	   cloning	   purposes	   and	   BL21-­‐CodonPlus	   (DE3)	   RIL	   cells	   for	  recombinant	  protein	  expression.	  	  	  
Table	  2	  ⋅ 	  Escherichia	  coli	  strains	  
Strain	   Genotype	   Source	  XL-­‐1	  Blue	   rec1A,	  endA1,	  gyrA96,	  thi-­‐1,	  hsdR17,	  supE44,	  relA1,	  lac[F	  ́	  proAB	  lacIqZ∆M15	  Tn10(Tetr)]	   Stratagene	  BL21-­‐CodonPlus	  (DE3)	  RIL	   B,	  F−,	  ompT,	  hsdS(r	  −	  m	  −),	  dcm+,	  Tetr,	  gal	  λ(DE3),	  endA,	  Hte	  [argU,	  ileY,	  leuW,	  Camr]	   Stratagene	  	  	  
2.1.2 Yeast	  strains	  	  Yeast	  strains	  used	  in	  this	  study	  are	  listed	  in	  Table	  3.	  They	  were	  generated	  as	   part	   of	   this	   work,	   obtained	   from	   Euroscarf	   or	   received	   from	   other	  laboratories.	  Some	  stains	  were	  used	  for	  experiments	  that	  can	  be	  found	  in	  Elmar	  Czeko’s	  laboratory	  documentation	  and	  that	  are	  not	  discussed	  in	  this	  thesis	  (PCY	  IDs	  233,	  234,	  247	  and	  248).	  	  	  
Table	  3	  ⋅ 	  Saccharomyces	  cerevisiae	  strains.	  PCY	  IDs	  (Patrick	  Cramer	  Yeast	  Identifiers)	  refer	  to	  the	  laboratory	  collection.	  
PCY	  ID	   Strain	   Genotype	   Source	  047	   wild-­‐type	  (haploid)	   BY4742;	  MATa	  his3∆1	  leu2∆0	  lys2∆0	  ura3∆0	   Euroscarf	  Y10000	  068	   wild-­‐type	  (diploid)	   BY4743;	  MATa/α	  his3∆0/his3∆0	  leu2∆0/leu2∆0	  met15∆0/MET15	  
lys2∆0/LYS2	  ura3∆0/ura3∆0	   Euroscarf	  Y20000	  231	   iwr1∆	   BY4742;	  iwr1::kanMX4	   this	  work	  232	   iwr1∆,	  rpb4∆	   BY4742;	  iwr1::kanMX4	  rpb4::natMX4	   this	  work	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PCY	  ID	   Strain	   Genotype	   Source	  233	   tfg2∆	   BY4742;	  MATa	  or	  α	  lys2∆0	  or	  LYS2	  met15∆0	  or	  MET15	  
tfg2::natMX4;	  pRS316:	  URA3	  TFG2	   this	  work	  234	   iwr1∆,	  tfg2∆	   BY4742;	  MATa	  or	  α	  lys2∆0	  or	  LYS2	  met15∆0	  or	  MET15	  
iwr1::kanMX4	  tfg2::natMX4;	  pRS316:	  URA3	  TFG2	   this	  work	  235	   Rpb1-­‐EGFP	   BY4742;	  rpb1::RPB1-­‐EGFP-­‐HIS3MX6	   this	  work	  236	   Rpb1-­‐EGFP,	  iwr1∆	   BY4742;	  rpb1::RPB1-­‐EGFP-­‐HIS3MX6	  iwr1::kanMX4	   this	  work	  237	   Rpb3-­‐EGFP	   BY4742;	  rpb3::RPB3-­‐EGFP-­‐HIS3MX6	   this	  work	  238	   Rpb3-­‐EGFP,	  iwr1∆	   BY4742;	  iwr1::kanMX4	  rpb3::RPB3-­‐EGFP-­‐HIS3MX6	   this	  work	  239	   Rpb3-­‐EGFP,	  rpb4∆	   BY4742;	  rpb3::RPB3-­‐EGFP-­‐HIS3MX6	  rpb4::natMX4	   this	  work	  240	   Rpb3-­‐EGFP,	  iwr1∆,rpb4∆	   BY4742;	  rpb3::RPB3-­‐EGFP-­‐HIS3MX6	  iwr1::kanMX4	  rpb4:natMX4	   this	  work	  241	   Rpb4-­‐EGFP	   BY4742;	  rpb4::RPB4-­‐EGFP-­‐HIS3MX6	   this	  work	  242	   Rpb4-­‐EGFP,	  iwr1∆	   BY4742;	  rpb4::RPB4-­‐EGFP-­‐HIS3MX6	  iwr1::kanMX4	   this	  work	  243	   Rpa190-­‐EGFP	   BY4742;	  rpa190::RPA190-­‐EGFP-­‐HIS3MX6	   this	  work	  244	   Rpa190-­‐EGFP,	  iwr1∆	   BY4742;	  rpa190::RPA190-­‐EGFP-­‐HIS3MX6	  iwr1::kanMX4	   this	  work	  245	   C160-­‐EGFP	   BY4742;	  rpo31::RPO31-­‐EGFP-­‐HIS3MX6	   this	  work	  246	   C160-­‐EGFP,	  iwr1∆	   BY4742;	  rpo31::RPO31-­‐EGFP-­‐HIS3MX6	  iwr1::kanMX4	   this	  work	  066	   Pol	  II	  purification	  strain	   MATa	  or	  α;	  ura3-­‐52	  trp1∆	  leu2∆1	  his3∆200	  pep4::HIS3	  prb1∆1.6R	  
can1∆	  GAL	  rpb3::URA3-­‐N-­‐6xHis-­‐RPB3	   Kashlev	  lab	  247	   Pol	  II	  purification	  strain,	  iwr1∆	   PCY066;	  iwr1::kanMX4	   this	  work	  075	   Pol	  III	  purification	  strain	   MATα	  ret1::HIS3	  ura3∆	  trp1∆	  leu2∆	  his3∆	  met4∆	  lys20∆	  ade20∆	  
can10∆	  cyhZR;	  pNZ85:	  TRP1	  N-­‐(His)6-­‐(FLAG)4-­‐RET1	   Bartholomew	  lab	  (Zecherle	  et	  al,	  1996)	  248	   Pol	  III	  purification	  strain,	  iwr1∆	   PCY075;	  iwr1::kanMX4	   this	  work	  	  	  
2.1.3 Oligonucleotides	  	  Oligonucleotides	   (Table	   4)	   used	   in	   this	   study	   were	   ordered	   at	   Thermo	  Scientific	  in	  RP-­‐HPLC	  quality.	  	  	  
Table	  4	   ⋅ 	  Oligonucleotides.	  The	  name	  generally	   indicates	   the	   targeted	  gene	  and	   its	   species	  of	  origin,	   direction	   of	   the	   oligonucleotide	   (forward	   F,	   reverse	   R),	   restriction	   sites,	   tags	   and	   other	  relevant	  sequence	  elements.	  
ID	   Name	   Sequence	  (5’	  to	  3’)	  
	   IWR1.Sc	  full-­‐length	  for	  expression	  EC-­‐P005	   IWR1-­‐Sc-­‐F-­‐NdeI	   GGGCACGGGCATATGAGCACTATTAGTACCACAAC	  EC-­‐P006	   IWR1-­‐Sc-­‐F-­‐NdeI-­‐His	   GGGCACGGGCATATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCATGAGCACTATTAGTACCACAAC	  EC-­‐P008	   IWR1-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GGGCACGGGCTCGAGTTAGCTTCTATTAATTTTTTTCTGTAG	  EC-­‐P009	   IWR1-­‐Sc-­‐R-­‐XhoI-­‐Stop-­‐His	   GGGCACGGGCTCGAGTCAGTGGTGGTGGTGGTGGTGGCTTCTATTAATTTTTTTCTG	  EC-­‐P011	   IWR1-­‐Sc-­‐F-­‐exon1	   ATGAGCACTATTAGTACCACAACGG	  EC-­‐P012	   IWR1-­‐Sc-­‐R-­‐exon1/2	   CTCTTTTCCCCTCATCAATTAATAATGCCTGCACAGAATCC	  EC-­‐P013	   IWR1-­‐Sc-­‐F-­‐exon1/2	   GGATTCTGTGCAGGCATTATTAATTGATGAGGGGAAAAGAG	  EC-­‐P014	   IWR1-­‐Sc-­‐R-­‐exon2	   TTAGCTTCTATTAATTTTTTTCTGTAGC	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ID	   Name	   Sequence	  (5’	  to	  3’)	  EC-­‐P015	   IWR1-­‐Sc-­‐F-­‐exon1[complete]/2	   ATGAGCACTATTAGTACCACAACGGCACCTGAGTTTATCAGAGTAAAGAGAAGAAGGGATGAGGATTCTGTGCAGGCATTATTAATTGATGAGGGGAAAAGAG	  EC-­‐P024	   IWR1-­‐[N1]-­‐Sc-­‐F-­‐NdeI	   GAAGGGCATATGAGCACTATTAGTACCACAAC	  EC-­‐P035	   IWR1-­‐[C353]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTAGCTTCTATTAATTTTTTTCTG	  EC-­‐P036	   IWR1-­‐[C353]-­‐Sc-­‐R-­‐XhoI	   GAAGGGCTCGAGGCTTCTATTAATTTTTTTCTG	  EC-­‐P038	   IWR1-­‐Sc-­‐R-­‐XhoI-­‐Stop-­‐Strep	   GAAGGGCTCGAGTTATTTTTCGAACTGCGGGTGGCTCCAAGCGCTGCTTCTATTAATTTTTTTCTG	  
	   IWR1.Sc	  deletion	  sequencing	  EC-­‐P055	   IWR1-­‐Sc-­‐F-­‐5-­‐UTR	   AATTGTTGCTTCAAATAAGTTCGCAG	  EC-­‐P056	   IWR1-­‐Sc-­‐R-­‐5-­‐gene[353]	   GCTGCAAGCCGCTGTTGTG	  EC-­‐P057	   IWR1-­‐Sc-­‐R-­‐5-­‐gene[240]	   GTCATTAGAATCCTCATCGTCTGAAC	  EC-­‐P058	   IWR1-­‐Sc-­‐F-­‐3-­‐gene	   TACCACGATGTGGAGGAAGAGTAC	  EC-­‐P059	   IWR1-­‐Sc-­‐R-­‐3-­‐UTR	   TGGTCGCTAATGAGAACGACAAG	  EC-­‐P060	   kanMX4-­‐R	   CTGCAGCGAGGAGCCGTAAT	  EC-­‐P061	   kanMX4-­‐F	   TGATTTTGATGACGAGCGTAAT	  
	   IWR1.Sc	  minimal	  Pol	  II	  binding	  domain	  for	  expression	  EC-­‐P062	   IWR1-­‐Sc-­‐F-­‐NdeI-­‐His	   GAAGGGCATATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCATGAGCACTATTAGTACCACAACGG	  EC-­‐P063	   IWR1[N9]-­‐Sc-­‐F-­‐NdeI-­‐His	   GAAGGGCATATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCGCACCTGAGTTTATCAGAGTAAAGAG	  EC-­‐P064	   IWR1[N19]-­‐Sc-­‐F-­‐NdeI-­‐His	   GAAGGGCATATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCAGGGATGAGGATTCTGTGCAG	  EC-­‐P065	   IWR1[C218]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTACTCCGGATAATCATTTTGGTAATAG	  EC-­‐P066	   IWR1[C230]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTAGCTACCAAATAGAATAGATCTATCATC	  EC-­‐P067	   IWR1[C233]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTACTCTCCTTCGCTACCAAATAGAATAG	  EC-­‐P068	   IWR1[C245]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTACCCTATAACAATCTCTTCACCCAA	  
	   IWR1.Sc	  deletion	  EC-­‐P069	   IWR1-­‐Sc-­‐up-­‐KanMX4	   TGCTCTCTGAGGTATAGCTTTTGTTGAGGTAGGCATACAAGATTTCGGGATTCGTACGCTGCAGGTCGAC	  EC-­‐P070	   IWR1-­‐Sc-­‐down-­‐KanMX4	   AATTACAGATGCAGTTACTTACATACATTGAACAGTTTCTGACGGCAAATATATCATCGATGAATTCGAGCTCG	  
	   IWR1.Hs	  (codons	  optimized	  for	  Sc)	  EC-­‐P078	   IWR1-­‐Hs.synthetic-­‐F-­‐BamHI	   GAAGGGGGATCCATGGAAGCTGCTAGAAC	  EC-­‐P079	   IWR1-­‐Hs.synthetic-­‐R-­‐NotI-­‐Stop-­‐His	   GAAGGGGCGGCCGCTTAGTGGTGGTGGTGGTGGTGCTCGAGATCGGAATCCAAGTCATGAGGG	  
	   IWR1.Sc-­‐TAP	  sequencing	  EC-­‐P080	   TAP-­‐tag-­‐sequencing-­‐R	   GACGAGGCAAGCTAAACAGA	  EC-­‐P081	   IWR1.Sc-­‐TAP-­‐sequencing-­‐F	   CGATGTGGAGGAAGAGTACG	  
	   IWR1.Sc	  refined	  minimal	  Pol	  II	  binding	  domain	  for	  expression	  EC-­‐P086	   IWR1[C201]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTATGAACGGGCTTCATTGGG	  EC-­‐P087	   IWR1[C211]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTAATAGTTTTCGTCATTAGAATCCTCAT	  EC-­‐P088	   IWR1[C223]-­‐Sc-­‐R-­‐XhoI-­‐Stop	   GAAGGGCTCGAGTTAATCATCATCTTCATCCTCCGG	  
	   IWR1.Sc	  with	  promoter/3'UTR	  for	  in	  vivo	  analysis	  EC-­‐P097	   IWR1[promoter]-­‐Sc-­‐F-­‐XbaI	   GAAGGGTCTAGACCTTGAGGTGTTTTGTAGTTCCAC	  EC-­‐P098	   IWR1[promoter]-­‐Sc-­‐R	   TCCCGAAATCTTGTATGCCTACCTC	  EC-­‐P099	   IWR1[C223]-­‐Sc-­‐R-­‐3'UTR-­‐Stop	   CATTGAACAGTTTCTGACGGCAAATTTAATCATCATCTTCATCCTCCGG	  EC-­‐P100	   IWR1[C223]-­‐Sc-­‐R-­‐3'UTR-­‐Stop-­‐His	   CATTGAACAGTTTCTGACGGCAAATTTAGTGGTGGTGGTGGTGGTGCTCGAGATCATCATCTTCATCCTCCGG	  EC-­‐P101	   IWR1[N224]-­‐Sc-­‐F-­‐ATG	   GTAGGCATACAAGATTTCGGGAATGAGATCTATTCTATTTGGTAGCG	  EC-­‐P102	   IWR1[N224]-­‐Sc-­‐F-­‐ATG-­‐His	   GTAGGCATACAAGATTTCGGGAATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCAGATCTATTCTATTTGGTAGCG	  EC-­‐P103	   IWR1[3'UTR]-­‐Sc-­‐F	   ATTTGCCGTCAGAAACTGTTC	  EC-­‐P104	   IWR1[3'UTR]-­‐Sc-­‐R-­‐XhoI	   GAAGGGCTCGAGCTGATCAATTAATGTATTGC	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ID	   Name	   Sequence	  (5’	  to	  3’)	  EC-­‐P105	   IWR1-­‐Sc-­‐R-­‐3'UTR-­‐Stop-­‐His	   CATTGAACAGTTTCTGACGGCAAATTTAGTGGTGGTGGTGGTGGTGCTCGAGGCTTCTATTAATTTTTTTCTGTAGC	  EC-­‐P112	   IWR1-­‐Sc-­‐F-­‐promoter-­‐ATG-­‐His	   GTAGGCATACAAGATTTCGGGAATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCATGAGCACTATTAGTACCACAACGG	  
	   RPB3.Sc	  genomic	  EGFP-­‐tag	  EC-­‐P113	   RPB3.Sc-­‐EGFP[pYM28]-­‐F	   ATGCATCTCAAATGGGTAATACTGGATCAGGAGGGTATGATAATGCTTGGCGTACGCTGCAGGTCGAC	  EC-­‐P114	   RPB3.Sc-­‐EGFP[pYM28]-­‐R	   TCGGTTCGTTCACTTGTTTTTTTTCCTCTATTACGCCCACTTGAGAACTAATCGATGAATTCGAGCTCG	  EC-­‐P119	   natNT2-­‐R-­‐sequencing	   CCAGGTCGCCGTCGTC	  EC-­‐P120	   natNT2-­‐F-­‐sequencing	   ACGAATCGGACGACGG	  EC-­‐P123	   RPB3-­‐Sc-­‐F-­‐sequencing	   CAAGTTGTCGTCAGAGGTAT	  EC-­‐P124	   RPB3-­‐Sc-­‐R-­‐sequencing	   AGACTGCTGTAGATGGAATG	  EC-­‐P125	   EGFP-­‐5-­‐R-­‐sequencing	   ATGTTGTGGCGGATCTTG	  EC-­‐P126	   EGFP-­‐3-­‐F-­‐sequencing	   GCGGCTACTAGTCTTACTGG	  EC-­‐P127	   EGFP-­‐internal-­‐F-­‐sequencing	   TCGACTTCAAGGAGGACG	  EC-­‐P128	   EGFP-­‐internal-­‐R-­‐sequencing	   GACCTACAGGAAAGAGTTACTC	  
	   IWR1.Hs	  recombination	  for	  pEC069/pPC1328	  and	  in	  vivo	  analysis	  EC-­‐P133	   IWR1-­‐Hs/Sc-­‐up	   TGCTCTCTGAGGTATAGCTTTTGTTGAGGTAGGCATACAAGATTTCGGGAATGGAAGCTGCTAGAACTGC	  EC-­‐P134	   IWR1-­‐Hs/Sc-­‐down	   ATTACAGATGCAGTTACTTACATACATTGAACAGTTTCTGACGGCAAATTCAATCGGAATCCAAGTCATGAG	  
	   IWR1.Sc	  truncations	  and	  EGFP-­‐tag	  for	  in	  vivo	  analysis	  EC-­‐P135	   IWR1-­‐Sc-­‐N1-­‐F	   TGCTCTCTGAGGTATAGCTTTTGTTGAGGTAGGCATACAAGATTTCGGGAATGAGCACTATTAGTACCACAAC	  EC-­‐P136	   IWR1-­‐Sc-­‐N9-­‐F	   TGCTCTCTGAGGTATAGCTTTTGTTGAGGTAGGCATACAAGATTTCGGGAATGGCACCTGAGTTTATCAGAG	  EC-­‐P137	   IWR1-­‐Sc-­‐N55-­‐F	   TGCTCTCTGAGGTATAGCTTTTGTTGAGGTAGGCATACAAGATTTCGGGAATGTCCGAGCAAGAGTCTTCTACG	  EC-­‐P138	   IWR1-­‐Sc-­‐N114-­‐F	   TGCTCTCTGAGGTATAGCTTTTGTTGAGGTAGGCATACAAGATTTCGGGAATGGTGAATGACTATTTAAAGTTG	  EC-­‐P139	   IWR1-­‐Sc-­‐N224-­‐F	   TGCTCTCTGAGGTATAGCTTTTGTTGAGGTAGGCATACAAGATTTCGGGAATGAGATCTATTCTATTTGGTAGCG	  EC-­‐P140	   IWR1-­‐Sc-­‐C223-­‐R	   ATTACAGATGCAGTTACTTACATACATTGAACAGTTTCTGACGGCAAAT	  GGATCCTTAATCATCATCTTCATCCTCCG	  EC-­‐P141	   IWR1-­‐Sc-­‐C353-­‐R	   ATTACAGATGCAGTTACTTACATACATTGAACAGTTTCTGACGGCAAAT	  GGATCCTTAGCTTCTATTAATTTTTTTCTGTAGC	  EC-­‐P142	   IWR1-­‐Sc-­‐C223-­‐EGFP-­‐F	   ATGACGAAAACTATTACCAAAATGATTATCCGGAGGATGAAGATGATGATCGTACGCTGCAGGTCGAC	  EC-­‐P143	   IWR1-­‐Sc-­‐C353-­‐EGFP-­‐F	   ATCATAGGGACAGAATTTTTCATCAGCTACAGAAAAAAATTAATAGAAGCCGTACGCTGCAGGTCGAC	  EC-­‐P144	   EGFP-­‐IWR1-­‐Sc-­‐terminator-­‐R	   AATTACAGATGCAGTTACTTACATACATTGAACAGTTTCTGACGGCAAATTTACTTGTACAGCTCGTCC	  
	   IWR1.Sc	  NES	  deletion	  and	  NLS	  mutation	  EC-­‐P145	   IWR1-­‐Sc-­‐NES	  deletion-­‐F	   CGAGAAAAATATAGGGTTTGTGAAAGATGAAGAAAGTGATCCCAATG	  EC-­‐P146	   IWR1-­‐Sc-­‐NES	  deletion-­‐R	   CATTGGGATCACTTTCTTCATCTTTCACAAACCCTATATTTTTCTCG	  EC-­‐P153	   IWR1-­‐Sc-­‐NLS1N-­‐R	   GATAAACTCAGGTGCCGTTG	  EC-­‐P154	   IWR1-­‐Sc-­‐NLS1N-­‐F	   CAACGGCACCTGAGTTTATCGCTGTAGCTGCTGCTAGGGATGAGGATTCTGTGC	  EC-­‐P155	   IWR1-­‐Sc-­‐NLS1C-­‐R	   CCCCTCATCAATTAATAATGCCTG	  EC-­‐P156	   IWR1-­‐Sc-­‐NLS1C-­‐F	   CAGGCATTATTAATTGATGAGGGGGCTGCTGTGGCTAAGCAGAAGTTCATATTTAAATTATCAAAG	  
	   TFG2.Sc	  deletion	  EC-­‐P179	   TFG2-­‐Sc-­‐deletion-­‐natMX4-­‐F	   TCAACGCATAACGCAATATTAAGAGTAAAATAGAAGACCAACTTAACACCCGTACGCTGCAGGTCGAC	  EC-­‐P180	   TFG2-­‐Sc-­‐deletion-­‐natMX4-­‐R	   CTCAAGAAACTGCGTAAATATAAAATTAATGAAGAAAATCTGATTGTCAAATCGATGAATTCGAGCTCG	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ID	   Name	   Sequence	  (5’	  to	  3’)	  EC-­‐P181	   TFG2-­‐Sc-­‐F-­‐sequencing	   CTTCCCTTGCGCGAAATG	  EC-­‐P182	   TFG2-­‐Sc-­‐R-­‐sequencing	   TGCATCTAAATACATATGTACAGATAGC	  EC-­‐P183	   TFG2-­‐Sc-­‐F-­‐SacI	   GAAGGGGAGCTCTTCCTTCAGTAGAACCAATTTGTG	  EC-­‐P184	   TFG2-­‐Sc-­‐R-­‐BamHI	   GAAGGGGGATCCCCCCATATGGACAACAACG	  EC-­‐P185	   TFG2-­‐Sc-­‐mutagenesis-­‐PY203AA	   ACAGATAGGGATGGTAGAGATAGATATATAGCAGCTGTGAAGACGATTCCCAAAAAAAC	  EC-­‐P186	   TFG2-­‐Sc-­‐mutagenesis-­‐NLS∆	   GGCAAGCTTACCTGAAGAAG-­‐GTGAAGACGATTCCCAAAAAAAC	  EC-­‐P187	   TFG2-­‐Sc-­‐mutagenesis-­‐sequencing	   CAACTTGCATGGCCAAGAAC	  
	   Pol	  I,	  II,	  III	  genomic	  EGFP-­‐tags	  	  EC-­‐P188	   RPA190-­‐Sc-­‐F-­‐homologous	   ATGTTGGTACGGGTTCATTTGATGTGTTAGCAAAGGTTCCAAATGCGGCTCGTACGCTGCAGGTCGAC	  EC-­‐P189	   RPA190-­‐Sc-­‐R-­‐homologous	   ATAAACTAATATTAAATCGTAATAATTATGGGACCTTTTGCCTGCTTCTAATCGATGAATTCGAGCTCG	  EC-­‐P190	   RPA190-­‐Sc-­‐F-­‐sequencing	   TGATGACCAGGCAAGGTAC	  EC-­‐P191	   RPA190-­‐Sc-­‐R-­‐sequencing	   CCGCTTGATGATGATGCAC	  EC-­‐P192	   RPB1-­‐Sc-­‐F-­‐homologous	   ATTCTCCAAAGCAAGACGAACAAAAGCATAATGAAAATGAAAATTCCAGACGTACGCTGCAGGTCGAC	  EC-­‐P193	   RPB1-­‐Sc-­‐R-­‐homologous	   CTATATATAATGTAATAACGTCAAATACGTAAGGATGATATACTATATCAATCGATGAATTCGAGCTCG	  EC-­‐P194	   RPB1-­‐Sc-­‐F-­‐sequencing	   CAGCCCAACGTCTCCAG	  EC-­‐P195	   RPB1-­‐Sc-­‐R-­‐sequencing	   GCATTTACTAGCGCCGTTG	  EC-­‐P196	   C160-­‐Sc-­‐F-­‐homologous	   AGCGATGTCTATTTGAAAGTCTCTCAAATGAGGCAGCTTTAAAAGCGAACCGTACGCTGCAGGTCGAC	  EC-­‐P197	   C160-­‐Sc-­‐R-­‐homologous	   GTAGAAAAATAATACAAATGCTATAAAAAAGTTTAAAAACGACTACTTTAATCGATGAATTCGAGCTCG	  EC-­‐P198	   C160-­‐Sc-­‐F-­‐sequencing	   GCAGCTAGCCTCCTTCG	  EC-­‐P199	   C160-­‐Sc-­‐R-­‐sequencing	   AGCTTGTGAGTGCATACCAG	  EC-­‐P200	   RPB4-­‐Sc-­‐F-­‐homologous	   ATGAGTTGGAAAGGATACTAAAGGAATTGTCAAACCTAGAAACACTCTATCGTACGCTGCAGGTCGAC	  EC-­‐P201	   RPB4-­‐Sc-­‐R-­‐homologous	   CAGGGTGAAAATTCATTACTAGTTACACACACGTATACATACAGTTATTAATCGATGAATTCGAGCTCG	  EC-­‐P202	   RPB4-­‐Sc-­‐F-­‐sequencing	   CAAATTTCTCCCGATTTAGAGACC	  EC-­‐P203	   RPB4-­‐Sc-­‐R-­‐sequencing	   TCGATCAGAGGTGTAGATGC	  
	   RPB4.Sc	  deletion	  EC-­‐P204	   RPB4-­‐Sc-­‐deletion-­‐natMX4-­‐F	   TACACAAATATTCATCCGTATTGAAAATATATATATAAGAATATAGAAAACGTACGCTGCAGGTCGAC	  EC-­‐P205	   RPB4-­‐-­‐Sc-­‐deletion-­‐natMX4T-­‐R	   CCACAGGGTGAAAATTCATTACTAGTTACACACACGTATACATACAGTTAATCGATGAATTCGAGCTCG	  EC-­‐P206	   RPB4-­‐Sc-­‐F-­‐sequencing	   CCAGAAGGGGTAAATCTGAGG	  EC-­‐P207	   RPB4-­‐Sc-­‐R-­‐sequencing	   GGCCAGCGAAGAGACC	  	  	  
2.1.4 Plasmids	  	  Plasmids	   (Table	   5)	   were	   generated	   by	   classical	   cloning,	   yeast	   in	   vivo	  recombination	  or	  site-­‐directed	  mutagenesis	  (see	  2.2.2).	  Inserts	  were	  amplified	  in	  single-­‐	   or	   multi-­‐step	   PCRs	   using	   the	   indicated	   oligonucleotides.	   Plasmid	  identifiers	   (IDs)	   are	   provided	   for	   both	   the	   original	   Elmar	   Czeko	   plasmid	  collection	  (pEC)	  and	  for	  the	  Patrick	  Cramer	  laboratory	  plasmid	  collection	  (pPC).	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Table	  5	  ⋅ 	  Plasmids	  
ID	   Plasmid	   Type	   Cloning	   	   	   	  	   	   	   from	   into	   using	  oligonucleotides	   via	  
	   IWR1.Sc	  full-­‐length	  expression	  pEC003	  pPC1317	   IWR1.Sc-­‐His6	   pET-­‐21b	   genomic	  DNA	   pET-­‐21b	   EC-­‐P024,	  EC-­‐P036	   classical	  cloning	  (NdeI,	  XhoI)	  pEC005	  pPC1318	   His6-­‐IWR1.Sc	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P006,	  EC-­‐P035	   classical	  cloning	  (NdeI,	  XhoI)	  pEC023	  pPC1319	   IWR1.Sc-­‐Strep	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P024,	  EC-­‐P038	   classical	  cloning	  (NdeI,	  XhoI)	  
	   IWR1.Sc	  minimal	  Pol	  II	  binding	  pEC040	  pPC1320	   His6-­‐IWR1.Sc	  [1-­‐218]	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P062,	  EC-­‐P065	   classical	  cloning	  (NdeI,	  XhoI)	  pEC041	  pPC1321	   His6-­‐IWR1.Sc	  [1-­‐230]	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P062,	  EC-­‐P066	   classical	  cloning	  (NdeI,	  XhoI)	  pEC043	  pPC1322	   His6-­‐IWR1.Sc	  [9-­‐245]	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P063,	  EC-­‐P068	   classical	  cloning	  (NdeI,	  XhoI)	  pEC044	  pPC1323	   His6-­‐IWR1.Sc	  [19-­‐245]	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P064,	  EC-­‐P068	   classical	  cloning	  (NdeI,	  XhoI)	  
	   IWR1.Hs	  synthetic	  gene	  pEC047	  pPC1324	   IWR1.Hs	   pMA	   Mr.	  Gene	   pMA	   -­‐	   chemical	  synthesis	  
	   IWR1.Sc	  refined	  minimal	  Pol	  II	  binding	  pEC058	  pPC1325	   His6-­‐IWR1.Sc	  [9-­‐201]	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P063,	  EC-­‐P086	   classical	  cloning	  (NdeI,	  XhoI)	  pEC059	  pPC1326	   His6-­‐IWR1.Sc	  [9-­‐211]	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P063,	  EC-­‐P087	   classical	  cloning	  (NdeI,	  XhoI)	  pEC061	  pPC1327	   His6-­‐IWR1.Sc	  [9-­‐223]	   pET-­‐21b	   pEC003	   pET-­‐21b	   EC-­‐P063,	  EC-­‐P088	   classical	  cloning	  (NdeI,	  XhoI)	  	   IWR1.Sc	  for	  in	  vivo	  analysis	  pEC069	  pPC1328	   IWR1.Sc	  [promoter+3'UTR]	   pRS316	   genomic	  DNA	   pRS316	   EC-­‐P097,	  EC-­‐P104	   classical	  cloning	  (XbaI,	  XhoI)	  pEC074	  pPC1329	   IWR1.Hs	  [promoter+3'UTR	  from	  Sc]	   pRS317	   pEC047	   pEC069	   EC-­‐P133,	  EC-­‐P134	   yeast	  in	  vivo	  recombination	  (BglII,	  BstEII)	  pEC076	  pPC1330	   IWR1.Sc	  (1-­‐353)	   pRS318	   pEC003	   pEC074	   EC-­‐P135,	  EC-­‐P141	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC077	  pPC1331	   IWR1.Sc	  (9-­‐223)	   pRS319	   pEC003	   pEC074	   EC-­‐P136,	  EC-­‐P140	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC078	  pPC1332	   IWR1.Sc	  (55-­‐353)	   pRS320	   pEC003	   pEC074	   EC-­‐P137,	  EC-­‐P141	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC079	  pPC1333	   IWR1.Sc	  (114-­‐353)	   pRS321	   pEC003	   pEC074	   EC-­‐P138,	  EC-­‐P141	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC080	  pPC1334	   IWR1.Sc	  (224-­‐353)	   pRS322	   pEC003	   pEC074	   EC-­‐P139,	  EC-­‐P141	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC081	  pPC1335	   IWR1.Sc	  (1-­‐353,	  dNES)	   pRS316	   pEC094	   pEC074	   EC-­‐P135,	  EC-­‐P141	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC082	  pPC1336	   IWR1.Sc	  (9-­‐223,	  dNES)	   pRS316	   pEC094	   pEC074	   EC-­‐P136,	  EC-­‐P140	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC083	  pPC1337	   IWR1.Sc	  (55-­‐353,	  dNES)	   pRS316	   pEC094	   pEC074	   EC-­‐P137,	  EC-­‐P141	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC084	  pPC1338	   IWR1.Sc	  (114-­‐353,	  dNES)	   pRS316	   pEC094	   pEC074	   EC-­‐P138,	  EC-­‐P141	   yeast	  in	  vivo	  recombination	  (EcoRI)	  pEC085	  pPC1339	   IWR1.Sc	  (1-­‐353)-­‐EGFP	   pRS316	   EGFP	  from	  pYM28	   pEC076	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC086	  pPC1340	   IWR1.Sc	  (9-­‐223)-­‐EGFP	   pRS316	   EGFP	  from	  pYM28	   pEC077	   EC-­‐P142,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	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ID	   Plasmid	   Type	   Cloning	   	   	   	  pEC087	  pPC1341	   IWR1.Sc	  (55-­‐353)-­‐EGFP	   pRS316	   EGFP	  from	  pYM28	   pEC078	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC088	  pPC1342	   IWR1.Sc	  (114-­‐353)-­‐EGFP	   pRS316	   EGFP	  from	  pYM28	   pEC079	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC089	  pPC1343	   IWR1.Sc	  (224-­‐353)-­‐EGFP	   pRS316	   EGFP	  from	  pYM28	   pEC080	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC090	  pPC1344	   IWR1.Sc	  (1-­‐353,	  dNES)-­‐EGFP	   pRS316	   EGFP	  from	  pYM28	   pEC081	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC091	  pPC1345	   IWR1.Sc	  (9-­‐223,	  dNES)-­‐EGFP	   pRS316	   EGFP	  from	  pYM28	   pEC082	   EC-­‐P142,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  	   IWR1.Sc	  NES	  deletion	  and	  NLS	  mutants	  pEC094	  pPC1346	   His6-­‐IWR1(d182-­‐190,	  dNES).Sc	  	   pET-­‐21b	   pEC005	   -­‐	   EC-­‐P145	   site-­‐directed	  mutagenesis	  pEC095	  pPC1347	   His6-­‐IWR1(RVKRR14-­‐18AVAAA).Sc	   pET-­‐21b	   pEC005	   pET-­‐21b	   EC-­‐P006,	  EC-­‐P153,	  EC-­‐P154,	  EC-­‐P035	   2-­‐step	  PCR	  mutagenesis,	  classical	  cloning	  (NdeI,	  XhoI)	  pEC096	  pPC1348	   His6-­‐IWR1(KRVK33-­‐36AAVA).Sc	   pET-­‐21b	   pEC005	   pET-­‐21b	   EC-­‐P006,	  EC-­‐P155,	  EC-­‐P156,	  EC-­‐P035	   2-­‐step	  PCR	  mutagenesis,	  classical	  cloning	  (NdeI,	  XhoI)	  pEC097	  pPC1349	   His6-­‐IWR1(14-­‐18/33-­‐36	  mutated).Sc	   pET-­‐21b	   pEC095	   pET-­‐21b	   EC-­‐P006,	  EC-­‐P153,	  EC-­‐P154,	  EC-­‐P035	   2-­‐step	  PCR	  mutagenesis,	  classical	  cloning	  (NdeI,	  XhoI)	  pEC098	  pPC1350	   IWR1(RVKRR14-­‐18AVAAA).Sc	   pRS316	   pEC076	   -­‐	   EC-­‐P097,	  EC-­‐P153,	  EC-­‐P154,	  EC-­‐P104	   2-­‐step	  PCR	  mutagenesis,	  classical	  cloning	  (XbaI,	  XhoI)	  pEC099	  pPC1351	   IWR1(KRVK33-­‐36AAVA).Sc	   pRS316	   pEC076	   -­‐	   EC-­‐P097,	  EC-­‐P155,	  EC-­‐P156,	  EC-­‐P104	   2-­‐step	  PCR	  mutagenesis,	  classical	  cloning	  (XbaI,	  XhoI)	  pEC100	  pPC1352	   IWR1(14-­‐18/33-­‐36	  mutated).Sc	   pRS316	   pEC098	   -­‐	   EC-­‐P097,	  EC-­‐P153,	  EC-­‐P154,	  EC-­‐P104	   2-­‐step	  PCR	  mutagenesis,	  classical	  cloning	  (XbaI,	  XhoI)	  pEC101	  pPC1353	   IWR1(RVKRR14-­‐18AVAAA)-­‐EGFP.Sc	   pRS316	   EGFP	  from	  pYM28	   pEC098	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC102	  pPC1354	   IWR1(KRVK33-­‐36AAVA)-­‐EGFP.Sc	   pRS316	   EGFP	  from	  pYM28	   pEC099	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC103	  pPC1355	   IWR1(14-­‐18/33-­‐36	  mutated)-­‐EGFP.Sc	   pRS316	   EGFP	  from	  pYM28	   pEC100	   EC-­‐P143,	  EC-­‐P144	   yeast	  in	  vivo	  recombination	  (BamHI)	  pEC104	  pPC1356	   IWR1(RVKRR14-­‐18AVAAA,	  dNES)-­‐EGFP.Sc	   pRS316	   pEC101	   -­‐	   EC-­‐P145	   site-­‐directed	  mutagenesis	  pEC105	  pPC1357	   IWR1(KRVK33-­‐36AAVA,	  dNES)-­‐EGFP.Sc	   pRS316	   pEC102	   -­‐	   EC-­‐P145	   site-­‐directed	  mutagenesis	  pEC106	  pPC1358	   IWR1(14-­‐18/33-­‐36	  mutated,	  dNES)-­‐EGFP.Sc	   pRS316	   pEC103	   -­‐	   EC-­‐P145	   site-­‐directed	  mutagenesis	  	   TFG2.Sc	  rescue	  plasmids	  pEC119	  pPC1359	   TFG2	  rescue	  in	  pRS316	   pRS315	   genomic	  DNA	   pRS315	   EC-­‐P183,	  EC-­‐P184	   classical	  cloning	  (SacI,	  BamHI)	  pEC120	  pPC1360	   TFG2	  rescue	  in	  pRS315	   pRS316	   genomic	  DNA	   pRS316	   EC-­‐P183,	  EC-­‐P184	   classical	  cloning	  (SacI,	  BamHI)	  pEC121	  pPC1361	   TFG2	  (PY203/204AA)	  rescue	  in	  pRS315	   pRS316	   pEC120	   -­‐	   EC-­‐P185	   site-­‐directed	  mutagenesis	  pEC122	  pPC1362	   TFG2	  (d165-­‐204)	  rescue	  in	  pRS315	   pRS316	   pEC120	   -­‐	   EC-­‐P186	   site-­‐directed	  mutagenesis	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2.1.5 Reagents	  and	  Consumables	  	  Chemicals	   were	   obtained	   from	   Merck	   (Darmstadt,	   Germany),	   Roth	  (Karlsruhe,	   Germany)	   or	   Sigma-­‐Aldrich	   (Seelze,	   Germany),	   unless	   otherwise	  stated.	  Cloning	  enzymes	  and	  reagents	  were	  obtained	  from	  Fermentas	  (St.	  Leon-­‐Rot,	   Germany),	   New	   England	   Biolabs	   (Frankfurt	   am	   Main,	   Germany)	   or	  Agilent/Stratagene	   (Waldbronn,	   Germany).	   For	   DNA	   preparation	   commercial	  kits	   from	   Qiagen	   (Hilden,	   Germany)	   were	   used.	   DNA	   oligonucleotides	   were	  ordered	  at	  ThermoScientifc	  (Ulm,	  Germany).	  Antibodies	  were	  generally	  supplied	  by	  abcam	  (Cambridge,	  UK)	  or	  Santa	  Cruz	  Biotechnology	  (Heidelberg,	  Germany).	  Reagents	  and	  consumables	  were	  ordered	  at	  standard	  laboratory	  suppliers.	  	  	  
2.1.6 Media	  and	  additives	  	  Media	  were	  usually	  taken	  from	  lab	  stocks	  (Table	  6).	  Media	  additives	  were	  sterile	  filtered	  (Table	  7).	  	  	  
Table	  6	  ⋅ 	  Media	  for	  Escherichia	  coli	  and	  Saccharomyces	  cerevisiae	  
Media	   Application	   Description	  LB	   Escherichia	  coli	  culture	   1%	  (w/v)	  tryptone;	  0.5%	  (w/v)	  yeast	  extract;	  0.5%	  (w/v)	  NaCl	  SOB	   Escherichia	  coli	  transformation	   2%	  (w/v)	  tryptone;	  0.5%	  (w/v)	  yeast	  extract;	  8.55	  mM	  NaCl;	  2.5	  mM	  KCl;	  10	  mM	  MgCl2	  SOC	   Escherichia	  coli	  transformation	   SOB	  +	  20	  mM	  glucose	  (before	  use)	  YPD	   Yeast	  culture	   2%	  (w/v)	  peptone;	  2%	  (w/v)	  glucose;	  1%	  (w/v)	  yeast	  extract	  Synthetic	  complete	  (SC)	  amino	  acid	  drop-­‐out	  medium	   Yeast	  culture	   0.69%	  (w/v)	  nitrogen	  base;	  amino	  acid	  drop	  out	  mix	  (w/v)	  as	  indicated	  by	  manufacturer;	  2%	  (w/v)	  glucose;	  pH	  5.6-­‐6.0	  YPD	  plates	   Yeast	  plate	   YPD,	  2%	  (w/v)	  agar	  SC	  amino	  acid	  drop-­‐out	  plates	   Yeast	  plate	   SC	  amino	  acid	  drop-­‐out	  medium;	  2%	  (w/v)	  agar	  	  5-­‐FOA	  plates	   Yeast	  plate	   SC	  (-­‐ura)	  +	  0.01%	  (w/v)	  uracil;	  0.2%	  (w/v)	  5-­‐FOA;	  2%	  (w/v)	  agar	  Pre-­‐sporulation	  plates	   Yeast	  plate	   1%	  (w/v)	  KCH3COO;	  0.1%	  (w/v)	  yeast	  extract;	  0.079%	  (w/v)	  CSM	  amino	  acid	  complete	  mix;	  0.25%	  (w/v)	  glucose;	  pH	  5.6-­‐6.0	  Sporulation	  t	  plate	   Yeast	  plate	   1%	  (w/v)	  KCH3COO;	  0.079%	  (w/v)	  CSM	  amino	  acid	  complete	  mix;	  pH	  5.6-­‐6.0	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Table	  7	  ⋅ 	  Media	  additives	  for	  Escherichia	  coli	  and	  Saccharomyces	  cerevisiae	  
Additive	   Description	   Stock	  solution	   Applied	  concentration	  IPTG	   Escherichia	  coli	  induction	   1	  M	  in	  H2O	   0.5	  mM	  Ampicillin	   Antibiotic	   100	  mg/ml	  in	  H2O	   100	  μg/ml	  for	  Escherichia	  coli	  culture,	  50	  μg/ml	  for	  yeast	  culure	  Kanamycin	   Antibiotic	   30	  mg/ml	  in	  H2O	   30	  μg/ml	  for	  Escherichia	  coli	  culture	  Chloramphenicol	   Antibiotic	   50	  mg/ml	  in	  EtOH	   50	  μg/ml	  for	  Escherichia	  coli	  culture	  Tetracyclin	   Antibiotic	   12.5	  mg/ml	  in	  70%	  EtOH	   12.5	  μg/ml	  for	  yeast	  culture	  Geneticin	  (G418)	   Antibiotic	   200	  mg/ml	  in	  H2O	   200	  μg/ml	  for	  yeast	  culture	  Nourseothricin	  (cloneNAT)	   Antibiotic	   100	  mg/ml	  in	  H2O	   100	  μg/ml	  for	  yeast	  culture	  	  	  
2.1.7 Buffers	  and	  solutions	  	  General	   buffers,	   dyes	   and	   solutions	   are	   listed	   in	   Table	   8.	   Purification	  buffers	   for	   HPLC	   systems	   were	   filtered	   and	   degassed	   before	   usage	   (Table	   9,	  Table	  10,	  Table	  11).	  	  
Table	  8	  ⋅ 	  General	  buffers,	  dyes	  and	  solutions	  
Name	   Application	   Description	  1x	  Bradford	  dye	  	   Determination	  of	  protein	  concentration	   1:5	  dilution	  of	  Bradford	  concentrate	  (BioRad)	  4x	  stacking	  gel	  buffer	   SDS-­‐PAGE	   0.5M	  Tris,	  0.4%	  (w/v)	  SDS,	  pH	  6.8	  at	  25°C	  4x	  separation	  gel	  buffer	   SDS-­‐PAGE	   3	  M	  Tris,	  0.4%	  (w/v)	  SDS,	  pH	  8.9	  at	  25°C	  electrophoresis	  buffer	   SDS-­‐PAGE	   25	  mM	  Tris,	  0.1%	  (w/v)	  SDS,	  250	  mM	  glycine	  5x	  SDS	  sample	  buffer	   SDS-­‐PAGE	   250	  mM	  Tris/HCl	  pH	  7.0	  at	  25°C,	  50%	  (v/v)	  glycerol,	  0.5%	  (w/v)	  bromophenol	  blue,	  7.5%	  (w/v)	  SDS,	  12.5%	  (w/v)	  ␣-­‐mercaptoethanol	  Gel	  staining	  solution	   Coomassie	  staining	   50%	  (v/v)	  ethanol,	  7%	  (v/v)	  acetic	  acid,	  0.125%	  (w/v)	  Coomassie	  Brilliant	  Blue	  R-­‐250	  Gel	  destaining	  solution	   Coomassie	  staining	   5%	  (v/v)	  ethanol,	  7.5%	  (v/v)	  acetic	  acid	  1x	  TBE	   Agarose	  gel	  electrophoresis	   8.9	  mM	  Tris,	  8.9	  mM	  boric	  acid,	  2	  mM	  EDTA	  (pH	  8.0,	  25°C)	  1x	  TE	   Nucleic	  acids,	  yeast	  transformation	   10	  mM	  Tris	  pH	  7.4,	  1mM	  EDTA	  10x	  TBS	   Agarose	  gel	  electrophoresis	   500	  mM	  Tris/HCl	  pH	  7.5,	  1.5	  M	  NaCl	  1x	  PBS	   Divers	   2	  mM	  KH2PO4,	  4	  mM	  Na2HPO4,	  140	  mM	  NaCl,	  3	  mM	  KCl,	  pH	  7.4	  @	  25°C	  6x	  Loading	  dye	   Agarose	  gel	  electrophoresis	   1.5	  g/l	  bromophenol	  blue,	  1.5	  g/l	  xylene	  cyanol,	  50%	  (v/v)	  glycerol	  2x	  Tris/Glycine	  transfer	  buffer	   Western	  Blotting	   2.4%	  (w/v)	  glycin,	  0.8%	  (w/v)	  Tris,	  40%	  (v/v)	  ethanol	  1x	  CAPS	  transfer	  buffer	   Western	  Blotting	  for	  Edman	  sequencing	   0.221%	  (w/v)	  CAPS,	  0.05%	  (w/v)	  DTT,	  15%	  (v/v)	  methanol,	  pH	  10.5	  (adjusted	  with	  NaOH)	  pre-­‐treatment	  solution	   lysis	  for	  quantitative	  western	  blotting	   7.5%	  (v/v)	  β-­‐mercaptoethanol,	  1.85	  M	  NaOH	  TFB-­‐1	   Chemically	  competent	  cells	   30	  mM	  KOAc,	  50	  mM	  MnCl2,	  100	  mM	  RbCl,	  10	  mM	  CaCl2,	  15%	  (v/v)	  glycerol,	  pH	  5.8	  at	  25°C	  TFB-­‐2	   Chemically	  competent	  cells	   10	  mM	  MOPS	  pH	  7.0	  at	  25°C,	  10	  mM	  RbCl,	  75	  mM	  CaCl2,	  15%	  (v/v)	  glycerol	  
MATERIALS	  AND	  METHODS	  
25	  
Name	   Application	   Description	  100x	  PI	   Protease	  inhibitor	  mix	   0.028	  mg/ml	  Leupeptin,	  0.137	  mg/ml	  Pepstatin	  A,	  0,017	  mg/ml	  PMSF,	  0.33	  mg/ml	  benzamidine,	  in	  100%	  EtOH	  p.a.	  Avidin	   Strep	  purification	   50	  μmol/l	  avidin,	  50%	  (w/v)	  glycerin,	  20	  mM	  Tris	  pH	  8.0,	  150	  mM	  NaCl,	  10	  mM	  β-­‐mercaptoethanol	  50x	  d-­‐desthiobiotin	   Strep-­‐tag	  purification	   125	  mM	  d-­‐desthiobiotin,	  in	  500	  mM	  Tris	  pH	  8.0	  50%	  (w/v)	  PEG	  3,350	  	   Yeast	  genomic	  transformation	   50%	  (w/v)	  PEG	  3,350,	  autoclaved	  1	  M	  lithium	  acetate	   Yeast	  genomic	  transformation	   1	  M	  lithium	  acetate,	  pH	  7.5	  adjusted	  with	  acetic	  acid	  Salmon	  sperm	  DNA	   Yeast	  genomic	  transformation	   2	  mg/ml	  Salmon	  sperm	  DNA	  One-­‐step	  buffer	   Yeast	  plasmid	  transformation	   0.2	  M	  lithium	  acetate,	  40%	  (w/v)	  PEG	  3,350,	  100	  mM	  DTT	  Paraformaldehyde	  fixing	   Light	  microscopy	   10%	  (w/v)	  paraformaldehyde,	  13	  mM	  NaOH,	  1	  M	  K3PO4	  	  	  
Table	  9	  ⋅ 	  Iwr1	  purification	  buffers	  
Name	   Description	  IMAC	  lysis	  buffer	   20	  mM	  Tris/HCl,	  pH	  8.0,	  150	  mM	  NaCl,	  10	  mM	  imidazole,	  10	   β-­‐mercaptoethanol,	  1x	  PI	  IMAC	  washing	  buffer	   20	  mM	  Tris/HCl,	  pH	  8.0,	  150	  mM	  NaCl,	  20/30/40	  mM	  imidazole,	  10	   β-­‐mercaptoethanol	  IMAC	  elution	  buffer	   20	  mM	  Tris/HCl	  pH	  8.0,	  150	  mM	  NaCl,	  250	  mM	  imidazole,	  10	   β-­‐mercaptoethanol	  Strep	  lysis	  buffer	   20	  mM	  Tris/HCl	  pH	  8.0,	  150	  mM	  NaCl,	  10	   β-­‐mercaptoethanol,	  1x	  PI,	  250	  pmol	  avidin	  per	  1	  l	  culture	  Strep	  washing	  buffer	   20	  mM	  Tris/HCl	  pH	  8.0,	  150	  mM	  NaCl,	  10	   β-­‐mercaptoethanol	  Strep	  elution	  buffer	   20	  mM	  Tris/HCl	  pH	  8.0,	  150	  mM	  NaCl,	  10	   β-­‐mercaptoethanol,	  2.5	  mM	  desthiobiotin	  anion	  exchange	  buffer	  A	   20	  mM	  Tris/HCl	  pH	  8.0,	  50	  mM	  NaCl,	  10	  mM	  DTT	  anion	  exchange	  buffer	  B	   20	  mM	  Tris/HCl	  pH	  8.0,	  2	  M	  NaCl,	  10	  mM	  DTT	  	  	  
Table	  10	  ⋅ 	  Pol	  II	  purification	  buffers	  
Name	   Description	  3x	  freezing	  buffer	  (used	  as	  4x)	   150	  mM	  Tris/HCl	  (pH	  7.9	  at	  4	  °C),	  3	  mM	  EDTA,	  30	  μM	  ZnCl2,	  30%	  (v/v)	  glycerol,	  3%	  (v/v)	  DMSO,	  30	  mM	  DTT,	  3×	  PI	  HSB	  150	   50	  mM	  Tris/HCl	  (pH	  7.9	  at	  4	  °C),	  150	  mM	  KCl,	  1	  mM	  EDTA,	  10	  μM	  ZnCl2,	  10%	  (v/v)	  glycerol,	  10	  mM	  DTT,	  1×	  PI	  HSB	  0/0	   50	  mM	  Tris/HCl	  (pH	  7.9	  at	  4	  °C),	  1	  mM	  EDTA,	  10	  μM	  ZnCl2,	  10%	  (v/v)	  glycerol,	  2.5	  mM	  DTT,	  1×	  PI	  HSB	  1000/0	   50	  mM	  Tris/HCl	  (pH	  7.9	  at	  4	  °C),	  1000	  mM	  KCl,	  1	  mM	  EDTA,	  10	  μM	  ZnCl2,	  10%	  (v/v)	  glycerol,	  2.5	  mM	  DTT,	  1×	  PI	  HSB	  1000/7	   50	  mM	  Tris/HCl	  (pH	  7.9	  at	  4	  °C),	  1000	  mM	  KCl,	  7	  mM	  imidazole,	  1	  mM	  EDTA,	  10	  μM	  ZnCl2,	  10%	  (v/v)	  glycerol,	  2.5	  mM	  DTT,	  1×	  PI	  5x	  IMAC	  buffer	   100	  mM	  Tris/HCl	  (pH	  7.9	  at	  4	  °C),	  750	  mM	  KCl,	  50	  μM	  ZnCl2	  	  Ni	  buffer	  7,	  50,	  100	  	   20	  mM	  Tris/HCl	  (pH	  7.9	  at	  4	  °C),	  150	  mM	  KCl,	  7/50/100	  mM	  imidazole,	  10	  μM	  ZnCl2,	  2.5	  mM	  DTT,	  1×	  PI	  	  5x	  anion	  exchange	  buffer	   100	  mM	  Tris-­‐acetate	  (pH	  7.9	  at	  4	  °C),	  50%	  (v/v)	  glycerol,	  2.5	  mM	  EDTA	  pH	  7.9,	  50	  μM	  ZnCl2	  MonoQ	  0	   20	  mM	  Tris-­‐acetate	  (pH	  7.9	  at	  4	  °C),	  10%	  (v/v)	  glycerol,	  0.5	  mM	  EDTA	  pH	  7.9,	  10	  μM	  ZnCl2,	  10	  mM	  DTT	  MonoQ	  150	   20	  mM	  Tris-­‐acetate	  (pH	  7.9	  at	  4	  °C),	  150	  mM	  KOAc,	  10%	  (v/v)	  glycerol,	  0.5	  mM	  EDTA	  pH	  7.9,	  10	  μM	  ZnCl2,	  10	  mM	  DTT	  MonoQ	  2000	   20	  mM	  Tris-­‐acetate	  (pH	  7.9	  at	  4	  °C),	  2000	  mM	  KOAc,	  10%	  (v/v)	  glycerol,	  0.5	  mM	  EDTA	  pH	  7.9,	  10	  μM	  ZnCl2,	  10	  mM	  DTT	  Pol	  II	  size	  exclusion	  buffer	   5	  mM	  HEPES	  (pH	  7.25	  at	  20	  °C),	  40	  mM	  (NH4)2SO4,	  10	  µM	  ZnCl2,	  10	  mM	  DTT	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Table	  11	  ⋅ 	  Rpb4/7	  purification	  buffers	  
Name	   Description	  Rpb4/7	  freezing	  buffer	   50	  mM	  Tris	  (pH	  7.0	  at	  4	  °C),	  150	  mM	  NaCl,	  10%	  glycerol,	  10	  mM	  β-­‐mercaptoethanol,	  1	  ×	  PI	  IMAC	  buffer	   50	  mM	  Tris	  (pH	  7.5	  at	  4	  °C),	  150	  mM	  NaCl,	  0/10/20/50/200	  mM	  imidazole,	  10	  mM	  β-­‐mercaptoethanol,	  1	  ×	  PI	  IMAC	  salt	  buffer	   50	  mM	  Tris	  (pH	  7.5	  at	  4	  °C),	  2	  M	  NaCl,	  10	  mM	  β-­‐mercaptoethanol,	  1	  ×	  PI	  SourceQ	  0	   20	  mM	  Tris	  (pH	  7.5	  at	  4	  °C),	  1	  mM	  EDTA,	  10	  mM	  DTT	  SourceQ	  100	   20	  mM	  Tris	  (pH	  7.5	  at	  4	  °C),	  100	  mM	  NaCl,	  1	  mM	  EDTA,	  10	  mM	  DTT	  SourceQ	  2000	   20	  mM	  Tris	  (pH	  7.5	  at	  4	  °C),	  2	  M	  NaCl,	  1	  mM	  EDTA,	  10	  mM	  DTT	  Pol	  II	  buffer	   5	  mM	  HEPES	  (pH	  7.25	  at	  20	  °C),	  40	  mM	  (NH4)2SO4,	  10	  µM	  ZnCl2,	  10	  mM	  DTT	  	  	  
2.2 General	  methods	  
2.2.1 Preparation	  and	  transformation	  of	  competent	  bacterial	  cells	  	  Chemically	  competent	  Escherichia	  coli	  cells	  were	  prepared	  from	  a	  200	  ml	  LB	   culture	   containing	   appropriate	   antibiotics.	   After	   inoculation	   at	   an	   OD600	   of	  0.05	  with	  an	  overnight	  pre-­‐culture,	  cells	  were	  grown	  at	  37	  °C	  to	  an	  OD600	  of	  0.5	  and	   chilled	   on	   ice	   for	   10	  min.	   For	   all	   following	   steps,	   care	   was	   taken	   for	   the	  samples	   to	   be	   constantly	   kept	   at	   4	  °C.	   Cells	   were	   centrifuged	   at	   3,200	  g	   for	  10	  min,	   thoroughly	   washed	   with	   50	  ml	   TFB-­‐1	   buffer,	   pelleted	   again	   and	  thoroughly	   resuspended	   in	   4	  ml	   TFB-­‐2	   buffer.	   50	  µl	   aliquots	   were	   frozen	   in	  liquid	  nitrogen	  and	  cells	  stored	  at	  -­‐80	  °C.	  For	  transformation,	  100	  ng	  of	  a	  plasmid	  or	   5	  μl	   from	   a	   ligation	   reaction	   was	   added	   to	   an	   aliquot	   of	   competent	   cells,	  followed	  by	  incubation	  on	  ice	  for	  20	  min	  and	  a	  45	  s	  heat	  shock	  at	  42	  °C	  in	  a	  water	  bath	   with	   subsequent	   cooling	   on	   ice	   for	   1	  min.	   After	   addition	   of	   250	  μl	   LB	  medium	   the	   transformation	   mix	   was	   incubated	   in	   a	   thermomixer	   shaking	   at	  1,400	  rpm	  for	  1	  h	  at	  37	  °C.	  Finally,	  cells	  were	  plated	  onto	  selective	  LB	  plates	  and	  incubated	  overnight	  at	  37	  °C.	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2.2.2 Cloning	  and	  mutagenesis	  	  As	   Escherichia	   coli	   expression	   vectors	   the	   Novagen	   pET	   series	   and	   as	  
Saccharomyces	   cerevisiae	   vectors	   the	   pRS	   series	   obtained	   from	   Euroscarf	   was	  used.	   For	   polymerase	   chain	   reaction	   (PCR)	   primers	   the	   following	   properties	  were	  considered:	  1)	  A	  6	  bp	  GC-­‐rich	  sequence	  was	  added	  at	   the	  primer’s	  5’	  end	  next	  to	  a	  restriction	  sites;	  2)	  complementary	  regions	  consisted	  of	  at	  least	  18	  bp,	  the	   melting	   temperature	   was	   targeted	   to	   be	   at	   55	  °C	   as	   calculated	   with	   ApE	  (Wayne	   Davis,	   2009)	   and	   the	   region	   concluded	   with	   a	   G	   or	   C	   nucleotide;	  3)	   hairpins	   and	   complementary	   regions	   between	   primer	   pairs	   were	   avoided.	  Purification	  tags	  were	  either	  introduced	  via	  the	  primer	  or	  by	  in-­‐frame	  cloning	  in	  the	   vector.	   PCR	   reactions	   were	   carried	   out	   with	   Herculase	   or	   Herculase	  II	  polymerases	   (Stratagene),	   Phusion	   polymerase	   (Finnzymes),	   Pfu	   polymerase	  (Fermentas)	   or	   Taq	   polymerase	   (Fermentas),	   depending	   on	   requirements.	  Reaction	   were	   typically	   performed	   at	   50	  μl	   scale	   and	   contained	   polymerase	  specific	   buffers,	   1-­‐30	  ng	   of	   plasmid	   DNA	   or	   100-­‐200	  ng	   of	   genomic	   DNA	  template,	  0.2	  mM	  dNTP-­‐mix,	  0.5	  μM	   forward	  and	   reverse	  primer	  each,	   variable	  amounts	   of	   polymerase	   (0.5	   to	   5.0	  U),	   and	   optionally	  MgCl2	   or	   DMSO.	   For	   test	  PCRs	  the	  reaction	  volume	  was	  usually	  scaled	  down	  to	  20	  µl.	  PCR	  programs	  were	  optimized	   for	   each	   reaction,	   in	   particular	   in	   terms	   of	   annealing	   temperature	  (using	  a	  gradient	  PCR	  cycler)	  and	  elongation	  times.	  PCR	   products	   were	   purified	   using	   PCR-­‐purification	   kits	   (Qiagen	   or	  Metabion).	   PCR	   products	   and	   vectors	   were	   digested	   with	   restriction	  endonucleases	   (NEB	   or	   Fermentas)	   under	   conditions	   recommended	   by	   the	  supplier.	   Digested	   vectors	  were	   dephosphorylated	   by	   addition	   of	   1.0	  U	   FastAP	  enzyme	   (Fermentas)	   and	   incubation	   for	   10	  min	   at	   37	  °C	   followed	   by	   heat	  inactivation	   for	   5	  min	   at	   75	  °C.	   Samples	   were	   separated	   by	   agarose	   gel	  electrophoresis	   (typically	   1%	  w/v)	   in	   1×	  TBE	   buffer	   and	   visualized	   by	  ethidiumbromide	   or	   SYBR	   Safe	   DNA	   staining	   (1:10,000,	   Invitrogen).	   DNA	  fragments	   were	   extracted	   and	   purified	   using	   the	   QIAquick	   gel	   extraction	   kit	  (Qiagen).	   PCR	   products	   and	   linearized	   vectors	   were	   ligated	   using	   5.0	  U	   of	   T4	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DNA	  ligase	  (Fermentas)	  in	  a	  20	  μl	  reaction	  volume	  for	  1	  h	  at	  20	  °C	  or	  overnight	  at	   18	  °C.	   Usually	   a	   molar	   vector	   to	   insert	   ratio	   of	   1:2	   was	   applied,	   calculated	  based	  on	  the	  DNA	  concentration	  and	  –	  as	  a	  proxy	  for	  the	  molecular	  weight	  of	  the	  nucleic	  acids	  –	  their	  length	  in	  base	  pairs.	  Ligation	  products	  were	  transformed	  as	  described	  (see	  2.2.1).	  5	  ml	  overnight	  cultures	  were	  inoculated	  with	  single	  clones	  from	  selective	  LB	  plates.	  Plasmids	  were	  isolated	  from	  the	  Escherichia	  coli	  clones	  using	  miniprep	  purification	  kits	  (Qiagen	  or	  Metabion)	  and	  verified	  by	  restriction	  analysis	  and	  DNA	  sequencing	  (MWG).	  Site-­‐directed	  mutagenesis	  was	  applied	  to	   introduce	  point	  mutations	   into	  plasmids.	   Usually,	   10	  ng	   of	   template	   plasmid	   was	   used	   in	   the	   mutational	   PCR	  with	   Pfu	   polymerase	   (Fermentas).	   Primers	   typically	   contained	   at	   least	   15	  bp	  complementary	   regions	   on	   both	   sides	   of	   a	   mutation.	   PCR	   reactions	   were	  performed	  with	  only	  one	  primer	  and	  annealing	  temperatures	  between	  45	  °C	  and	  55	  °C	  and	  2	  min	  per	  kb	  extension	   time.	  Next,	   the	   template	  vector	  was	  digested	  with	  10	  U	  DpnI	  (Fermentas)	  for	  1	  h	  at	  37	  °C	  and	  5	  µl	  of	  the	  reaction	  were	  directly	  used	  for	  transformation	  of	  competent	  Escherichia	  coli	  cells.	  For	  the	  generation	  of	  mutations	   that	   were	   not	   amenable	   to	   site-­‐directed	   mutagenesis	   a	   2-­‐step	   PCR	  approach	  was	  used.	  Specifically,	  two	  overlapping	  PCR	  fragments	  were	  generated	  in	  a	  first	  step	  that	  contained	  the	  desired	  mutation	  introduced	  via	  primers.	  Next,	  the	   two	  PCR	   fragments	  were	   used	   as	   a	   template	   in	   a	   second	  PCR	   to	   amplify	   a	  single	  fragment	  carrying	  the	  mutation,	  which	  could	  be	  cloned	  into	  a	  vector.	  As	   an	   alternative	   to	   restriction	   enzyme	   based	   classical	   cloning,	   in	   vivo	  homologous	   recombination	   in	   yeast	   was	   applied	   for	   plasmids	   carrying	   both	  selectable	   markers	   in	   yeast	   and	   Escherichia	   coli.	   In	   addition	   to	   the	   general	  robustness	   of	   the	   technique,	   the	   location	   of	   the	   insertion	   can	   be	   chosen	   freely	  under	  the	  single	  constraint	  that	  a	  restriction	  site	  is	  present	  on	  the	  plasmid	  only	  between	  the	  two	  homologous	  regions	  used	  for	  recombination,	  but	  not	  outside	  of	  them.	  Briefly,	  yeast	  cells	  were	  transformed	  as	  described	  (see	  2.3.2)	  with	  1	  µg	  of	  digested	   and	   gel-­‐purified	   plasmid	   and	   2-­‐	   to	   3-­‐fold	   molar	   excess	   of	   the	   PCR-­‐generated	  insert	  containing	  50	  bp	  homologous	  regions	  at	  its	  5’	  and	  3’	  ends.	  After	  two	   to	   four	   days	   up	   to	   five	   clones	   were	   picked	   from	   the	   selective	   plates	   for	  overnight	   growth	   in	   5	  ml	   selective	   medium	   at	   30	  °C	   with	   subsequent	   yeast	  plasmid	  preparation	  according	  to	  a	  modified	  version	  of	   the	  Qiagen	  protocol	   for	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DNA	  preparation	   from	  Escherichia	  coli	  (Jones,	  2001).	  5	  µl	  of	   the	  obtained	  yeast	  plasmid	  DNA	  was	  transformed	  into	  Escherichia	  coli	  cells	  (see	  2.2.1)	  followed	  by	  selection	   of	   a	   single	   clone	  per	   original	   yeast	   clone,	   growth	  of	   a	   5	  ml	   culture	   at	  37	  °C,	  plasmid	  preparation	  (Qiagen),	  test	  digestion	  and	  sequencing	  (MWG).	  	  	  
2.2.3 Protein	  expression	  in	  Escherichia	  coli	  	  Recombinant	  proteins	  were	  routinely	  expressed	  in	  Escherichia	  coli	  BL21-­‐CodonPlus	   (DE3)	   RIL	   cells	   (Stratagene).	   Plasmids	   carrying	   desired	   protein	  variants	  were	  transformed	  as	  described	  (see	  2.2.1).	  Cells	  were	  grown	  at	  37	  °C	  in	  LB	  medium	  with	  required	  antibiotics	  up	  to	  an	  OD600	  of	  0.5	  to	  0.8.	  Cultures	  were	  then	   cooled	   on	   ice	   for	   30	  min,	   induced	   by	   addition	   of	   0.5	  mM	   IPTG	   with	  subsequent	  overnight	  expression	  at	  18	  °C.	  Cells	  were	  harvested	  by	  centrifugation	  at	   3,500	  g	   and	   4	  °C	   for	   20	  min,	   washed	   in	   lysis	   buffer,	   flash	   frozen	   in	   liquid	  nitrogen	  and	  stored	  at	  -­‐80°	  C.	  	  	  
2.2.4 Protein	  analysis	  	  
Determination	  of	  protein	  concentrations	  Total	   protein	   concentrations	   were	   usually	   determined	   with	   a	   Bradford	  assay	  (Bradford,	  1976)	  by	  measuring	  the	  absorption	  at	  595	  nm	  in	  1	  ml	  of	  a	  dye	  reagent	   solution	   (Bio-­‐Rad)	   after	   addition	   of	   typically	   1	  µl	   to	   5	  µl	   of	   protein.	  Reference	  curves	  were	  prepared	  for	  each	  new	  batch	  of	  dye	  reagent	  using	  bovine	  serum	   albumin	   as	   a	   standard	   (Fraktion	   V,	   Roth).	   Alternatively,	   protein	  concentrations	  were	   calculated	   via	   the	   absorption	   at	   280	  nm	  using	   a	  ND-­‐1000	  (NanoDrop)	   spectrophotometer.	   Molar	   absorption	   coefficients	   were	   calculated	  with	  ProtParam	  based	  on	  the	  protein	  sequence	  (Gasteiger	  et	  al,	  2005).	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SDS-­‐polyacrylamide	  gel	  electrophoresis	  Electrophoretic	   separation	   of	   proteins	  was	   routinely	   conducted	  by	   SDS-­‐PAGE	   in	   BioRad	   gel	   systems	   with	   15%	   acrylamide/0.4%	   bisacrylamide	   gels	  (Laemmli,	   1970).	   For	   sharper	   resolution,	   commercial	  NuPAGE	  Novex	  Midi	  Bis-­‐Tris	  4-­‐12%	  gradient	  gels	  (Invitrogen)	  were	  used	  according	  to	  the	  manufacturer’s	  instructions.	   Gels	   were	   stained	   with	   Coomassie	   solution	   for	   20	  min	   and	  destained	  overnight	  in	  gel	  destaining	  solution	  (Table	  8).	  	  
Limited	  proteolysis	  analyses	  Limited	   proteolysis	   time	   courses	  were	   performed	   to	   identify	   stable	   and	  compactly	   folded	   protein	   regions.	   Protein	   was	   digested	   with	   chymotrypsin	   or	  trypsin	   protease	   at	   37	  °C	   and	   samples	   were	   taken	   at	   30	  s	   and	   1,	   3,	   8,	   15	   and	  30	  min.	  Digests	  were	  performed	  with	  20	  μg	  protein	  and	  0.1	  μg	  protease	  per	  time	  point	   in	   the	   Iwr1	   size	   exclusion	   buffer	   supplemented	   with	   5	  mM	   CaCl2.	   The	  reactions	  were	  stopped	  by	  the	  addition	  of	  1×	  SDS	  sample	  buffer	  and	  immediate	  heating	   at	   95	  °C	   for	   5	  min.	   After	   separation	   of	   degraded	   protein	   fragments	   by	  SDS-­‐PAGE	  bands	  were	  excised	  and	  analyzed	  by	  Edman	  sequencing	  (Niall,	  1973).	  	  
Edman	  sequencing	  For	   N-­‐terminal	   sequencing,	   proteins	   were	   separated	   by	   a	   SDS-­‐PAGE,	  stained	  with	   Coomassie	   blue	   and	   transferred	   either	   by	  western	   blotting	   or	   by	  passive	  adsorption	  onto	  PVDF	  membranes.	  Western	  blotting	  was	  performed	   in	  CAPS	   transfer	   buffer	   at	   100	  V	   for	   1	  h	   or	   20	  V	   overnight	   at	   4	  °C.	   For	   passive	  adsorption,	  bands	  of	  interest	  were	  excised	  from	  the	  gel,	  dried	  in	  a	  speed-­‐vac	  and	  rehydrated	  in	  20	  μl	  swelling	  buffer	  at	  room	  temperature.	  Next,	  100	  μl	  of	  double-­‐distilled	   water	   and	   a	   piece	   of	   PVDF	  membrane,	   previously	   soaked	   in	   ethanol,	  were	   added	   (Schleicher	   &	   Schuell	   BioScience).	   Once	   the	   solution	   turned	   blue,	  10	  μl	  of	  methanol	  was	  added	  and	  the	  sample	  was	  incubated	  for	  up	  to	  4	  days	  until	  the	  transfer	  was	  complete,	  as	  indicated	  by	  the	  migration	  of	  the	  blue	  colour	  from	  the	  solution	  onto	  the	  PVDF	  membrane.	  The	  membrane	  was	  washed	  five	  times	  by	  vortexing	   for	  30	  s	   in	  10%	  methanol.	  Finally,	   the	  membrane-­‐bound	  protein	  was	  N-­‐terminally	   sequenced	   in	   a	   PROCISE	   491	   sequencer	   (Applied	   Biosystems)	  based	  on	  automated	  Edman	  degradation	  (Niall,	  1973).	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2.2.5 Quantitative	  western	  blots	  	  To	   quantify	   the	   relative	   amounts	   of	   Rpb1	   in	   the	   wild-­‐type	   and	   Δiwr1	  strains	  an	  alkaline	  lysis	  of	  yeast	  cells	  was	  performed.	  Briefly,	  5	  ml	  of	  yeast	  grown	  in	  exponential	  phase	  to	  an	  OD600	  of	  1.0	  were	  washed,	  resuspended	  in	  150	  µl	  pre-­‐treatment	   solution,	   vortexed	   and	   incubated	   on	   ice	   for	   20	  min.	   Next,	   150	  µl	   of	  55%	   TCA	   were	   added	   followed	   by	   another	   20	  min	   incubation	   on	   ice	   with	  intermittent	   vortexing.	   Cells	  were	   pelleted,	   resuspended	   in	   85	  µl	   of	   1×	   sample	  buffer	  and	  boiled	  at	  95	  °C	  for	  a	  short	  period	  of	  time	  (90	  s)	  to	  avoid	  degradation	  of	   large	   proteins.	   After	   centrifugation	   the	   absorption	   at	   280	  nm	   of	   a	   1:200	  dilution	  of	  each	  sample	  was	  measured,	  using	  a	  1:200	  dilution	  of	  1×	  sample	  buffer	  as	   a	   blank.	   If	   required,	   samples	   were	   diluted	   to	   the	   same	   absorbance	   and	   an	  equivalent	  of	  0.2	  absorbance	  units	  (as	  referred	  to	  the	  measurement	  of	  the	  1:200	  dilution)	   was	   diluted	   to	   10	  µl	   and	   loaded	   onto	   an	   SDS	   gel.	   Then	   the	   gel	   was	  blotted	  onto	  a	  nitrocellulose	  membrane	  for	  1	  h	  at	  100	  V	  in	  the	  cold	  room	  and	  the	  membrane	  was	  stained	  with	  Ponceau	  afterwards	  to	  confirm	  an	  even	  transfer	  of	  protein.	  The	  membrane	  was	  blocked	  in	  1×	  PBS	  with	  2%	  (w/v)	  milk	  powder	  for	  1	  h	  at	  room	  temperature	  and	  cut	  into	  two	  parts	  approximately	  at	  the	  height	  of	  a	  70	  kDa	   marker	   band.	   All	   following	   antibody	   incubations	   were	   performed	   in	  10	  ml	  1×	   PBS	  with	  2%	   (w/v)	  milk	  powder,	  while	  washing	  was	  done	  with	   four	  consecutive	  5	  min	  incubations	  in	  1×	  PBS.	  The	  upper	  part	  of	  the	  membrane	  was	  incubated	  with	  8WG16	  antibody	  against	  Rpb1	  (Covance,	  1:500,	  mouse)	  and	  the	  lower	   part	   in	   anti-­‐Pgk1	   (Invitrogen,	   1:20,000,	   mouse)	   for	   1	  h	   at	   room	  temperature.	  After	  washing,	   both	  membranes	  were	   incubated	   together	   in	   anti-­‐mouse	  antibody	  coupled	  to	  horse-­‐reddish-­‐peroxidase	  (BioRad,	  1:2,000,	  goat)	  for	  1	  h	  at	  room	  temperature,	   followed	  by	  washing	  and	  detection	  of	   the	  transferred	  protein	  with	   the	  ECL	  Plus	  Western	  Blotting	  Detection	  Reagent	   (GE	  Healthcare)	  on	   a	   LAS-­‐3000	   system	   (Fujifilm,	   standard	   sensitivity,	   normal	   binning,	   1	  min	  increments).	   Exposure	   times	   were	   up	   to	   10	  min,	   images	   were	   saved	   as	   16	  bit	  TIFF	   files	   and	   quantification	  was	   done	  with	   ImageJ	   (rsbweb.nih.gov/ij/).	   Rpb1	  band	   intensity	  was	  normalized	  by	   the	  Pgk1	  band	   intensity	   and	  mean	  values	  of	  the	   ratios	   were	   calculated	   from	   three	   independent	   lysis	   samples.	   The	   linear	  range	  of	  the	  antibodies	  was	  confirmed	  by	  1:2	  step	  serial	  dilutions.	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2.2.6 Bioinformatic	  tools	  	  Protein	   and	   gene	   sequences	   were	   retrieved	   from	   the	   NCBI	  (www.ncbi.nlm.nih.gov)	  or	  the	  SGD	  (www.yeastgenome.org)	  database.	  Sequence	  data	   was	   displayed	   and	   edited	   using	   VectorNTI	   (Invitrogen)	   and	   ApE	  (biologylabs.utah.edu/jorgensen/wayned/ape).	   Bioinformatic	   analysis	   were	  performed	   using	   the	   Bioinformatics	   Toolkit	   (Biegert	   et	   al,	   2006).	   Multiple	  sequence	  alignments	  were	  generated	  using	  MUSCLE	  (Edgar,	  2004)	  and	  displayed	  with	   ESPript	   (Gouet	   et	   al,	   1999).	   Sequence	   conservation	   was	   calculated	   with	  EMBOSS	   (www.ebi.ac.uk)	   (Needleman	   &	   Wunsch,	   1970).	   Protein	   secondary	  structures	  were	  predicted	  by	  HHpred	  (Soding	  et	  al,	  2005).	  NLS	  sequences	  were	  identified	  and	  scored	  with	  cNLS	  Mapper	  (Kosugi	  et	  al,	  2009b).	  	  	  
2.3 Yeast	  genetics	  and	  assays	  
2.3.1 Isolation	  of	  genomic	  DNA	  from	  yeast	  	  Genomic	  DNA	   from	  yeast	  was	   isolated	  using	   the	  DNeasy	  Blood	  &	  Tissue	  Kit	   (Qiagen)	   following	   the	  manufacturer’s	   yeast-­‐specific	  protocol	   on	   a	  QIAcube	  robot	  (Qiagen).	  	  	  
2.3.2 Transformation	  of	  yeast	  cells	  	  Chemically	   competent	   yeast	   cells	   were	   prepared	   from	   a	   100	  ml	   culture	  inoculated	  with	  cells	  from	  an	  overnight	  pre-­‐culture	  at	  an	  OD600	  of	  0.2	  and	  grown	  to	   an	   OD600	   of	   0.8.	   Cells	   were	   centrifuged	   at	   1,250	  g	   for	   5	  min,	   washed	   with	  sterile	   water	   and	   centrifuged	   again.	   The	   pellets	   were	   resuspended	   in	   1	  ml	  100	  mM	   lithium	   acetate,	   split	   into	   two	   1.5	  ml	   reaction	   tubes,	   centrifuged	   at	  18,000	  g	   for	   15	  s	   and	   resuspended	   in	   500	  μl	   per	   tube.	   Cells	   were	   vortexed,	  pooled,	   incubated	   for	  1	  h	   at	   room	   temperature	  or	   overnight	   at	   4	  °C	   and	   finally	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split	  into	  100	  µl	  aliquots.	  After	  centrifugation,	  supernatants	  were	  discarded	  and	  240	  μl	   50%	   (w/v)	   PEG	   3,350	   was	   added.	   If	   not	   stored	   at	   -­‐80	  °C,	   cells	   were	  directly	   used	   for	   transformation	   at	   highest	   competence	   by	   adding	   36	  μl	   1	  M	  lithium	  acetate,	  50	  μl	  2	  mg/ml	  salmon	  sperm	  DNA	  (previously	  heated	  at	  95	  °C	  for	  5	  min	  and	  afterwards	  kept	  on	   ice)	   and	  1	  µg	  DNA	   in	  34	  μl	  water.	   Samples	  were	  vortexed	  vigorously	   for	  1	  min,	   incubated	  at	  30	  °C	   for	  30	  min,	   followed	  by	  42	  °C	  for	  25	  min	  and	  pelleted	  at	  5,200	  g	  for	  15	  sec.	  If	  required,	  cells	  were	  resuspended	  in	  1	  ml	  YPD	  and	  recovered	   for	  3	  h	  at	  30	  °C	   to	  develop	  antibiotic	  resistance	  and	  then	  centrifuged	  at	  1,250	  g	   for	  5	  min.	  Finally,	   cells	  were	  resuspended	   in	  200	  μl	  1×	  TE	  buffer	  and	  plated	  onto	  selective	  plates.	  	  	  
2.3.3 Gene	  disruption	  and	  epitope-­‐tagging	  For	   gene	   deletion	   and	   tagging	   Saccharomyces	   cerevisiae	   cells	   were	  chemically	   transformed	   with	   the	   required	   PCR	   amplified	   cassette	   that	   was	  targeted	   to	   a	   certain	   locus	   via	   its	   50	  bp	   homologues	   ends	   (Janke	   et	   al,	   2004).	  After	  growth	  of	  transformants	  on	  selective	  plates,	  colonies	  were	  restreaked	  and	  then	   tested	   for	   successful	   integration	   of	   the	   cassette	   by	   PCR	   with	   locus-­‐	   and	  cassette-­‐specific	   primers.	   If	   necessary,	   the	   PCR	   product	   was	   additionally	  sequenced	  or	  test	  digested.	  	  	  
2.3.4 Long-­‐term	  storage	  of	  yeast	  strains	  	  For	   long-­‐term	   storage,	   yeast	   strains	   were	   grown	   on	   a	   YPD	   or	   selective	  plate,	  transferred	  into	  1	  ml	  30%	  glycerol	  in	  1.5	  ml	  reaction	  tubes	  and	  then	  stored	  at	   -­‐80	  °C.	   For	   re-­‐plating,	   frozen	  material	  was	   scratched	   from	   the	   reaction	   tube	  using	  a	  glass	  pipette	  and	  then	  directly	  transferring	  it	  onto	  a	  plate.	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2.3.5 Determination	  of	  yeast	  doubling	  times	  	  Doubling	  times	  of	  strains	  carrying	  rescue	  plasmids	  were	  based	  on	  OD600	  measurements	   in	   –URA	   medium.	   Cultures	   were	   inoculated	   at	   an	   OD600	   of	   0.1	  from	   an	   overnight	   pre-­‐culture.	   After	   2	  h	   the	   first	   measurement	   was	   taken	  followed	  by	  three	  more	  measurements	  during	  exponential	  growth	  over	  a	  period	  of	  7	  h	  or	  until	  an	  OD600	  of	  0.8	  was	  reached	  to	  avoid	  the	  requirement	  of	  diluting	  the	  sample	  for	  the	  measurement.	  Doubling	  times	  were	  calculated	  as	  means	  from	  three	  independent	  cultures.	  	  	  
2.3.6 Determination	  of	  protein	  half-­‐lives	  	  For	  determination	  of	  protein	  half-­‐lives,	  culture	  were	  grown	  to	  an	  OD600	  of	  0.8.	   After	   addition	   of	   the	   translational	   inhibitor	   cycloheximide	   to	   a	   final	  concentration	  of	  300	  µg/ml	   in	   the	   culture,	   samples	   containing	  an	  equivalent	  of	  5	  ml	   of	   yeast	   cells	   at	   an	  OD600	   of	   1.0	  were	   collected	   at	   each	   time	   point	   over	   a	  period	   of	   45	  min.	   Half-­‐lives	   were	   calculated	   by	   linear	   regression	   on	   the	  logarithmised	   relative	   protein	   levels	   determined	   by	   quantitative	   western	   blot	  (see	  2.2.5).	  	  	  
2.3.7 In	  vitro	  transcription	  assays	  	  
In	   vitro	   transcription	   assays	   were	   performed	   by	   Martin	   Seizl.	   Nuclear	  extracts	  were	  prepared	  from	  3	  l	  of	  culture	  as	  described	  by	  the	  Hahn	  laboratory	  (www.fhcrc.org/labs/hahn/).	   Plasmid	   transcription	   was	   performed	   essentially	  as	  described	  (Ranish	  &	  Hahn,	  1991).	  Transcription	  reactions	  were	  carried	  out	  in	  a	  25	  μl	  volume.	  The	  reaction	  mixture	  contained	  100	  μg	  nuclear	  extract,	  150	  ng	  of	  pSH515	   plasmid,	   1×	   transcription	   buffer	   (10	  mM	   HEPES	   pH	  7.6,	   50	  mM	  potassium	  acetate,	  0.5	  mM	  EDTA,	  and	  2.5	  mM	  magnesium	  acetate),	  2.5	  mM	  DTT,	  192	  μg	   of	   phosphocreatine,	   0.2	  mg	   of	   creatine	   phosphokinase,	   10	  U	   of	   RNase	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inhibitor	   (GE	   Healthcare),	   and	   100	  μM	   nucleoside	   triphosphates.	   For	   activated	  transcription,	   150	  ng	   of	   Gal4–VP16	   or	   200	  ng	   of	   Gal4–Gal4AH	  was	   added.	   The	  reaction	  was	  incubated	  at	  room	  temperature	  for	  40	  min	  and	  then	  stopped	  with	  180	  μl	  of	  100	  mM	  sodium	  acetate,	  10	  mM	  EDTA,	  0.5%	  sodium	  dodecyl	  sulphate,	  and	   17	  μg	   of	   tRNA/ml.	   Samples	   were	   extracted	   with	   phenol–chloroform	   and	  precipitated	   with	   ethanol.	   Transcripts	   were	   analysed	   by	   primer	   extension	  essentially	   as	   described	   (Ranish	  &	  Hahn,	   1991).	   Instead	   of	   the	   32P-­‐labeled	   lacI	  oligo,	   0.125	  pmol	   of	   a	   fluorescently	   labelled	   50-­‐FAM-­‐oligo	   was	   used.	  Quantification	   was	   performed	   with	   a	   Typhoon	   9400	   and	   the	   ImageQuant	  Software	  (GE	  Healthcare).	  	  	  
2.4 Fluorescence	  microscopy	  
2.4.1 Paraformaldehyde	  fixation	  of	  yeast	  cells	  	  For	  fixation,	  500	  µl	  of	  fresh	  paraformaldehyde	  solution	  was	  added	  to	  1	  ml	  of	   Rpb1-­‐EGFP,	   Rpb3-­‐EGFP,	   Rpb4-­‐EGFP,	   Rpa190-­‐EGFP,	   C160-­‐EGFP	   and	   Iwr1-­‐EGFP	  cells	  with	  our	  without	  IWR1	  deletion	  and	  grown	  to	  an	  OD600	  of	  0.8	  to	  1.0.	  Samples	  were	  incubated	  for	  10	  min	  at	  room	  temperature,	  carefully	  pelleted	  in	  a	  tabletop	   centrifuge	   at	   4,000	  rpm	   for	   2	  min,	   resuspended	   in	   500	  µl	   1×	   PBS	   and	  stored	   at	   4	  °C.	   For	   preparation	   of	   microscopy	   samples,	   12-­‐well	   slides	   were	  washed	   in	   100%	   ethanol	   and	   incubated	   for	   10	  min	   with	   0.02%	   poly-­‐L-­‐lysine.	  Depending	  on	  the	  pellet	  size,	  5	  to	  20	  µl	  of	   fixed	  cells	  were	  applied	  (per	  well,	  as	  for	  all	  following	  indications)	  and	  the	  slide	  was	  kept	  in	  a	  humid	  and	  dark	  chamber	  during	   all	   ensuing	   incubation	   times.	   Cells	   were	   allowed	   to	   settle	   for	   10	  min,	  liquid	  was	   aspirated	   off	   and	   20	   µl	   1×	   PBS	  with	   1.0	  ng/µl	   DAPI	  was	   added	   for	  10	  min.	   After	   two	   washes	   with	   one	   drop	   of	   1×	   PBS	   each,	   2.5	  µl	   1×	   PBS	   were	  added,	  a	  cover	  glass	  was	  placed	  on	  top	  and	  the	  slide	  was	  sealed	  with	  nail	  polish	  and	  stored	  in	  the	  dark	  at	  4	  °C.	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2.4.2 Fluorescence	  microscopy	  data	  collection	  	  Imaging	  was	  performed	  with	  a	  Leica	  AF6000	  fluorescence	  microscope	  at	  100×	   magnification	   and	   the	   Leica	   LAS	   AF	   Software.	   For	   DIC	   images,	   the	   DAPI	  channel	   and	   the	   GFP	   channel	   contrast	   was	   set	   to	   “TL-­‐DIC”,	   “Fluo”	   and	   “Fluo”,	  respectively	   and	   the	   filter	   cube	  was	   set	   to	   “Ana”,	   “Tri”	   and	   “GFP”,	   respectively.	  Exposure	   time	  and	   intensity	  were	  adjusted	  as	  needed	   to	  have	  optimal	  contrast	  and	  not	  to	  overexpose	  the	  image.	  In	  general,	  exposure	  times	  were	  between	  100	  and	  200	  ms	  for	  DIC	  images,	  around	  500	  ms	  for	  the	  DAPI	  channel	  and	  1	  to	  2	  s	  for	  the	  GFP	  channel.	  The	  intensity	  was	  set	  to	  the	  lowest	  or	  second	  lowest	  level	  (i.e.	  1	  or	  2)	  for	  DIC	  images	  and	  the	  DAPI	  channel	  and	  to	  the	  highest	  or	  second	  highest	  for	  the	  GFP	  channel	  (i.e.	  5	  or	  4).	  Images	  were	  exported	  as	  TIFF	  files.	  	  	  
2.4.3 Analysis	  of	  localization	  ratios	  	  Quantification	   of	   nuclear	   and	   cytoplasmic	   fluorescence	   was	   done	   with	  ImageJ	   (rsbweb.nih.gov/ij).	   The	   cytoplasm	   and	   the	   nucleus	   were	   manually	  masked	  using	  the	  DAPI	  image	  as	  a	  guide.	  The	  EGFP	  intensity	  was	  integrated	  and	  divided	  by	  the	  size	  of	  the	  mask,	  yielding	  the	  average	  intensity	  for	  each	  of	  the	  two	  compartments.	   For	   each	   analysed	   cell,	   the	   ratio	   between	   average	   nuclear	   and	  cytoplasmic	   fluorescence	   was	   calculated.	   Mean	   values	   were	   calculated	   for	   at	  least	  10	  cells	  per	  strain	  carrying	  a	  certain	  rescue	  construct.	  	  	  
2.4.4 Fluorescence	  microscopy	  figure	  preparation	  	  For	  EGFP	  images,	  linear	  contrast	  adjustment	  was	  used.	  For	  DAPI	  images,	  non-­‐linear	   contrast	   adjustment	   was	   used	   in	   some	   cases	   to	   facilitate	   the	  identification	   of	   the	   nucleus	   and	   to	   reduce	   background	   levels.	   No	   contrast	  adjustment	  was	  applied	  to	  the	  images	  before	  quantification.	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2.5 Preparation	  of	  the	  RNA	  polymerase	  II-­‐Iwr1	  
complex	  
2.5.1 Purification	  of	  recombinant	  Iwr1	  and	  variants	  
	  
Escherichia	   coli	   BL21	   (DE3)	   RIL	   cells	   (Stratagene)	   transformed	   with	  plasmids	   carrying	   IWR1	   full-­‐length	   and	   truncation	   variants	  were	   grown	   in	   LB	  medium	  at	  37	  °C	   to	  an	  OD600	  of	  0.5.	  Expression	  was	   induced	  with	  0.5	  mM	  IPTG	  for	  16	  h	  at	  18	  °C.	  Cells	  were	   lysed	  by	  sonication	   in	   IMAC	   lysis	  buffer	   (Table	  9).	  After	   centrifugation,	   the	   supernatant	   was	   loaded	   onto	   a	   1	  ml	   Ni-­‐NTA	   agarose	  column	   (Qiagen)	   equilibrated	  with	   IMAC	   lysis	   buffer.	   The	   column	  was	  washed	  three	   times	   with	   20	   CV	   each	   of	   IMAC	   washing	   buffer	   (Table	   9)	   sequentially	  containing	   20,	   30,	   and	   40	  mM	   imidazole,	   and	   eluted	   with	   IMAC	   elution	   buffer	  (Table	  9)	  containing	  250	  mM	  imidazole	  in	  0.5	  ml	  fractions	  whose	  protein	  content	  was	  assessed	  by	  means	  of	  the	  Bradford	  assay	  (see	  2.2.4).	  Proteins	  were	  further	  purified	   on	   an	   ÄKTA	   HPLC	   system	   (GE	   Healthcare)	   by	   anion	   exchange	  chromatography	  with	  a	  Mono	  Q	  5/50	  column	  (GE	  Healthcare).	  The	  column	  was	  equilibrated	  with	   anion	   exchange	  buffer	  A	   (Table	  9),	   and	  proteins	  were	   eluted	  with	   a	   linear	   gradient	   of	   20	  CV	   from	   100	  mM	   to	   1	  M	   NaCl	   in	   anion	   exchange	  buffer	  B	  (Table	  9).	  After	  concentration,	  the	  sample	  was	  applied	  to	  an	  ÄKTA	  HPLC	  system	   with	   a	   Superdex	  75	   10/300	   or	   Superose	  12	   10/300	   size	   exclusion	  column	  (GE	  Healthcare)	  equilibrated	  with	  Pol	  II	  size	  exclusion	  buffer	  (Table	  10).	  Protein	   was	   concentrated	   to	   usually	   2	  mg/ml	   with	   an	   Amicon	   Ultra-­‐15	  centrifugal	   filter	  unit	  with	  a	  molecular	  weight	  cut-­‐off	  at	  10	  kDa	  (Millipore)	  and	  flash-­‐frozen	  in	  liquid	  nitrogen.	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2.5.2 Purification	  of	  endogenous	  RNA	  polymerase	  II	  	  
Cell	  lysis	  Fermented	   yeast	   pellets	   from	   the	   Pol	  II	   purification	   strain	   (PCY	   ID	   068,	  Table	   3)	   were	   provided	   by	   Stefan	   Benkert.	   Two	   200	  ml	   cell	   suspension	   were	  thawed	   in	   a	   water	   bath	   at	   a	   maximum	   of	   30	  °C.	   All	   following	   steps	   were	  performed	   on	   ice	   or	   at	   4	  °C.	   1	  ml	   100×	   PI	   (Table	   8)	   was	   added	   and	   the	  suspension	   was	   transferred	   to	   the	   metal	   chamber	   of	   a	   BeadBeater	   (BioSpec	  Products),	   containing	  200	  ml	   soda	   lime	  glass	  beads	   (0.5	  mm	  diameter,	  BioSpec	  Products).	   Air	   bubbles	   were	   removed	   stirring	   gently	   with	   a	   glass	   rod.	   The	  chamber	  was	  completely	  filled	  up	  with	  HSB	  150	  (Table	  10)	  before	  assembly	  with	  the	  impeller.	  The	  motor	  was	  run	  for	  80	  min	  with	  a	  duty	  cycle	  of	  30	  s	  on	  and	  90	  s	  off.	  To	  prevent	  warming,	  the	  lysis	  chamber	  was	  covered	  with	  a	  salt-­‐ice	  mixture,	  which	  was	   regularly	   replenished.	   The	   lysate	  was	   separated	   from	   the	   beads	   by	  filtering	  through	  a	  mesh	  funnel	  and	  washed	  with	  HSB	  150,	  not	  exceeding	  a	  total	  volume	  of	  1	  l.	  Finally,	  the	  lysate	  was	  centrifuged	  (45	  min,	  13,690	  g,	  4	  °C).	  	  
Ultracentrifugation,	  ammonium	  sulphate	  precipitation	  and	  redissolving	  The	   lysate	   was	   subjected	   to	   ultracentrifugation	   (90	  min,	   76,220	  g,	   4	  °C)	  using	  an	  SW28	  rotor	  (Beckman-­‐Coulter).	  The	  aqueous	  phase	  of	  the	  supernatant	  was	   collected.	   To	   precipitate	   protein,	   291	  g	   fine	   ground	   ammonium	   sulphate	  were	  add	  per	   litre	  of	   the	  elution	   fraction	  which	  was	  stirred	  at	  around	  100	  rpm	  overnight	  at	  4	  °C.	  The	  solution	  was	  centrifuged	   (2×	   45	  min,	  34,200	  g,	  4	  °C)	  and	  the	   precipitate	   was	   dissolved	   in	   140	  ml	   HSB	  0/0	   (Table	   10)	   per	   100	  g	   of	  ammonium	  sulphate	  pellet	  by	  stirring	  1	  to	  2	  h	  at	  4	  °C.	  Conductivity	  of	  the	  protein	  solution	  was	   reduced	   to	   the	   conductivity	   corresponding	   to	  HSB	  1000/7	   (Table	  10)	   by	   dilution	   with	   HSB	  0/0.	   The	   sample	   was	   centrifuged	   (10	  min,	   34,200	  g,	  4	  °C)	  and	  7	  mM	  imidazole	  were	  added.	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Ni-­‐NTA	  affinity	  chromatography	  Ni-­‐NTA	   agarose	   (Qiagen)	  was	   equilibrated	  with	  HSB	  1000/7	   (Table	   10)	  without	  DTT.	  The	  sample	  was	  mixed	  with	  16	  ml	  Ni-­‐NTA	  agarose	  and	  incubated	  for	   60	  min,	   stirring	   at	   4	  °C.	   The	   suspension	   was	   split	   into	   three	   aliquots	   and	  applied	  to	  a	  gravity	  flow	  column.	  The	  resin	  was	  washed	  with	  five	  CV	  HSB	  1000/7	  and	   then	   three	   CV	   Ni	  buffer	  7	   (Table	   10).	   Three	   CV	   each	   of	   Ni	  buffer	  50	   and	  Ni	  buffer	  100	   (Table	   10)	   were	   applied	   to	   the	   column.	   Elution	   fractions	   were	  pooled	  and	  its	  conductivity	  was	  set	  corresponding	  to	  MonoQ	  150	  by	  addition	  of	  MonoQ	  0	  (Table	  10).	  	  
Anion	  exchange	  chromatography	  The	   Ni-­‐NTA	   affinity	   elution	   was	   centrifuged	   (20	  min,	   17,210	  g,	   4	  °C).	   A	  Mono	  Q	  10/100	  GL	  column	  (GE	  Healthcare)	  was	  equilibrated	  with	  Mono	  Q	  150	  using	  an	  ÄKTA	  HPLC	  system	  (GE	  Healthcare),	  the	  sample	  was	  loaded	  and	  washed	  with	   four	   CV	   Mono	  Q	  150.	   For	   elution	   a	   linear	   salt	   gradient	   over	   twelve	   CV	  starting	  with	  100%	  Mono	  Q	  150	  and	  finishing	  with	  100%	  Mono	  Q	  2000	  was	  run.	  Pol	  II	   typically	   eluted	   at	   a	   conductivity	   of	   50–55	  mS/cm	   and	   the	   respective	  fractions	  were	  pooled.	  	  
Buffer	  exchange,	  ammonium	  sulphate	  precipitation	  and	  storage	  After	  anion	  exchange	  chromatography	  the	  pooled	  sample	  was	  diluted	  and	  buffer	   was	   exchanged	   in	   an	   Amicon	   Ultra-­‐15	   concentrator	   with	   a	   molecular	  weight	   cut-­‐off	   at	   100	  kDa	   (Millipore)	   to	   Pol	  II	   size	   exclusion	   buffer	   (Table	   10)	  followed	   by	   ammonium	   sulphate	   precipitation,	   freezing	   of	   the	   pellet	   in	   liquid	  nitrogen	  and	  storage	  at	  -­‐80	  °C.	  	  	  
2.5.3 Purification	  of	  the	  recombinant	  Rpb4/7	  subcomplex	  	  Cells	   from	   8	  l	   expression	   culture	   were	   pooled	   and	   lysed	   using	   a	  homogeniser	   (EmulsiFlex-­‐C5,	   Avestin).	   Lysates	   were	   cleared	   by	   centrifugation	  (2×	   30	  min,	   26,890	  g,	   4	  °C).	   Four	   times	   2	  ml	   Ni-­‐NTA	   agarose	   (Qiagen)	   were	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equilibrated	   with	   five	   CV	   IMAC	   buffer	  without	   imidazole	   (Table	   11).	   All	  subsequent	  steps	  were	  carried	  out	  at	  4	  °C.	  The	  lysate	  was	  loaded	  twice	  by	  gravity	  flow.	   The	   resin	   was	   washed	   with	   five	   CV	   IMAC	   buffer	  without	   imidazole	   then	  with	  three	  CV	  each	  of	  IMAC	  salt	  buffer	  (Table	  11),	  IMAC	  buffer	  with	  10	  mM	  and	  with	  20	  mM	  imidazole.	  Proteins	  were	  eluted	  applying	  three	  CV	  IMAC	  buffer	  with	  50	  mM	  and	  six	  CV	  with	  200	  mM	  imidazole.	  Ni-­‐NTA	  elution	  fractions	  were	  pooled	  and	  diluted	  slowly	  with	  SourceQ	  0	  to	  the	  conductivity	  of	  SourceQ	  100	  (Table	  11).	  The	   sample	  was	   filtered	  using	   a	  Millex-­‐GP,	   filter	   pore	   size	   0.22	  µm	   (Millipore).	  The	   following	   steps	   were	   performed	   using	   an	   ÄKTA	   HPLC	   system	   (GE	  Healthcare).	  The	  anion	  exchange	  column	  (Source	  15Q	  16/10,	  GE	  Healthcare)	  was	  equilibrated	   with	   a	   mixture	   of	   5%	   Source	  Q	  2000	   and	   95%	   Source	  Q	  0.	   The	  pooled	  Ni-­‐NTA	  elution	  fractions	  were	  loaded	  onto	  the	  column	  and	  washed	  with	  two	   CV.	   Elution	  was	   performed	  with	   a	   linear	   salt	   gradient	   of	   100	   to	   1000	  mM	  NaCl	  (5%	  to	  50%	  Source	  Q	  2000)	  over	  ten	  CV.	  Rpb4/7	  eluted	  at	  a	  conductivity	  of	  28	   to	   31	  mS/cm.	   Rpb4/7	   containing	   fractions	   from	   the	   anion	   exchange	  chromatography	   were	   pooled	   and	   concentrated	   to	   a	   volume	   of	   5	   ml	   using	   an	  Amicon	  Ultra-­‐15	  centrifugal	  filter	  unit	  with	  a	  molecular	  weight	  cut-­‐off	  at	  10	  kDa	  (Millipore).	   The	   protein	   solution	   was	   filtered	   as	   before	   and	   subjected	   to	   size	  exclusion	   chromatography	   using	   a	   HiLoad	  26/60	   Superdex	  75	  pg	   column	   (GE	  Healthcare)	  with	   Pol	  II	   size	   exclusion	   buffer.	   Fractions	   of	   interest	  were	   pooled	  and	   concentrated	   as	   before	   to	   a	   concentration	   of	   6	  mg/ml.	   40	  µl	   aliquots	  corresponding	   to	   5	  nmol	   Rpb4/7	  were	   frozen	   in	   liquid	   nitrogen	   and	   stored	   at	  -­‐80	  °C.	  	  	  
2.5.4 Assembly	  of	  the	  RNA	  polymerase	  II-­‐Iwr1	  complex	  	  To	  assemble	  the	  Pol	  II-­‐Iwr1	  complex,	  pure	  Pol	  II,	  Rpb4/7	  and	  Iwr1	  were	  mixed	  in	  a	  1:5:5	  stoichiometric	  ratio.	  The	  volume	  was	  increased	  to	  at	  least	  100	  µl	  by	  adding	  Pol	  II	  buffer.	  The	  sample	  was	  incubated	  in	  a	  thermomixer	  at	  20	  °C	  over	  a	  period	  of	  20	  min.	  Next,	  size	  exclusion	  chromatography	  was	  performed	  with	  a	  Superose	  6	  column	  (GE	  Healthcare)	  and	  Pol	  II	  buffer.	  Elution	  fractions	  of	  interest	  were	  either	  pooled	  and	  concentrated	  for	  structural	  analysis	  or	  TCA	  precipitated	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and	   run	   on	   a	   SDS-­‐PAGE.	   The	   Pol	   II-­‐Iwr1	   complex	   eluted	   at	   around	   12	  ml.	  Optionally,	   static	   light	   scattering	   was	   applied	   along	   with	   the	   size	   exclusion	  chromatography	   to	  measure	   the	  molecular	  weight	  of	   the	  eluted	  complexes	  and	  proteins.	  	  	  
2.5.5 Competition	  of	  Iwr1	  with	  nucleic	  acids	  and	  GTFs	  for	  RNA	  polymerase	  
II	  binding	  	  For	   competition	   experiments	   the	  Pol	  II-­‐Iwr1	   complex	  was	   assembled	   as	  described	   (see	   2.5.4).	   Competing	   species	   were	   either	   added	   to	   the	   assembly	  mixture	   or	   to	   a	   preformed	   Pol	  II-­‐Iwr1	   complex.	   Nucleic	   acids,	   such	   as	   the	   FC*	  aptamer	  (Kettenberger	  et	  al,	  2006)	  or	  a	  minimal	  promoter	  scaffold	  (Damsma	  et	  al,	  2007)	  were	  added	  in	  2-­‐fold	  excess	  relative	  to	  Pol	  II	   in	  the	  assembly	  mixture.	  Competition	  was	  not	  dependent	  on	  the	  order	  of	  addition,	  i.e.	  if	  nucleic	  acids	  were	  added	   before	   or	   after	   Iwr1.	   TFIIB	   (10-­‐fold	   excess)	   and	   TBP/TFIIB	   (10-­‐fold	  excess)	  together	  with	  a	  closed	  promoter	  scaffold	  (4-­‐fold	  excess,	  template	  strand	  5'-­‐AAG	  CTC	  AAG	  TAC	  TTA	  CGC	  CTG	  GTC	  ATT	  ACT	  AGC	  TGA	  CCA	  TAC	  TGC	  ATT	  TTA	  TAG	  GCG	  CCC	  GC-­‐3',	  non-­‐template	  strand	  fully	  complementary)	  were	  added	  to	   a	   preformed	   Pol	  II-­‐Iwr1	   complex.	   The	   sample	   was	   incubated	   for	   30	  min	   at	  20	  °C	   in	   a	   thermomixer	   and	   analysed	   by	   size	   exclusion	   chromatography,	   TCA	  precipitation	  of	  Pol	   II-­‐Iwr1	   fractions	  and	  SDS-­‐PAGE.	  Binding	  of	  nucleic	  acids	   to	  polymerase	  was	  monitored	  by	  an	  increase	  in	  the	  260/280	  nm	  absorption	  ratio.	  	  	  
2.5.6 Reciprocal	  pull-­‐down	  experiments	  	  To	   more	   closely	   investigate	   the	   interaction	   of	   Iwr1	   with	   Pol	  II,	   Strep-­‐tagged	   Iwr1	   variants	  were	   purified	   (see	   2.5.1)	   for	   use	   in	   reciprocal	   pull-­‐down	  experiments	   with	   His-­‐tagged	   polymerase.	   The	   Iwr1	   variants	   were	   incubated	  with	  20	  µg	  His-­‐tagged	  Pol	  II	  in	  5-­‐fold	  molar	  excess	  for	  20	  min	  at	  20	  °C	  in	  a	  50	  µl	  reaction	  volume.	  The	  mixture	  was	  then	  subjected	  to	  either	  30	  µl	  Ni-­‐NTA	  agarose	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beads	   (Qiagen)	   or	   20	  µl	   Strep	   agarose	   beads	   (IBA	   BioTAGnology)	   and	   binding	  was	   allowed	   for	   30	  min	   at	   20	  °C	   in	   a	   thermomixer	   shaking	   at	   1,400	  rpm.	  Next,	  three	  wash	  steps	  were	  performed	  with	  300	  µl	  Pol	  II	  buffer	  each,	  including	  10	  mM	  imidazole	   for	   Ni-­‐NTA	   agarose	   beads.	   Protein	   was	   eluted	   with	   20	  µl	   Pol	  II	   size	  exclusion	   buffer	   including	   300	  mM	   imidazole	   for	   Ni-­‐NTA	   agarose	   beads	   or	  2.5	  mM	  desthiobiotin	  for	  Strep	  agarose	  beads.	  Post-­‐binding	  and	  elution	  fractions	  were	  analysed	  by	  SDS-­‐PAGE.	  As	  controls	  to	  assess	  unspecific	  binding,	  pull-­‐downs	  with	  only	  either	  Iwr1	  variants	  or	  Pol	  II	  were	  used.	  	  	  
2.5.7 Static	  light	  scattering	  analysis	  	  Static	   light	   scattering	   analysis	   was	   performed	   using	   a	   Superose	  6	   size	  exclusion	   column	   (GE	   Healthcare)	   combined	   with	   a	   triple	   detector	   TDA	  (Viscotek).	  Runs	  were	  performed	  with	  Pol	  II-­‐Iwr1	  assembly	  mixtures	  (see	  2.5.4)	  containing	  typically	  100	  µg	  Pol	  II.	  Smaller	  molecular	  weight	  peaks,	  such	  as	  those	  of	   unbound	   Rpb4/7	   and	   Iwr1,	   were	   used	   as	   internal	   controls	   for	   the	  measurement.	   For	   direct	   comparison	   the	   molecular	   weight	   of	   Pol	  II	   was	  measured	  in	  a	  subsequent	  run	  with	  the	  same	  experimental	  setup.	  Data	  analysis	  was	  performed	  with	  the	  OmniSEC	  software	  (Viscotek).	  	  	  
2.6 Structural	  analysis	  of	  the	  RNA	  polymerase	  II-­‐Iwr1	  
complex	  
2.6.1 Negative	  stain	  	  Assembled	   Pol	  II-­‐Iwr1	   complexes	   were	   concentrated	   to	   0.1	  mg/ml	   and	  applied	   to	   glow-­‐discharged	   carbon	   coated	   holey	   grids	   (Quantifoil	  R3/3,	   2	  nm	  carbon	  on	  top).	  Negative-­‐stain	  samples	  were	  treated	  with	  2%	  uranyl	  acetate	  and	  subsequently	  dried	  at	  room	  temperature.	  Images	  were	  recorded	  on	  a	  FEI	  Tecnai	  Spirit	  microscope	  operating	  at	  120	  kV,	  equipped	  with	  a	  LaB6	  filament	  and	  a	  2k	  by	  2k	  FEI	  Eagle	  CCD	  camera	  at	  a	  magnification	  of	  90,000.	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2.6.2 Preparation	  of	  cryo-­‐grids	  	  Pol	  II-­‐Iwr1	   complexes	   were	   applied	   to	   carbon	   coated	   holey	   grids	   as	  described	   (see	   2.6.1).	   Cryo-­‐samples	  were	   flash-­‐frozen	   in	   liquid	   ethane	   using	   a	  semi-­‐automated	  controlled-­‐environment	  system	  (Vitrobot,	  FEI	  Company)	  at	  4°	  C,	  95%	  humidity,	  and	  stored	  in	  liquid	  nitrogen	  until	  transfer	  to	  the	  microscope.	  	  	  
2.6.3 Cryo-­‐electron	  microscopic	  data	  collection	  	  Micrographs	  were	  recorded	  on	  Kodak	  SO-­‐163	  electron	   film	  with	  100	  ms	  pre-­‐exposure	  under	  low-­‐dose	  conditions	  of	  ~25	  electrons/Å2	  on	  a	  Tecnai	  Polara	  F30	  field	  emission	  gun	  microscope	  operating	  at	  300	  kV	  and	  underfocus	  values	  in	  the	   range	   of	   1.5-­‐3.5	  µm.	   Negative	   film	   images	   were	   scanned	   on	   a	   Heidelberg	  drum	  scanner	  with	  a	  pixel	  size	  of	  1.23	  Å	  on	  the	  object	  scale.	  	  	  
2.6.4 Single	  particle	  reconstruction	  	  The	   contrast	   transfer	   function	   was	   determined	   using	   CTFFIND	   and	  SPIDER	  (Frank	  et	  al,	  1996).	  Particles	  were	  picked	  automatically	  with	  SIGNATURE	  (Chen	  &	  Grigorieff,	  2007)	  and	  subjected	  to	  manual	  negative	  selection.	  Data	  were	  processed	   using	   SPIDER	   (Frank	   et	   al,	   1996).	   Initially	   47,617	   particles	   from	   35	  micrographs	   were	   decimated	   three-­‐fold	   by	   pixel	   binning	   and	   aligned	   to	   the	  complete	   Pol	  II	   structure	   (1WCM)	   (Armache	   et	   al,	   2005a)	   that	   was	   Gaussian	  filtered	   to	   25	  Å	   resolution.	   After	   the	   first	   20	   rounds	   of	   angular	   refinement	  particles	  were	  sorted	  against	  two	  references:	  1)	  the	  current	  reconstruction	  and	  2)	  the	  initial	  reference	  filtered	  to	  22.5	  Å	  resolution.	  A	  cross-­‐correlation	  value	  was	  calculated	  for	  each	  particle	  projected	  onto	  each	  of	   the	  two	  references.	  Particles	  were	  assigned	  to	  the	  reference	  group	  bearing	  the	  higher	  cross-­‐correlation	  value.	  Particle	   groups	   were	   then	   back-­‐projected	   separately	   and	   the	   resulting	  reconstructions	  were	  used	  as	  input	  references	  for	  the	  next	  round	  of	  sorting.	  This	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procedure	  was	   repeated	   until	   the	   distribution	   of	   particles	   converged	   after	   five	  more	   rounds	  of	   sorting	  and	   refinement.	   Sorting	   resulted	   in	   a	   volume	  based	  on	  25,206	   particles	   showing	   a	   significant	   difference	   density	   in	   the	   Pol	  II	   cleft	   and	  22,411	  particles	  being	  assigned	  to	  the	  initial	  reference.	  Also	  a	  significant	  positive	  difference	  density	  appeared	  next	  to	  the	  Rpb4/7	  region	  that	  was	  complemented	  by	  a	  negative	  difference	  density	  on	  the	  opposite	  side	  of	  Rpb4/7.	  This	   implied	  a	  shift	   of	   this	   region	   relative	   to	   the	   position	   in	   the	   crystal	   structure	   and	  substantiated	   that	   the	   map	   was	   free	   of	   reference	   bias	   and	   represented	  experimental	   data.	   The	   images	   were	   back-­‐projected	   in	   real	   space	   using	   the	  refined	   angles.	   The	   resulting	   reconstruction	  was	  Butterworth	   low-­‐pass	   filtered	  to	  22.5	  Å	  and	  used	  as	  a	  reference	  for	  another	  round	  of	  alignment	  and	  refinement	  as	  described	  above.	  This	  procedure	  was	   iterated	  until	  no	   changes	   in	  growth	  of	  additional	  densities	  were	  observed.	  Finally,	  a	  20.9	  Å	  reconstruction	  in	  real	  space	  using	  the	  BP	  RP	  algorithm	  of	  SPIDER	  was	  obtained.	  The	  resolution	  for	  the	  final	  volume	   was	   estimated	   based	   on	   a	   cut-­‐off	   value	   of	   0.5	   for	   the	   Fourier	   shell	  correlation.	   A	   difference	   density	   was	   calculated	   by	   subtracting	   the	   reference	  filtered	   to	   the	   same	   resolution	   from	   the	   Pol	  II-­‐Iwr1	   reconstruction	   using	  normalized	   maps.	   Additionally,	   a	   difference	   density	   with	   a	   reconstruction	   of	  Pol	  II	   by	   itself	  was	   calculated	  which	  was	   in	   agreement	  with	   the	   location	  of	   the	  major	  difference	  density	  derived	  by	   the	  prior	  analysis.	  Although	  this	  difference	  density	   was	   larger,	   interpretation	   was	   complicated	   by	   the	   presence	   of	   higher	  noise	  levels.	  	  	  
2.7 Gene	  expression	  profiling	  
2.7.1 Sample	  preparation	  and	  microarray	  measurement	  	  	  For	  microarray	  measurements	  cells	  were	  grown	   in	  YP	  medium	  with	  2%	  glucose.	  Three	  independent	  colonies	  were	  used	  for	  inoculation	  of	  overnight	  pre-­‐cultures,	  which	  were	  diluted	   to	   an	  OD600	   of	   0.1	   and	   grown	   to	  0.8	   the	  next	   day	  (25	  ml	   cultures,	   incubator	   shaking	   at	   160	  rpm,	   30	  °C).	   Cells	  were	   harvested	   by	  centrifugation	  (4,000	  rpm,	  3	  min,	  20	  °C).	  Total	  RNA	  was	  prepared	  after	  cell	  lysis	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using	   a	   mixer	   mill	   (Retsch)	   and	   subsequent	   purification	   using	   the	   RNeasy	   kit	  (Qiagen).	   The	   total	   RNA	   preparation	   was	   treated	   on-­‐column	   with	   DNase	  (Qiagen).	   All	   following	   steps	   were	   conducted	   according	   to	   the	   Affymetrix	  GeneChip	   Expression	   Analysis	   Technical	   Manual	   (P/N	   702232	   rev.	   2).	   Briefly,	  one-­‐cycle	   cDNA	   synthesis	   was	   performed	   with	   1	  μg	   of	   total	   RNA.	   In	   vitro	  transcription	   labelling	  was	   carried	   out	   for	   16	  h.	   The	   fragmented	   samples	  were	  hybridized	  for	  16	  h	  on	  Yeast	  Genome	  2.0	  expression	  arrays	  (Affymetrix),	  washed	  and	   stained	   using	   a	   Fluidics	  450	   station,	   and	   scanned	   on	   an	   Affymetrix	  GeneArray	  scanner	  3000	  7G.	  	  	  
2.7.2 Statistical	  data	  analysis	  	  Data	   analysis	  was	   performed	  with	   support	   from	  Tobias	  Koschubs	   using	  R/Bioconductor	   (Gentleman	   et	   al,	   2004).	   Schizosaccharomyces	   pombe	   probes	  were	  removed	  before	  normalization	  with	  the	  GCRMA	  algorithm	  (Wu	  &	  Irizarry,	  2004).	   Linear	  model	   fitting	   and	  multiple	   testing	   correction	   using	   an	   empirical	  Bayes	   approach	   was	   performed	   using	   the	   LIMMA	   package	   (Smyth,	   2004).	  Differentially	   expressed	   genes	   were	   defined	   as	   having	   an	   adjusted	   P-­‐value	  smaller	   than	   0.05	   and	   an	   estimated	   fold-­‐change	   of	   at	   least	   2.0	   (based	   on	   the	  mean	   expression	   levels	   in	   the	   triplicate	   measurements).	   Classification	   of	  significantly	   differentially	   expressed	   genes	  was	   carried	   out	   according	   to	   Super	  GO-­‐Slim:	   Process	   of	   the	   SGD	   Gene	   Ontology	   Slim	   Mapper	  (www.yeastgenome.org).	   To	   check	   whether	   the	   effects	   of	   an	   IWR1	   knockout	  resemble	   those	  of	  a	   transcription	   factor	  knockout,	  Achim	  Tresch	  compared	   the	  IWR1	   knockout	   profiles	   with	   a	   re-­‐analysis	   (Reimand	   et	   al,	   2010)	   of	   a	   yeast	  transcription	   factor	   knockout	   compendium	   (Hu	  et	   al,	   2007).	  Pair-­‐wise	  Pearson	  correlations	   of	   the	   fold	   expression	   (relative	   to	   wild	   type)	   were	   calculated	  between	   all	   profiles.	   The	   first	   two	   principal	   components	   of	   the	   resulting	  correlation	  matrix	  were	  visualized	  in	  Figure	  13	  (see	  3.4.3).	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3 Results	  and	  Discussion	  
3.1 RNA	  polymerase	  II	  nuclear	  localization	  is	  
specifically	  dependent	  on	  the	  Iwr1	  NLS	  	  Pol	  II	  assembles	   from	  its	  subunits	   in	   the	  cytoplasm	  (Boulon	  et	  al,	  2010).	  How	   the	   entire	   complex	   is	   imported	   into	   the	   nucleus	   is	   unknown.	   Since	   Pol	  II	  subunit	  sequences	  lack	  a	  known	  nuclear	  localisation	  signal	  (NLS)	  nuclear	  import	  apparently	   requires	   an	   additional	   factor	   (see	   1.5.2).	   Analysis	   of	   the	   protein	  interactome	   in	   the	  yeast	  Saccharomyces	   cerevisiae	   revealed	   that	  Pol	  II	   subunits	  co-­‐purify	  with	  the	  protein	  Iwr1	  (Gavin	  et	  al,	  2002;	  Krogan	  et	  al,	  2006)	  (see	  1.3).	  As	   shown	   in	  proteome-­‐wide	   localization	  experiments,	   Iwr1	   is	   localized	  both	   in	  the	  cytoplasm	  and	  in	  the	  nucleus	  (Huh	  et	  al,	  2003),	  making	  it	  a	  likely	  candidate	  for	  being	  involved	  in	  nuclear	  import	  of	  Pol	  II.	  	  	  
3.1.1 Iwr1	  contains	  a	  bioinformatically	  predicted	  bipartite	  NLS	  that	  is	  
functional	  in	  vivo	  	  Inspection	   and	   bioinformatic	   analysis	   of	   several	   Iwr1	   homologues	   with	  the	   program	   cNLS	   Mapper	   (Kosugi	   et	   al,	   2009b)	   led	   to	   the	   identification	   of	   a	  putative	   bipartite	   classical	   NLS	   (Figure	   1).	   Earlier	   computational	   identification	  might	  have	  been	  missed	  due	  to	  the	  unusually	  long	  linker	  of	  14	  a.	  a.	  between	  the	  two	  basic	  parts	  of	  the	  NLS	  in	  Saccharomyces	  cerevisiae	  that	  is	  not	  accounted	  for	  by	  the	  PROSITE	  profile	  (Dingwall	  &	  Laskey,	  1991).	  	  
RESULTS	  AND	  DISCUSSION	  
47	  
	  	  
Figure	  1	  ⋅ 	  Sequence	  conservation	  and	  functional	  elements	  of	  Iwr1.	  Schematic	  representation	  of	  yeast	  (S.c.)	  Iwr1	  and	  amino	  acid	  sequence	  conservation.	  The	  Pol	  II-­‐binding	  region	  is	  indicated	  in	   grey,	   boxes	   delineate	   NLS	   and	   NES	   sequences.	   Invariant	   residues	   are	   highlighted	   in	   green,	  residues	  with	  ≥80%	  conservation	  in	  yellow.	  Asterisks	  indicate	  mutations	  to	  alanine	  in	  the	  mutant	  variants.	   S.c.	   Saccharomyces	   cerevisiae,	   C.g.	   Candida	   glabrata,	   A.t.	   Arabidopsis	   thaliana,	   D.m.	  
Drosophila	  melanogaster,	  H.s.	  Homo	  sapiens.	  	  	  While	  this	  work	  was	  ongoing,	  a	  leucine-­‐rich	  nuclear	  export	  signal	  (NES)	  in	  Iwr1	   being	   recognized	   by	   the	   karyopherin	   Xpo1	  was	   reported	   (Peiro-­‐Chova	  &	  Estruch,	  2009).	  As	  the	  functional	  relevance	  of	  the	  putative	  Iwr1	  NLS	  could	  not	  be	  shown	  easily	  by	  nuclear	  exclusion	  of	  the	  protein	  upon	  mutation	  of	  the	  NLS,	  the	  possibility	  was	  used	  to	  trap	  the	  factor	  within	  the	  nucleus	  by	  deleting	  its	  NES.	  As	  expected	   enhanced	   green	   fluorescent	   protein	   (EGFP)-­‐tagged	   Iwr1	   expressed	  from	   a	   plasmid	   under	   its	   natural	   promoter	   showed	   a	   pan-­‐cellular	   localization,	  which	  was	  shifted	  to	  an	  exclusively	  nuclear	  localization	  upon	  deletion	  of	  its	  NES	  (Figure	  2).	  Additionally	  mutating	  the	  conserved	  arginines	  and	  lysines	  to	  alanines	  in	  the	  N-­‐terminal	  part	  of	  the	  bipartite	  NLS	  (Figure	  1)	  abrogated	  nuclear	  trapping	  and	  consequently	  led	  to	  cytoplasmic	  localization	  of	  Iwr1ΔNES/NLS-­‐Nmutant-­‐EGFP	  (Figure	   2).	   Thus,	   the	   in	   vivo	   functionality	   of	   the	   bioinformatically	   predicted	  bipartite	   NLS	   in	   Iwr1	   could	   be	   confirmed.	   Accordingly,	   Iwr1	   is	   a	   nucleo-­‐cytoplasmic	  shuttling	  protein	  by	  means	  of	  its	  own	  NLS	  and	  NES.	  	  
RESULTS	  AND	  DISCUSSION	  
48	  
	  	  
Figure	  2	  ⋅ 	  Nuclear	  entry	  of	  Iwr1	  is	  dependent	  on	  its	  bipartite	  NLS.	  Localization	  of	  Iwr1-­‐EGFP	  in	  ∆iwr1	  cells	  expressing	  the	  indicated	  Iwr1	  variants.	  Nuclear	  staining	  with	  DAPI.	  	  	  
3.1.2 RNA	  polymerase	  II	  mislocalizes	  to	  the	  cytoplasm	  in	  cells	  lacking	  
Iwr1	  	  To	   test	   the	   hypothesis	   that	   Iwr1	   is	   involved	   in	   nuclear	   import	   of	   Pol	  II,	  yeast	   strains	   carrying	   an	  EGFP	   fusion	   of	   the	   genes	   encoding	   the	  Pol	   II	   subunit	  Rpb1,	   Rpb3	   and	   Rpb4,	   respectively,	   were	   constructed.	   These	   subunits	   were	  chosen,	  as	  Rpb1	  and	  Rpb3	  represented	  two	  major	  Pol	  II	  assembly	  intermediates	  (Boulon	   et	   al,	   2010)	   and	   Rpb4	   was	   described	   to	   additionally	   be	   involved	   in	  processes	   independent	   of	   the	   core	   polymerase	   (Selitrennik	   et	   al,	   2006).	   In	  growing	   cells	   from	   these	   strains,	   fluorescence	   was	   restricted	   to	   the	   nucleus,	  indicating	   that	   Pol	  II	   was	   localized	   in	   the	   nucleus	   as	   expected	   (Figure	   3).	  However,	  in	  a	  strain	  that	  additionally	  contained	  a	  deletion	  of	  the	  gene	  encoding	  Iwr1	   (Δiwr1),	   Pol	  II,	   represented	   by	   the	   three	   subunits,	   accumulated	   in	   the	  cytoplasm	  (Figure	  3).	  The	  delocalization	  of	  Rpb4	  was	  not	  as	  severe	  as	  for	  Rpb1	  and	  Rpb3,	  which	  seems	  understandable	  as	  Rpb4	  is	  described	  to	  undergo	  nucleo-­‐cytoplasmic	   shuttling	   independent	   of	   the	   core	   polymerase	   (Selitrennik	   et	   al,	  2006)	  and	  considering	  the	  up	  to	  eleven-­‐fold	  higher	  amount	  of	  Rpb4	  as	  compared	  to	  Rpb3	  that	  is	  limiting	  for	  Pol	  II	  complex	  formation	  (Kimura	  et	  al,	  2001).	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In	  addition	  to	   the	  Pol	  II	  delocalization,	  Δiwr1	  cells	  had	  an	   increased	  size	  and	   typically	  possessed	  an	  elongated	  shape.	  Nuclear	   localization	  of	  Pol	  II	   could	  however	   be	   rescued	   by	   transformation	   of	   a	   plasmid	   expressing	   Iwr1	   from	   its	  natural	   promoter	   (Figure	   3A).	   Similarly,	   the	   cells	   returned	   to	   their	   wild-­‐type	  morphology.	  Iwr1	  is	  therefore	  required	  for	  proper	  nuclear	  localisation	  of	  Pol	  II.	  	  	  
	  	  
Figure	  3	  ⋅ 	  Iwr1	  is	  required	  for	  nuclear	  localization	  of	  Pol	  II.	  Localization	  of	  Rpb3-­‐	  (A),	  Rpb1-­‐	  (B)	   and	   Rpb4-­‐EGFP	   (C)	   in	   wild-­‐type	   and	   ∆iwr1	   cells	   expressing	   the	   indicated	   Iwr1	   variants	  (-­‐,	  empty	  plasmid).	  Nuclear	  staining	  with	  DAPI.	  	  	  
3.1.3 RNA	  polymerase	  II	  nuclear	  localization	  requires	  the	  Iwr1	  NLS	  	  Rescue	  of	  Δiwr1	  cells	  depended	  on	  the	  NLS	  of	  Iwr1,	  as	  it	  was	  not	  achieved	  with	  Iwr1	  variants	  that	  lacked	  the	  NLS	  (not	  shown)	  or	  carried	  mutations	  in	  NLS	  subsites	  (Figure	  3A).	  In	  general,	  Pol	  II	  mislocalization	  persisted	  upon	  expression	  of	   Iwr1	   variants	   with	   mutations	   in	   either	   the	   N-­‐	   or	   C-­‐terminal	   part	   of	   the	  bipartite	   NLS,	   as	  well	   as	  with	   both	   of	   them	   combined.	   Yet,	   the	   severity	   of	   the	  mislocalization	  seemed	  to	  vary	  between	  different	  NLS	  mutants,	  which	   is	  why	  a	  more	  detailed	  quantitative	  investigation	  was	  carried	  out	  in	  addition	  (see	  3.5.1).	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Surprisingly,	   the	   Iwr1	   variant	   with	   the	   NES	   deletion	   was	   capable	   of	  restoring	  nuclear	  Pol	  II	  localization,	  although	  the	  cells	  seemed	  to	  have	  a	  tendency	  towards	  the	  more	  elongated	  shape,	  characteristic	  for	  the	  Δiwr1	  mutant.	  Apparently,	  cells	  can	  tolerate	  loss	  of	  cyclic	  shuttling	  of	  Iwr1	  between	  the	  cytoplasm	   and	   the	   nucleus	   during	   exponential	   growth.	   In	   this	   view,	   nuclear	  import	  of	  one	  Pol	  II	  complex	  per	  Iwr1	  protein	  is	  sufficient	  to	  bring	  about	  a	  close-­‐to-­‐wild-­‐type	  phenotype.	  However,	  the	  function	  of	  the	  Iwr1	  NLS	  is	  indispensable	  for	  efficient	  Pol	  II	  nuclear	  import.	  	  	  
3.1.4 The	  human	  homologue	  of	  Iwr1	  partially	  rescues	  RNA	  polymerase	  II	  
nuclear	  localization	  in	  Saccharomyces	  cerevisiae	  	  To	   assess	   the	   evolutionary	   relevance	   of	   Iwr1-­‐dependent	   Pol	  II	   nuclear	  import	  beyond	  yeast,	  an	  in-­‐depth	  search	  for	  homologues	  was	  undertaken.	  Using	  the	  sensitive	  CSI-­‐BLAST	  method	  (Biegert	  &	  Soding,	  2009)	  a	  putative	  homologue	  in	   humans	   could	   be	   found	   (Figure	   1).	   Most	   importantly,	   the	   NLS	   sequence	   is	  conserved	   from	  yeast	   to	  humans.	  No	  homologues	  were	  detected	   in	  bacteria	   or	  archaea.	  The	  functional	  conservation	  of	  the	  human	  Iwr1	  homologue	  was	  assessed	  using	   the	  established	  Pol	  II	   localization	  assay	   in	  Δiwr1	  yeast	   cells	   (Figure	  4).	  A	  synthetic	   gene	   encoding	   human	   Iwr1	  with	   codons	   optimized	   for	   expression	   in	  
Saccharomyces	  cerevisiae	  (see	  2.2.2)	  was	  inserted	  under	  the	  control	  of	  the	  yeast	  Iwr1	   promoter	   and	   terminator	   sequences	   in	   a	   rescue	   plasmid.	   After	  transformation	   of	   the	   plasmid	   into	  Δiwr1	   yeast	   cells	   Pol	  II	   nuclear	   localization	  was	  indeed	  partly	  restored.	  Therefore,	  human	  Iwr1	  is	  functional	  in	  yeast,	  although	  the	  conservation	  of	  39%	   (conserved	   residues)	   between	   the	   yeast	   and	   corresponding	   human	   Pol	  II	  binding	   region	   (see	   3.2.2)	   is	   rather	   low.	   More	   importantly,	   the	   mechanism	  elucidated	   for	   yeast	   Pol	  II	   nuclear	   import	   in	   this	  work,	   is	   likely	   to	   hold	   true	   in	  humans.	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Figure	   4	   ⋅ 	   The	   human	   homologue	   of	   yeast	   Iwr1	   partially	   rescues	   the	   growth	   defect	   in	  
Δ iwr1	  cells.	  Localization	  of	  Rpb3-­‐EGFP	  in	  wild-­‐type	  and	  ∆iwr1	  cells	  expressing	  the	  human	  Iwr1	  homologue	  (-­‐,	  empty	  plasmid).	  Nuclear	  staining	  with	  DAPI.	  	  	  
3.1.5 RNA	  polymerase	  II	  nuclear	  localization	  is	  independent	  of	  Rpb4	  	  Although	   no	   NLS	   was	   found	   in	   any	   of	   the	   Pol	  II	   core	   subunits,	   a	   Pol	  II	  independent	   role	   for	   the	   Rpb4/7	   heterodimer	   involving	   nucleo-­‐cytoplasmic	  shuttling	  was	   reported	   as	   already	  mentioned	   (Selitrennik	   et	   al,	   2006).	   Yet,	   no	  NLS	  was	  described	  in	  the	  Rpb4/7	  heterodimer	  by	  this	  study.	  A	   closer	   bioinformatic	   inspection	   of	   the	   Rpb4	   sequence	   revealed	   a	  potential	   bipartite	   N-­‐terminal	   NLS	  with	   a	   good	   confidence	   score	   ranging	   from	  a.	  a.	  8	  to	  40	  (Kosugi	  et	  al,	  2009b).	  As	  RPB4	  is	  not	  essential	  the	  gene	  was	  deleted	  in	  the	  Rpb3-­‐EGFP	  reporter	  strain.	  Pol	  II	  localization	  was	  unaltered	  and	  remained	  exclusively	  nuclear	  (Figure	  5).	  The	  parallel	  deletion	  of	  IWR1	  and	  RPB4	  resulted	  in	  the	  typical	  Δiwr1	  phenotype,	  both	  in	  terms	  of	  Pol	  II	  delocalization	  and	  growth	  defect,	   also	   confirming	   earlier	   indications	   of	   a	   suppression	   of	   the	   RPB4	  phenotype	  upon	  deletion	  of	  IWR1	  that	  remains	  unexplained	  (Collins	  et	  al,	  2007).	  A	  role	  of	   the	  nucleo-­‐cytoplasmic	  shuttling	  of	   the	  Rpb4/7	  heterodimer	   in	  nuclear	  import	  of	  Pol	  II	  can	  thus	  be	  discarded	  further	  strengthening	  the	  case	  for	  Iwr1	  being	  the	  principal	  factor	  for	  Pol	  II	  nuclear	  import.	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Figure	  5	   ⋅ 	  Pol	  II	  nuclear	  import	  is	  independent	  of	  Rpb4.	  Localization	  of	  Rpb3-­‐EGFP	  in	  wild-­‐type,	  ∆rpb4	  and	  ∆rpb4/∆iwr1	  cells.	  Nuclear	  staining	  with	  DAPI.	  	  	  
3.1.6 RNA	  polymerase	  I	  and	  III	  nuclear	  localization	  are	  independent	  of	  
Iwr1	  	  To	  assess	   the	   role	  of	   Iwr1	   in	  nuclear	   import	  of	  Pol	  I	   and	  Pol	  III,	   the	   two	  largest	   subunits	   of	   these	   polymerases,	   Rpa190	   and	   C160,	   respectively,	   were	  genomically	   tagged	  with	   EGFP.	   From	   these	   strains,	   variants	  were	   derived	   that	  additionally	  contained	  a	  genomic	  deletion	  of	  IWR1.	  As	  expected,	  Rpa190	  shows	  a	  nucleolar1	  and	  C160	  a	  nuclear	   localization	  in	   wild-­‐type	   background	   (Figure	   6).	   In	   the	   strains	   with	   an	   IWR1	   deletion	   the	  localization	  of	  these	  two	  subunits	  was	  not	  altered.	  Although	  there	  seemed	  to	  be	  a	  slight	  increase	  in	  fluorescent	  signal	  for	  C160	  in	  the	  cytoplasm,	  the	  change	  was	  by	  far	  not	  as	  severe	  as	  for	  Rpb1	  or	  Rpb3	  representing	  Pol	  II.	  As	  association	  of	  Iwr1	  to	  Pol	  I	  or	  Pol	  III	  could	  neither	  be	  confirmed	  in	  vivo2	  (Gavin	  et	  al,	  2002;	  Krogan	  et	  al,	   2006)	   nor	   in	   vitro	   (see	   3.2.1)	   the	   slight	   delocalization	   might	   be	   due	   to	   an	  indirect	  effect.	  This	  seems	  plausible	  when	  the	  broad	  changes	  in	  gene	  expression	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  The	  nucleolar	  localisation	  is	  not	  well	  resolved	  in	  Figure	  6,	  although	  it	  was	  clearly	  visible	  by	  eye	  under	  the	  microscope.	  2	   Krogan	   et	   al,	   2006	   found	   a	   low-­‐confidence	   interaction	   with	   AC40,	   a	   subunit	   that	   is	   shared	  between	  Pol	  I	  and	  Pol	  III	  (see	  Table	  1).	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in	  the	  Δiwr1	  strain	  are	  considered	  that	  might	   lead	  to	   indirect	  alterations	  in	  the	  cell.	   Based	  on	  these	  findings	  the	  conclusion	  is	  drawn	  that	  Iwr1	  is	  not	  involved	  in	  nuclear	  import	  of	  the	  “odd”	  polymerases	  Pol	  I	  and	  Pol	  III	  and	  hence	  that	  Iwr1	  is	  a	  specific	  factor	  for	  Pol	  II	  nuclear	  import.	  	  	  
	  	  
Figure	  6	  ⋅ 	  Pol	  I	  and	  III	  nucleolar	  and	  nuclear	  localization,	  respectively	  are	  independent	  of	  
Iwr1.	  The	   localization	  of	  Pol	   I,	   II	   and	   III	   largest	   subunits	  Rpa190-­‐EGFP,	  Rpb1-­‐EGFP	  and	  C160-­‐EGFP,	  respectively,	  in	  cells	  with	  and	  without	  IWR1	  is	  depicted.	  Nuclear	  staining	  with	  DAPI.	  	  	  
3.2 Iwr1	  binds	  RNA	  polymerase	  II	  directly	  via	  an	  N-­‐
terminal	  binding	  region	  	  Co-­‐purification	  of	   Iwr1	  with	  Pol	  II	   subunits	  does	  not	  necessarily	   imply	  a	  direct	  interaction.	  Additional	  Pol	  II-­‐related	  proteins,	  such	  as	  Tfg1,	  Tfg2	  and	  Spt5,	  as	  well	  as	  other	  proteins,	  such	  as	  Cbf2	  (a	  kinetochore	  protein)	  or	  Cns1	  (a	  HSP90	  co-­‐chaperone)	   were	   identified	   in	   the	   complexes	   (Krogan	   et	   al,	   2006),	   which	  might	  provide	  a	  physical	  link	  between	  Iwr1	  and	  Pol	  II.	  To	  clarify	  this	  ambiguity	  the	  formation	  of	  the	  Pol	  II-­‐Iwr1	  complex	  was	  recapitulated	  in	  vitro.	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3.2.1 Iwr1	  binds	  directly	  and	  specifically	  to	  RNA	  polymerase	  II	  	  Recombinantly	  expressed	  and	  purified	  yeast	  Iwr1	  was	  incubated	  in	  five-­‐fold	  excess	  with	  pure	  Pol	  II.	  Then,	   the	  sample	  was	  passed	  over	  a	  size	  exclusion	  chromatography	   column	   and	   the	   peaks	   and	   fractions	   were	   analyzed	   by	   SDS-­‐PAGE	  (Figure	  7A)	  and	  static	  light	  scattering	  measurements.	  Iwr1	  co-­‐eluted	  with	  the	   other	   Pol	  II	   subunits	   in	   a	   high-­‐molecular	   weight	   peak,	   indicative	   of	   stable	  binding	   of	   the	   factor.	   The	   identity	   of	   the	   Iwr1	   band	   was	   confirmed	   by	   mass	  spectrometry.	  Moreover,	  the	  molecular	  weight	  of	  the	  protein	  complex	  based	  on	  the	  static	  light	  scattering	  analysis	  was	  around	  540	  kDa,	  as	  compared	  to	  514	  kDa	  for	  Pol	  II	  only,	  which	  was	  in	  support	  of	  complex	  formation.	  Also,	   in	   the	   same	  manner,	   binding	   to	   Pol	  I	   and	   Pol	  III	   was	   assessed.	   As	  only	  degradation	  products	   of	   larger	  polymerase	   subunits	   could	  be	  detected	  by	  mass	  spectrometric	  analysis	  of	  SDS-­‐PAGE	  bands	  in	  the	  region	  where	  Iwr1	  was	  to	  be	   expected,	   even	   a	   weak,	   sub-­‐stoichiometric	   association	   seems	   unlikely	   (not	  shown).	  Iwr1	   therefore	   binds	   directly	   and	   specifically	   to	   Pol	  II.	   No	   post-­‐translational	  modifications	  of	  the	  protein,	  such	  as	  a	  possible	  phosphorylation	  at	  serine	  313	  (Albuquerque	  et	  al,	  2008),	  are	  relevant	  for	  the	  association.	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Figure	  7	   ⋅ 	  Assemblies	  of	   Iwr1	  variants	  with	  Pol	  II.	  Coomassie-­‐stained	  SDS-­‐PAGEs	  after	   size-­‐exclusion	  chromatography	  (A-­‐C).	  (A)	  Assembly	  of	  full-­‐length	  Iwr1	  with	  Pol	  II.	  (B)	  Determination	  of	  minimal	  Pol	  II	  binding	  constructs.	  Assemblies	  with	  Pol	  II	  (lanes	  1-­‐3)	  and	  purified	  recombinant	  Iwr1	   variants	   (lanes	   4-­‐6).	   Iwr1	   (9-­‐223)	   binds	   stoichiometrically	   (defined	   as	   the	  minimal	   Pol	  II	  binding	  region);	  Iwr1	  (9-­‐211)	  binds,	  yet	  stoichiometry	  cannot	  be	  determined	  due	  to	  an	  overlap	  of	  the	  respective	  band	  with	  Rpb4;	  Iwr1	  (9-­‐201)	  binds	  substoichiometrically.	  (C)	  Assembly	  of	  Pol	  II	  with	  Iwr1	  NLS-­‐mutants	  N	  and	  C.	  	  	  
3.2.2 Iwr1	  contains	  a	  minimal	  RNA	  polymerase	  II-­‐binding	  region	  that	  is	  
sufficient	  for	  nuclear	  localization	  of	  the	  enzyme	  	  Using	  N-­‐	  and	  C-­‐terminally	  truncated	  variants	  of	   full-­‐length	  Iwr1	   in	  Pol	  II	  binding	   assays	   a	   minimal	   Pol	   II	   binding	   region	   of	   the	   protein	   was	   delineated	  (Table	   12,	   Figure	   7B).	   Truncation	   at	   the	   C-­‐terminus	   until	   position	   223	  did	   not	  affect	   Iwr1	   expression	   levels	   and	   stoichiometric	   binding	   to	   Pol	  II.	   Further	  C-­‐terminal	  truncation	  lead	  to	  an	  overlap	  of	  the	  bands	  of	  Iwr1	  [9-­‐211]	  and	  Rpb4.	  Although	  this	  band	  seemed	  to	  be	  stronger	  than	  expected	  for	  a	  single	  protein,	  full	  stoichiometric	   binding	   could	   not	   be	   confirmed	   unambiguously.	   C-­‐terminal	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truncation	   to	   position	   201,	   decreased	   expression	   levels	   and	   severely	   affected	  Pol	  II	   binding.	   At	   the	   N-­‐terminal	   end	   a	   truncation	   to	   position	   9	   was	   possible	  without	   any	   detrimental	   effect	   on	   expression	   and	   binding,	   whereas	   further	  shortening	   to	   position	   19	   almost	   abolished	   binding	   to	   Pol	  II.	   However,	   a	  construct	   starting	   only	   at	   position	   55	  was	   still	   capable	   of	   showing	   a	   similarly	  weak	  interaction	  with	  Pol	  II.	  A	  stable	  and	  well-­‐expressed	  minimal	  Pol	  II-­‐binding	  region	  was	  therefore	  defined	  as	  extending	  from	  position	  9	  to	  223.	  Interestingly,	  the	  boundaries	  of	  this	  construct	   coincided	  with	  and	   included	   the	  bipartite	  NLS	  at	   the	  N-­‐terminus	  and	  another	  strongly	  conserved	  region	  at	  the	  C-­‐terminus	  (Figure	  1).	  In	   in	   vivo	   rescue	   experiments	   of	   the	   Δiwr1	   strain,	   the	   minimal	   Pol	  II-­‐binding	  region	  turned	  out	  to	  be	  capable	  of	  an	  almost	  wild-­‐type-­‐like	  restoration	  of	  Pol	  II	  nuclear	   localization	   (Figure	  3A).	  The	   lowly	   conserved	  C-­‐terminal	   third	  of	  Iwr1	  therefore	  seems	  dispensable	  in	  terms	  of	  both	  binding	  to	  and	  nuclear	  import	  of	  Pol	  II.	  	  	  
Table	  12	  ⋅ 	  Constructs	  used	  for	  delineation	  of	  the	  Iwr1	  minimal	  Pol	  II-­‐binding	  region	  
Iwr1	   N-­‐terminus	  (extending	  to	  a.	  a.	  353)	   C-­‐terminus	  (starting	  at	  a.	  a.	  1)	  position	  [a.	  a.]	   9	   19	   55	   201	   211	   223	  expression	   good	   bad	   bad	   bad	   good	   good	  Pol	  II	  binding	   yes	   weak	   weak	   weak	   possibly	   good	  	  	  
3.2.3 RNA	  polymerase	  II-­‐binding	  is	  not	  affected	  by	  mutations	  of	  the	  Iwr1	  
NLS	  	  The	   Iwr1	   NLS	   mutants	   are	   not	   capable	   of	   restoring	   Pol	  II	   nuclear	  localization	   in	   the	   Δiwr1	   strain	   (see	   3.1.3,	   Figure	   3A).	   The	   most	   likely	  interpretation	  of	  this	  finding	  is	  to	  infer	  impaired	  NLS	  functionality.	  Alternatively,	  these	  mutations	  could	  impair	  Pol	  II	  binding	  and	  as	  a	  consequence	  result	  in	  non-­‐recruitment	   of	   required	   factors	   for	   Pol	  II	   assembly	   or	   import.	   To	   exclude	   this	  possibility	   the	   Iwr1	   NLS	   N	   and	   NLS	   C	  mutants	  were	   recombinantly	   expressed	  and	  purified	  in	  order	  to	  assess	  their	  capability	  of	  Pol	  II-­‐Iwr1	  complex	  formation.	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As	   expected,	   both	   mutants	   behaved	   like	   the	   wild-­‐type	   protein	   during	   the	  purification.	   No	   aggregate	   peak	   at	   the	   exclusion	   volume	   was	   detectable,	  indicating	   proper	   protein	   folding.	   Furthermore,	   degradation	   was	   present	   in	  similarily	   low	   amounts	   as	   for	   wild-­‐type	   Iwr1.	   Most	   importantly,	   both	   NLS	  mutants	  formed	  stoichiometric	  complexes	  with	  Pol	  II	  (Figure	  7C).	  Iwr1	   NLS	   mutants	   therefore	   should	   still	   be	   functional	   in	   recruiting	  hypothesized	  other	   factors	   of	   relevance	   to	  Pol	  II.	  Only	  binding	  of	   karyopherins	  that	  directly	  recognize	  the	  NLS	  should	  be	  affected	  by	  the	  point	  mutations.	  	  	  
3.3 Iwr1	  binds	  in	  the	  RNA	  polymerase	  II	  active	  centre	  
cleft	  	  Knowing	   about	   the	   architecture	   of	   protein	   complexes	   is	   a	   valuable	  starting	   point	   to	   infer	   possible	   mechanisms	   for	   a	   certain	   factor.	   As	   an	   atomic	  model	  was	  available	  for	  Pol	  II	  it	  was	  desirable	  and	  for	  a	  first	  model	  sufficient	  to	  locate	  Iwr1	  on	  Pol	  II.	  Therefore,	  the	  Pol	  II-­‐Iwr1	  complex	  was	  analysed	  by	  cryo-­‐	  electron	  microscopy	  (EM)	  and	  single	  particle	  reconstruction.	  	  	  
3.3.1 A	  major	  cryo-­‐EM	  difference	  density	  locates	  Iwr1	  in	  the	  RNA	  
polymerase	  II	  active	  centre	  cleft	  	  To	   assess	   the	   homogeneity	   of	   the	   Pol	   II-­‐Iwr1	   complex	   samples	   were	  negatively	   stained	   with	   Uranyl	   acetate.	   Single	   roundish	   particles	   that	   well	  represented	  polymerases	  were	  visible	  on	  the	  grid	  (Figure	  8B).	  Next,	  complexes	  were	   embedded	   in	   vitreous	   ice	   and	   images	  were	   recorded	   under	   low	   electron	  dose	   and	   cryo-­‐conditions	   (see	   2.6).	   Starting	   with	   47,617	   particles	   and	   sorting	  against	  the	  initial	  reference	  after	  the	  first	  20	  rounds	  of	  angular	  refinement	  a	  final	  volume	   based	   on	   25,206	   particles	   at	   21	   Å	   was	   obtained.	   The	   resolution	   was	  estimated	   based	   on	   a	   conservative	   cut-­‐off	   value	   of	   0.5	   for	   the	   Fourier	   shell	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correlation.	   Calculating	   a	   difference	   density	   map	   between	   the	   Pol	  II-­‐Iwr1	  reconstruction	  and	  the	  complete	  Pol	  II	  crystal	  structure	  (Armache	  et	  al,	  2005b)	  resulted	  in	  two	  significant	  positive	  densities	  (Figure	  8A).	  One	  of	  them	  appeared	  in	   the	  Pol	  II	   cleft,	  which	   is	   formed	  by	   the	   two	   largest	   subunits	  Rpb1	  and	  Rpb2.	  The	   other	   one	   was	   on	   the	   upstream	   side	   of	   the	   Rpb4/7	   heterodimer,	  complemented	   by	   a	   negative	   difference	   density	   on	   the	   downstream	   side.	   This	  implied	  a	  shift	  of	  this	  region	  relative	  to	  the	  position	  in	  the	  crystal	  structure	  and	  substantiated	   that	   the	   map	   was	   free	   of	   reference	   bias	   and	   represented	  experimental	  data.	  This	  flexibility	  can	  be	  rationalized	  as	  the	  Rpb4/7	  heterodimer	  contacts	  the	  polymerase	  core	  via	  the	  Rpb1	  clamp	  region	  that	  has	  been	  shown	  to	  be	   flexible	   in	   the	   first	   Pol	  II	   crystal	   structure	   (Cramer	   et	   al,	   2000).	   Also	  underpinning	  this	  flexibility,	  the	  density	  at	  the	  Rpb4/7	  heterodimer	  was	  smaller	  in	  cryo-­‐EM	  reconstructions	  of	  Pol	  II	  alone	  than	   in	  reconstructions	  of	  Pol	  II	  with	  nucleic	  acids	  that	  bind	  in	  the	  cleft	  and	  thus	  lock	  the	  clamp	  in	  a	  certain	  position.	  It	  was	  therefore	  assumed	  that	  the	  difference	  density	  within	  the	  cleft	  was	  due	  to	  the	  presence	  of	  Iwr1	  in	  the	  complex.	  As	  the	  size	  of	  the	  density	  does	  not	  seem	  to	  be	  sufficient	  to	  account	  for	  the	  full	  molecular	  weight	  of	  protein,	  parts	  of	  Iwr1	  need	  to	  be	   flexible.	  This	   is	  not	  unlikely	  as	   the	  C-­‐terminal	   third	  of	   the	  protein	  can	  be	  truncated	   without	   affecting	   the	   stability	   of	   the	   Pol	   II-­‐Iwr1	   complex	   in	   size	  exclusion	  experiments	  and	  therefore	  is	  probably	  not	  contacting	  the	  polymerase.	  Moreover,	  parts	  of	  the	  N-­‐terminal	  NLS	  might	  also	  be	  flexible,	  as	  they	  need	  to	  be	  accessible	  to	  karyopherins.	  Overall,	   the	  cryo-­‐EM	  reconstruction	  of	  the	  Pol	  II-­‐Iwr1	  complex	  indicated	  that	  Iwr1	  binds	  Pol	  II	  between	  its	  two	  larges	  subunits	  Rpb1	  and	  Rpb2	  within	  the	  active	  centre	  cleft.	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Figure	   8	   ⋅ 	   Iwr1	   binds	   Pol	  II	   in	   the	   active	   centre	   cleft.	   (A)	   Cryo-­‐EM	  map	   of	   the	   Pol	   II-­‐Iwr1	  complex	  at	  21	  Å	  resolution	  (grey).	  The	  difference	  density	  between	  this	  map	  and	  a	  Pol	  II	  crystal	  structure	  (PDB	  1WCM),	  both	  filtered	  to	  25	  Å,	  is	  in	  blue.	  A	  difference	  density	  calculated	  with	  a	  free	  Pol	  II	  cryo-­‐EM	  reconstruction	  is	  consistent,	  albeit	  noisier	  (not	  shown).	  Pol	  II	  views	  and	  regions	  as	  previously	   defined	   (Cramer	   et	   al,	   2001).	   Figures	   prepared	   with	   UCSF	   Chimera.	   (B)	   Electron	  micrograph	  of	  Pol	  II-­‐Iwr1	  complexes	  negatively	  stained	  with	  uranyl	  acetate.	  Red	  circles	  indicate	  distinct	  Pol	   II-­‐Iwr1	   complexes.	   (C,	   left)	   FC*	   as	   located	   in	   the	  X-­‐ray	   structure	   is	   in	  orange	   (PDB	  2B63).	  Figures	  prepared	  with	  PyMOL	  (Schrödinger,	  LLC).	  (C,	  right)	  Coomassie-­‐stained	  SDS-­‐PAGE	  of	   the	   Pol	  II-­‐Iwr1	   complex	   after	   size-­‐exclusion	   chromatography,	   before	   (left),	   and	   after	   (right)	  competition	  with	  the	  FC*	  RNA	  aptamer	  (Kettenberger	  et	  al,	  2006).	  The	  identity	  of	  the	  bands	  was	  confirmed	  by	  mass	  spectrometry.	  
	  	  
3.3.2 Competition	  experiments	  with	  nucleic	  acids	  confirm	  the	  predicted	  
location	  of	  Iwr1	  on	  RNA	  polymerase	  II	  	  To	   confirm	   the	   architecture	   of	   the	   Pol	  II-­‐Iwr1	   complex	   inferred	   from	  cryo-­‐EM	  and	  single	  particle	  analysis,	  competition	  experiments	  with	  nucleic	  acids	  were	   carried	   out.	   As	   the	   precise	   location	   of	   a	  minimal	   scaffold	   is	   known	   from	  structural	  studies	  on	  the	  Pol	  II	  elongation	  complex	  (Kettenberger	  et	  al,	  2004)	  it	  is	  suited	  to	  probe	  for	  binding	  of	  a	  factor	  in	  this	  region.	  Similarly,	  a	  structure	  of	  an	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RNA	   aptamer	   bound	   to	   Pol	   II	   is	   available	   (Kettenberger	   et	   al,	   2006).	   As	   the	  aptamer	  is	  small	  (10.7	  kDa)	  its	  spatial	  location	  is	  confined	  to	  only	  a	  small	  region	  directly	   above	   the	   bridge	   helix.	   Importantly,	   the	   structure	   of	   polymerase	   itself	  remains	   unaffected	   by	   the	   presence	   of	   either	   a	   minimal	   scaffold	   or	   the	   RNA	  aptamer,	  so	  that	  an	  allosteric	  mechanism	  of	  displacement	  can	  be	  excluded.	  Adding	  either	  the	  RNA	  aptamer	  (Figure	  8C)	  or	  a	  minimal	  scaffold	  (Figure	  10E)	   together	  with	   Iwr1	   to	   Pol	  II	   resulted	   in	   formation	   of	   the	   respective	  Pol	  II	  nucleic	   acid	   complexes.	   In	   size	   exclusion	   experiments	   the	   260	   to	   280	   nm	  absorption	   ratio	   in	   the	   Pol	  II	   peak	   was	   increased	   as	   compared	   to	   the	   ratio	   in	  absence	   of	   nucleic	   acids.	   Also	   in	   a	   SDS-­‐PAGE	   of	   these	   fractions	   the	   band	  corresponding	   to	   Iwr1	   almost	   completely	   disappeared	   (Figure	   8C	   and	   Figure	  10C).	   Introducing	  a	  specific	  order	  of	  addition	  of	   Iwr1	  and	  nucleic	  acids	  did	  not	  affect	   the	   final	   complex	   obtained,	   indicating	   that	   the	   chemical	   binding	  equilibrium	  between	  Iwr1,	  nucleic	  acids	  and	  the	  Pol	  II	  complex	  is	  reached	  fast	  as	  compared	  to	  the	  30	  min	  allowed	  for	  complex	  assembly	  (Figure	  10C).	  As	  a	  result,	  both	  the	  RNA	  aptamer	  and	  a	  DNA/RNA	  scaffold	  are	  capable	  of	  displacing	  Iwr1	  from	  Pol	  II	  confirming	  –	  with	  their	  defined	  spatial	  location	  –	  the	  architecture	   of	   the	   Pol	  II-­‐Iwr1	   complex	   derived	   by	   cryo-­‐EM.	   As	   a	   functional	  consequence	   in	  vivo,	   the	  presence	  of	  Iwr1	  is	   incompatible	  with	  a	  DNA	  template	  strand	   loaded	   into	   the	   Pol	  II	   active	   centre	   cleft.	   Presence	   of	   the	   factor	   on	  chromatin	  is	  therefore	  not	  to	  be	  expected.	  	  	   	  	  	  	  	  	  	  
Figure	  9	   ⋅ 	  Fourier	  shell	  correl-­‐
ation	  (FSC)	  curve	  of	  the	  Pol	   II-­‐
Iwr1	   cryo-­‐EM	   map.	   The	   reso-­‐lution	  at	  0.5	  is	  indicated.	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3.3.3 Iwr1	  is	  displaced	  from	  RNA	  polymerase	  II	  by	  transcription	  initiation	  
factors	  	  As	   Iwr1	   does	   not	   seem	   to	   be	   involved	   in	   transcription,	   release	   of	   the	  factor	   from	   Pol	  II	   might	   be	   facilitated	   by	   transcription	   initiation	   factors	   after	  entry	   of	   the	  polymerase	   into	   the	  nucleus.	   To	  probe	   for	   this	   possibility	   in	   vitro,	  competition	   of	   Iwr1	   with	   the	   initiation	   factor	   TFIIB	   (Figure	   10B)	   and	   with	   a	  closed	  promoter	  DNA	  bound	  to	  the	  initiation	  factors	  TBP	  and	  TFIIB	  (Figure	  10A)	  was	  assessed.	   In	  both	  cases	   Iwr1	  was	  partially	  displaced	   from	  Pol	  II	   in	  general	  supporting	   a	  mechanism	   in	  which	   Iwr1	   is	   displaced	   by	   initiation	   factors	   upon	  formation	  of	  the	  pre-­‐initiation	  complex.	  Yet,	  for	  complete	  Iwr1	  displacement	  this	  minimal	   promoter	   setup	   was	   insufficient.	   Compared	   to	   the	   in	   vivo	   situation	  where	  a	  series	  of	  factors	  such	  as	  additional	  GTFs,	  TAFs	  or	  the	  Mediator	  complex	  all	  contribute	  to	  the	  stability	  of	  the	  pre-­‐initiation	  complex	  (Hahn,	  2004),	  a	  partial	  Iwr1	  displacement	  does	  not	  seem	  surprising.	  	  	  
	  	  
Figure	  10	   ⋅ 	   Iwr1	   is	  displaced	   from	  Pol	  II	  by	   transcription	   initiation	   factors	  and	  a	  nucleic	  
acid	   scaffold.	   (A-­‐C)	   Coomassie-­‐stained	   SDS-­‐PAGE	   of	   the	   Pol	  II-­‐Iwr1	   complex	   exposed	   to	  competing	   species	   and	   subjected	   to	   size-­‐exclusion	   chromatography.	   (A)	   Competition	   with	   a	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closed	  DNA-­‐TBP-­‐TFIIB	   complex	  as	   indicated.	  The	  binding	  of	  DNA	   to	  Pol	  II	  was	  detected	  by	   the	  increased	   absorption	   at	   260	   nm	   in	   the	   Pol	  II	   size-­‐exclusion	   chromatography	   peak.	   (B)	  Competition	   of	   Iwr1	   and	   TFIIB	   for	   binding	   to	   Pol	  II.	   Iwr1	   (5-­‐fold	   excess)	   was	   incubated	   with	  Pol	  II	   for	  20	  min	  (lane	  1).	  TFIIB	  (5-­‐fold	  excess)	  was	  additionally	  added	  for	  20	  min	  (lane	  2).	   (C)	  Competition	  of	   Iwr1	  and	  a	  minimal	  DNA/RNA	  nucleic	   acid	   scaffold	   for	  binding	   to	  Pol	  II.	   Either	  Iwr1	  (5-­‐fold	  excess)	  was	  pre-­‐incubated	  with	  Pol	  II	  for	  20	  min	  and	  then	  the	  DNA/RNA	  scaffold	  (2-­‐fold	  excess)	  was	  added	   for	  20	  min	   (lane	  1)	  or	  vice	  versa	   (lane	  2).	  The	  binding	  of	  DNA/RNA	   to	  Pol	  II	   was	   detected	   by	   the	   increased	   absorption	   at	   260	   nm	   in	   the	   Pol	  II	   size-­‐exclusion	  chromatography	   peak.	   (D)	   Sequence	   of	   the	   closed	   promoter	   DNA	   used	   in	   (A).	   BREu/d,	  upstream/downstream	  TFIIB	   recognition	   element.	   (E)	  The	  minimal	  DNA/RNA	   scaffold	   used	   in	  (C).	  The	  bridge	  helix	  indicates	  the	  position	  at	  which	  the	  scaffold	  is	  located	  when	  bound	  to	  Pol	  II	  (Damsma	  et	  al,	  2007).	  	  	  
3.3.4 Iwr1	  hampers	  the	  crystallization	  of	  RNA	  polymerase	  II	  	  Beyond	   an	   architectural	   model	   of	   the	   Pol	  II-­‐Iwr1	   complex	   an	   atomic	  structure	   would	   be	   desirable.	   To	   this	   end	   crystallization	   of	   the	   complex	   in	  established	   Pol	  II	   crystallization	   conditions	   was	   tried	   (Armache	   et	   al,	   2005b;	  Kettenberger	  et	  al,	  2006).	  Crystal	  growth	  of	  Pol	  II-­‐Iwr1	  was	  delayed	  as	  compared	  to	  formation	  of	  crystals	  from	  Pol	  II	  alone	  and	  the	  final	  crystals	  in	  the	  Pol	  II-­‐Iwr1	  setup	  were	   small	   with	  most	   of	   them	   below	   100	   µm	   in	   diameter.	   Additionally,	  precipitate	  was	  present	   in	   the	  crystallization	  drops	   that	  was	   likely	  due	   to	   Iwr1	  protein	   (Figure	   11).	   A	   diffraction	   pattern	   for	   one	   of	   the	   small	   crystals	   could	  however	  be	  collected	  and	  an	  electron	  density	  map	  calculated.	  Yet,	  no	  density	  in	  addition	   to	   Pol	  II	   was	   present.	   Possibly	   the	   altered	   position	   of	   the	   Rpb4/7	  heterodimer	   seen	   in	   the	   cryo-­‐EM	   reconstruction	   (Figure	   8A)	   or	   parts	   of	   Iwr1	  would	   lead	   to	   clashes	   within	   the	   Pol	   II	   crystal	   lattice	   that	   is	   formed	   in	   the	  crystallization	   conditions	   used.	   A	   de	   novo	   crystallization	   screening	   led	   to	   the	  identification	  of	  novel	  conditions,	  which	  were	  akin	  to	  conditions	  already	  known.	  Macroscopically,	   the	   crystals	   in	   the	   screen	   resembled	   typical	   Pol	  II	   crystals	   so	  that	  optimization	  was	  not	  pursued	  into	  this	  direction.	  After	   these	   trials,	   the	  most	  promising	   approach	   to	   crystallize	   the	  Pol	   II-­‐Iwr1	  complex	  seems	  to	  be	  to	  use	  a	  minimal	  functionally	  relevant	  Iwr1	  truncation	  variant	  or	  the	  Pol	  II	  core	  instead	  of	  the	  complete	  polymerase	  (see	  4.2).	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  Pol	  II	   	  	  Pol	  II-­‐Iwr1	  	  
Figure	  11	   ⋅ 	  Crystallization	  of	  Pol	  II	  and	  trials	  with	  Pol	  II-­‐Iwr1.	  Protein	  was	  concentrated	   to	  around	   4	  mg/ml	   and	   hanging	   drop	   crystallization	   was	   set	   up	   in	   200	  mM	   ammonium	   acetate,	  300	  mM	  sodium	  acetate,	  50	  mM	  Hepes,	  pH	  7.0,	  5%	  PEG	  6,000,	  5	  mM	  TCEP.	  Crystal	  growth	  in	  the	  case	  of	  Pol	  II-­‐Iwr1	  was	  delayed	  for	  about	  three	  days.	  In	  addition,	  precipitate	  appeared.	  	  	  
3.4 Iwr1	  does	  not	  seem	  to	  be	  involved	  in	  transcription	  	  While	   this	   thesis	   was	   ongoing,	   a	   study	   was	   published	   that	   tried	   to	  establish	  Iwr1	  as	  a	  transcription	  factor	  (Peiro-­‐Chova	  &	  Estruch,	  2009).	  Knowing	  about	  the	  relevance	  of	  Iwr1	  for	  Pol	  II	  nuclear	  import,	   its	  direct	  interaction	  with	  Pol	  II	  that	  would	  seem	  unusual	  for	  a	  transcription	  factor,	  the	  architecture	  of	  the	  complex	   and	   the	   competition	   with	   nucleic	   acids,	   a	   further	   characterization	   of	  Iwr1	  regarding	  a	  direct	  involvement	  in	  transcription	  was	  required.	  	  	  
3.4.1 Iwr1	  is	  not	  required	  for	  promoter-­‐dependent	  transcription	  in	  vitro	  	  To	   assess	   the	   effect	   of	   Iwr1	   on	   transcriptional	   initiation	   an	   in	   vitro	  transcription	   system	   based	   on	   yeast	   nuclear	   extracts,	   recombinant	   Gal4-­‐VP16	  transcriptional	   activator	   and	   a	   plasmid	   with	   the	   yeast	   HIS4	   core	   promoter	  containing	   an	   upstream	   Gal4	   binding	   site	   was	   used.	   Nuclear	   extracts	   were	  prepared	   from	   wild-­‐type	   and	   Δiwr1	   cells.	   Both	   supported	   transcriptional	  initiation,	   with	   the	   Δiwr1	   extracts	   at	   possibly	   slightly	   higher	   levels	   as	   the	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wild-­‐type	   extract	   (Figure	   12).	   Addition	   of	   recombinant	   Iwr1	   protein	   led	   to	   a	  significant	  decrease	  in	  transcriptional	  signal,	  whereas	  addition	  of	  control	  protein	  did	  not.	  Therefore,	  Iwr1	  is	  generally	  not	  required	  for	  transcriptional	  initiation	  but	  rather	   interferes	   with	   it.	   Possibly,	   binding	   of	   Iwr1	   to	   Pol	  II	   reduces	   the	  concentration	  of	  free	  polymerases	  available	  for	  initiation	  and	  thereby	  exerts	  its	  inhibitory	  effect.	  	  	  
	  	  
Figure	   12	   ⋅ 	   Nuclear	   extracts	   from	   Δ iwr1	   cells	   support	   transcriptional	   initiation.	   Bands	  indicate	  the	  transcriptional	  signal.	  In	  lanes	  2	  and	  3,	  1	  and	  10	  pmol,	  respectively,	  of	  recombinant	  Iwr1	  were	  added	  to	  the	  reaction.	  	  	  
3.4.2 Iwr1	  is	  not	  present	  at	  chromatin	  	  According	   to	   the	   competition	   of	   Iwr1	   with	   nucleic	   acids	   in	   binding	   to	  Pol	  II	   and	   considering	   the	   architecture	   of	   the	   Pol	  II-­‐Iwr1	   complex	   the	   protein	  would	  not	  be	  expected	  to	  be	  bound	  in	  the	  context	  of	  chromatin.	  Nevertheless,	  a	  different	  mode	  of	  binding	  or	  a	  state	  in	  which	  Pol	  II	  is	  already	  partly	  recruited	  to	  a	  promoter	   but	   has	   not	   loaded	   the	   DNA	   template	   strand	   into	   its	   active	   centre	  might	  allow	  for	  the	  presence	  of	  Iwr1	  at	  chromatin.	  To	  assess	  these	  possibilities	  we	  tried	  to	  co-­‐immunoprecipitate	  (ChIP)	  genomic	  DNA	  with	  a	  C-­‐terminally	  TAP-­‐tagged	  version	  of	  Iwr1.	  After	  the	  immunoprecipitation	  with	  IgG	  beads	  DNA	  levels	  were	   comparable	   to	   the	  wild-­‐type	   control.	   Probing	   for	   the	  presence	  of	   Iwr1	  at	  the	  5’-­‐,	  ORF-­‐	  and	  3’-­‐region	  of	  the	  ADH1,	  ACT1	  and	  PMA1	  genes	  by	  real	  time	  PCR	  showed	   no	   enrichment	   of	   these	   DNA	   regions	   in	   the	   sample.	   This	   finding	   is	   in	  agreement	  with	  others	  that	  additionally	  varied	  the	  affinity	  tag	  and	  tested	  both	  N-­‐	  and	  C-­‐terminal	  fusions	  (Peiro-­‐Chova	  &	  Estruch,	  2009).	  Moreover,	  the	  C-­‐terminal	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TAP-­‐tag	  should	  be	  accessible	  as	  it	  was	  used	  in	  the	  original	  identification	  of	  Iwr1	  as	  a	  Pol	  II-­‐interacting	  factor	  (Krogan	  et	  al,	  2006).	  However,	  this	  finding	  cannot	  be	  easily	   reconciled	  with	   the	   reported	   co-­‐localization	   of	   Pol	  II	   and	   the	  Drosophila	  
melanogaster	  homologue	  of	  Iwr1	  on	  polytene	  chromosomes	  (Krogan	  et	  al,	  2006).	  In	  conclusion,	   Iwr1	   is	  not	  present	  at	  chromatin,	  which	   is	   in	   line	  with	   its	  inhibitory	   effect	   on	   transcriptional	   initiation	   (see	   3.4.1),	   its	   competition	   with	  nucleic	  acids	  (see	  3.3.2)	  for	  Pol	  II	  binding	  and	  the	  architecture	  of	  the	  Pol	  II-­‐Iwr1	  complex	  (see	  3.3.1).	  	  	  
3.4.3 The	  gene	  expression	  profile	  of	  the Δiwr1	  strain	  is	  dissimilar	  as	  
compared	  to	  profiles	  of	  263	  transcription	  factor	  gene	  deletion	  
strains	  	  To	  infer	  a	  possibly	  specific	  role	  of	  Iwr1	  in	  certain	  biochemical	  processes	  or	   pathways	   the	   gene	   expression	   profile	   of	   the	   Δiwr1	   strain	   was	   recorded.	  Compared	   to	   wild-­‐type	   cells	   794	   genes	   had	   significantly	   changed	   expression	  levels	  (fold-­‐change	  >2,	  p-­‐value	  <0.05)	  with	  40%	  (316	  genes)	  being	  up-­‐	  and	  60%	  (478	  genes)	  being	  downregulated.	  The	  20	  most	  strongly	  up-­‐	  and	  downregulated	  genes	   are	   shown	   in	   Table	   13.	   Generally,	   the	   higher	   fraction	   of	   downregulated	  genes	   suggests	   a	   rather	   activatory	   role	   for	   Iwr1.	   Clustering	   the	   affected	   genes	  according	   to	  gene	  ontology	  annotations	   reveals	   that	  many	  metabolic	  processes	  such	  as	  amino	  acid	  synthesis	  and	  energy	  related	  processes	  (ATP	  synthesis,	  NAD	  metabolism)	   are	   more	   strongly	   affected	   with	   a	   tendency	   towards	  downregulation	   of	   the	   genes	   involved.	   When	   looking	   at	   general	   biological	  processes	   in	   which	   the	   affected	   genes	   are	   involved,	   the	   cellular	   effects	   again	  appear	  to	  be	  very	  broad	  (Table	  14).	   In	  conclusion,	  no	  specific	   involvement	   in	  a	  single	  process	  could	  be	  identified.	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Table	   13	   ⋅ 	   Significantly	   differentially	   expressed	   genes	   in	   Δ iwr1	   cells.	  Absolute	   log2	   fold-­‐change	  ≥	  1,	  p-­‐value	  <	  0.05.	  The	  20	  most	   strongly	  up-­‐	  and	  downregulated	  genes	  out	  of	  794	  are	  shown	  representatively.	  
Upregulated	  (316	  total,	  40%)	   Downregulated	  (478	  total,	  60%)	  ORF	   Gene	  name	   log2	  fold-­‐change	   ORF	   Gene	  name	   log2	  fold-­‐change	  YLR343W	   GAS2	   6,96	   YGL089C	   MF(ALPHA)2	   -­‐9,88	  YKR046C	   PET10	   6,39	   YER011W	   TIR1	   -­‐9,77	  YDR216W	   ADR1	   6,01	   YAR071W	   PHO11	   -­‐9,67	  YOL058W	   ARG1	   5,89	   YDR534C	   FIT1	   -­‐8,49	  YKL109W	   HAP4	   5,88	   YBR093C	   PHO5	   -­‐8,43	  YFL014W	   HSP12	   4,83	   YHR216W	   IMD2	   -­‐8,36	  YKR039W	   GAP1	   4,81	   YHR136C	   SPL2	   -­‐8,12	  YJL088W	   ARG3	   4,70	   YCL064C	   CHA1	   -­‐8,02	  YEL011W	   GLC3	   4,39	   YDR033W	   MRH1	   -­‐7,58	  YKL161C	   YKL161C	   4,32	   YAR068W	   YAR068W	   -­‐7,52	  YLR142W	   PUT1	   4,24	   YAR073W	   IMD1	   -­‐7,02	  YER081W	   SER3	   3,94	   YLR231C	   BNA5	   -­‐6,86	  YJL102W	   MEF2	   3,93	   YJR025C	   BNA1	   -­‐6,82	  YPL152W	   RRD2	   3,84	   YDL115C	   IWR1	   -­‐6,13	  YKR091W	   SRL3	   3,82	   YHL047C	   ARN2	   -­‐6,11	  YDR042C	   YDR042C	   3,76	   YCL027W	   FUS1	   -­‐6,07	  YPR002W	   PDH1	   3,73	   YJL157C	   FAR1	   -­‐6,02	  YOR065W	   CYT1	   3,51	   YIL011W	   TIR3	   -­‐6,01	  YDL181W	   INH1	   3,45	   YLR136C	   TIS11	   -­‐5,77	  YBR230W-­‐A	   YBR230W-­‐A	   3,42	   YOR009W	   TIR4	   -­‐5,76	  	  	  
Table	   14	   ⋅ 	   Classification	   of	   significantly	   differentially	   expressed	   genes	   to	   general	  
biological	   processes	   according	   to	   the	   Super	   GO-­‐Slim:	   Process	   of	   the	   SGD	   Gene	   Ontology	  
Slim	  Mapper.	  
GOID	   GO	  term	   Frequency	  (out	  of	  794)	   Genome	  Frequency	  (out	  of	  6310)	  	   	   [total]	   [%]	   [total]	   [%]	  9987	   cellular	  process	   549	   69.1	   4835	   76.6	  8152	   metabolic	  process	   412	   51.9	   3595	   57.0	  8150	   biological	  process	  unknown	   198	   24.9	   1247	   19.8	  6810	   transport	   127	   16.0	   1034	   16.4	  6350	   transcription	   87	   11.0	   610	   9.7	  7049	   cell	  cycle	   57	   7.2	   521	   8.3	  6520	   cellular	  amino	  acid	  metabolic	  process	   41	   5.2	   207	   3.3	  23046	   signaling	  process	   33	   4.2	   239	   3.8	  -­‐	   other	   7	   0.9	   	   	  -­‐	   not	  yet	  annotated	   4	   0.5	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To	  further	  rationalize	  the	  data	  pairwise	  Pearson	  correlations	  of	  the	  fold-­‐expressions	  were	  calculated	  between	  the	  Δiwr1	  profile	  and	  a	  set	  of	  263	  profiles	  from	  transcription	  factor	  deletion	  strains	  (Hu	  et	  al,	  2007;	  Reimand	  et	  al,	  2010).	  In	  a	  visualization	  of	  the	  first	  two	  principal	  components	  of	  the	  correlation	  matrix	  the	  Δiwr1	  profile	  stands	  out	  as	  an	  outlier	  (Figure	  13).	  As	  proximity	   in	  this	  plot	  corresponds	   to	   similarity	   in	   transcriptional	   profiles	   the	   role	   of	   Iwr1	   can	   be	  interpreted	  as	  being	  distinct	  to	  all	  transcription	  factors	  considered.	  According	  to	   its	  gene	  expression	  profile	   Iwr1	  thus	  has	  a	  pleiotropic	  role	  rather	   than	   functioning	   as	   a	   specific	   transcription	   factor.	   This	   finding	   is	   in	  agreement	   with	   the	   proposed	   role	   for	   Iwr1	   to	   be	   a	   principal	   factor	   in	   Pol	  II	  nuclear	  import.	  	  	  
	  	  
Figure	  13	   ⋅ 	  The	  Δ iwr1	  gene	  expression	  profile	   is	  distinct	  as	  compared	   to	  263	  profiles	  of	  
transcription	  factor	  deletions.	  The	  correlation	  between	  the	  profiles	  (relative	  to	  wild-­‐type)	  was	  calculated.	   The	   first	   two	   principal	   components	   of	   the	   correlation	  matrix	   are	   plotted.	   ∆iwr1	   is	  indicated	  as	  a	  red	  dot.	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3.5 Nuclear	  import	  of	  RNA	  polymerase	  II	  is	  primarily	  
dependent	  on	  Iwr1	  and	  yet	  redundant	  
3.5.1 Cellular	  growth	  rate	  is	  independent	  of	  RNA	  polymerase	  II	  nuclear	  
localization	  above	  a	  critical	  threshold	  	  	  Different	  Iwr1	  variants	  led	  to	  varying	  degrees	  of	  Pol	  II	  nuclear	  localization	  when	  expressed	  from	  a	  rescue	  plasmid.	  To	  assess	  the	  relevance	  of	  proper	  Pol	  II	  nuclear	  localization	  for	  the	  growth	  fitness	  of	  rescued	  cells,	  both	  their	  nuclear	  to	  cytoplasmic	   fluorescence	   ratio	   of	   Rpb3-­‐EGFP	   and	   their	   doubling	   time	   was	  quantified	   (Figure	   14).	   As	   expected	   the	  wild-­‐type	   Iwr1	   rescue	   had	   the	   highest	  nuclear	   Pol	  II	   localization	   and	   the	   shortest	   doubling	   time	  whereas	   the	   control	  cells	  without	   a	   rescue	   had	  much	   less	   nuclear	   Pol	  II	   relative	   to	   the	   cytoplasmic	  amount	   and	  grew	   slower.	   Interestingly,	   the	   Iwr1	  minimal	  Pol	  II	   binding	   region	  was	  almost	  as	  competent	  as	  the	  full-­‐length	  protein	  both	  in	  restoration	  of	  growth	  fitness	  and	  Pol	  II	  nuclear	  localization.	  Although	  the	  Iwr1ΔNES	  and	  NLS-­‐C	  mutant	  were	  significantly	  worse	   in	  mediating	  Pol	  II	  nuclear	   import	   their	  doubling	   time	  was	   at	   wild-­‐type	   levels.	   Apparently,	   the	   cells	   can	   tolerate	   a	   certain	   level	   of	  impaired	  polymerase	  import	  without	  severe	  consequences	  for	  their	  fitness.	  The	  critical	  threshold	  seems	  to	  be	  between	  the	  import	  efficiency	  of	  the	  deletion	  strain	  and	  the	  NLS-­‐C	  mutation.	  Moreover,	  expression	  of	   the	  Iwr1	  NLS-­‐N	  and	  NLS-­‐N/C	  mutant	   led	   to	  Pol	  II	  nuclear	   localization	   levels	  and	  growth	   fitness	  below	  Δiwr1	  control	   cells	   without	   rescue.	   This	   finding	   might	   be	   explained	   by	   import-­‐incompetent	   Iwr1	   binding	   to	   Pol	  II	   and	   interfering	   with	   redundant	   import	  pathways	  (see	  4.2).	  As	  Iwr1	  seems	  to	  affect	  this	  alternative	  pathway,	  it	  is	  likely	  to	  be	  mediated	  by	  a	  factor	  that	  competes	  with	  Iwr1	  for	  Pol	  II	  binding.	  A	  candidate	  for	   this	   would	   be	   TFIIB	   for	   which	   an	   NLS	   and	   the	   responsible	   karyopherin	  Kap114	  have	  been	  described	  (Hodges	  et	  al,	  2005).	  The	   sharp	   increase	   in	   doubling	   time	   between	   the	   Iwr1	   NLS-­‐C	   mutant	  rescue	   and	   the	  Δiwr1	   control	   cells	   lacking	   Iwr1	   completely	  might	   also	   imply	   a	  second	  function	  of	  the	  protein	  before	  mediating	  import,	  possibly	  in	  polymerase	  biogenesis.	  This	  second	   function	  could	  be	  masked	  by	   the	  severe	   impairment	  of	  Pol	  II	  import	  by	  Iwr1	  NLS-­‐N	  and	  NLS-­‐N/C	  mutants.	  Although	  these	  NLS	  mutants	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should	   be	   capable	   of	   carrying	   out	   this	   hypothesized	   function	   the	   fitness	   of	   the	  cells	   ends	   up	  worse	   than	   that	   of	  Δiwr1	   cells	   as	   polymerase	   import	   is	   below	   a	  critical	  threshold.	  Pol	  II	  nuclear	  import	  is	  primarily	  dependent	  on	  Iwr1	  as	  specific	  mutations	  in	   its	   localization	  signals	   result	   in	  altered	  Pol	  II	   localization.	  The	  presence	  of	  at	  least	  one	  alternative	  import	  pathway	  that	  might	  be	  mutually	  exclusive	  with	  Iwr1	  is	   clear	  given	   the	  viability	  of	  Δiwr1	  cells.	  However,	  alternative	  pathways	  might	  play	   insignificant	  roles	   in	   the	  presence	  of	   Iwr1	  and	  only	  become	  relevant	   in	   its	  absence.	  Any	  sufficiently	  strong	  Pol	  II-­‐interacting	   factor	  with	  an	  NLS	  of	   its	  own	  or	   as	   part	   of	   an	   actively	   imported	   complex	   might	   be	   a	   candidate	   to	   mediate	  fractional	  Pol	  II	  nuclear	  import	  (see	  4.2).	  	  	  
	  	  
Figure	   14	   ⋅ 	   Growth	   fitness	   and	   degree	   of	   nuclear	   Pol	  II	   localization	   show	   a	   non-­‐linear	  
relation.	  Data	  from	  ∆iwr1/Rpb3-­‐EGFP	  cells	  expressing	  the	  indicated	  Iwr1	  variants.	  Mean	  ratio	  of	  quantified	   nuclear/cytoplasmic	   Rpb3-­‐EGFP	   fluorescence	   (n	   ≥	   10	   cells,	   ±SEM)	   plotted	   against	  growth	  rates	  (triplicates	  from	  three	  independent	  cultures,	  ±SEM).	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3.5.2 Rpb1	  levels	  and	  protein	  half-­‐life	  are	  increased	  in	  Δiwr1	  cells	  	  Altered	  localization	  of	  Pol	  II	  might	  lead	  to	  higher	  total	  Pol	  II	  protein	  levels.	  Firstly,	   these	  would	  be	   favoured	  by	  the	  need	  to	  overcome	   less	  efficient	  nuclear	  import.	  Secondly,	  in	  wild-­‐type	  cells	  degradation	  of	  Pol	  II	  is	  expected	  to	  take	  place	  in	  the	  nucleus	  (see	  1.4.2).	  Therefore,	  cytoplasmic	  Pol	  II	  might	  be	  protected	  from	  targeted	  degradation,	  resulting	  in	  prolonged	  protein	  half-­‐lives.	  To	  test	  this	  hypothesis,	  total	  Rpb1	  levels	  were	  measured	  in	  wild-­‐type	  and	  
Δiwr1	   cells	   by	   quantitative	   western	   blots	   (Figure	   15).	   Indeed,	   Rpb1	   levels	   in	  
Δiwr1	  cells	  were	  about	  8-­‐fold	  higher	  as	  compared	  to	  wild-­‐type	  (Figure	  15A).	  As	  none	   of	   the	   Pol	  II	   subunit	   genes	   was	   significantly	   more	   highly	   expressed	  according	   to	   the	   Δiwr1	   gene	   expression	   profile	   this	   was	   not	   the	   result	   of	   a	  specific	   transcriptional	  response	  of	   the	  cells	   to	   insufficient	  nuclear	  Pol	  II	   levels.	  To	   assess	   if	   Rpb1	   degradation	   was	   reduced	   the	   protein	   half-­‐live	   in	   a	  cycloheximide	  chase	  experiment	  was	  measured	  (Figure	  15B	  and	  C).	  In	  wild-­‐type	  cells	   the	  calculated	  Rpb1	  half-­‐live	  was	  around	  25	  min,	  which	  was	   in	  agreement	  with	  published	  results	  (Belle	  et	  al,	  2006).	  However,	  in	  Δiwr1	  cells	  no	  significant	  Rpb1	   degradation	   could	   be	   observed	   over	   the	   45	  min	   course	   of	   the	  measurement.	  Increased	  Rpb1,	  and	  possibly	  Pol	  II	  levels,	  in	  cells	  lacking	  Iwr1	  are	  due	  to	  an	  increased	  protein	  half-­‐live	  and	  not	  due	  to	   increased	  expression.	  Considering	  that	  a	  large	  Pol	  II	  fraction	  is	  localized	  in	  the	  cytoplasm	  this	  finding	  is	  consistent	  with	  Pol	  II	  assembly	  in	  the	  cytoplasm	  and	  degradation	  in	  the	  nucleus.	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Figure	  15	   ⋅ 	  Rpb1	  levels	  and	  protein	  half-­‐life	  are	  increased	  in	  Δ iwr1	  cells.	  (A)	  Quantitative	  western	   blots	   for	   Rpb1	   (8WG16)	   and	   Pgk1	   (α-­‐Pgk1).	   Rpb1	   intensity	   values	   are	   normalized	   to	  Pgk1	  and	  relative	   to	  wild-­‐type	  cells	   (triplicates,	  ±SEM).	   (B,	  C)	  Protein	  half-­‐life	  determination	  of	  Rpb1	  in	  the	  wild-­‐type	  and	  ∆iwr1	  strain.	  (B)	  Quantitative	  western	  blots	  for	  Rpb1	  (8WG16).	  Time	  points	   after	   addition	   of	   cycloheximide	   are	   indicated.	   (C)	   Quantification	   of	   wild-­‐type	   band	  intensity	   in	   (B)	   and	  Rpb1	  half-­‐life.	   Intensities	   (I)	   are	   normalized	   to	   the	   intensity	   at	   time	  point	  zero	  (I0).	  Time	  points	  outside	  of	  the	  linear	  range	  of	  the	  antibody	  are	  not	  considered.	  The	  standard	  error	  of	  the	  linear	  regression	  is	  indicated.	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4 Conclusions	  and	  Outlook	  
4.1 A	  model	  for	  RNA	  polymerase	  II	  nuclear	  import	  	  The	  results	  of	   this	   thesis	  and	  published	  data	  converge	  on	  a	  cyclic	  model	  for	   Iwr1-­‐directed	   Pol	  II	   nuclear	   import	   (Figure	   16):	   1)	   Pol	  II	   is	   completely	  assembled	   in	  the	  cytoplasm	  (Boulon	  et	  al,	  2010).	  2)	   Iwr1	  then	  binds	  Pol	  II	  (see	  3.2.1)	   between	   the	   large	   Pol	  II	   subunits	   (see	   3.3)	   maybe	   sensing	   complete	  assembly	  of	  the	  enzyme.	  3)	  Next,	  Iwr1	  uses	  its	  bipartite	  NLS	  (see	  3.1.1)	  to	  direct	  Pol	  II	   nuclear	   import	   (see	   3.1.3).	   4)	   In	   the	   nucleus,	   Iwr1	   is	   displaced	   from	   the	  Pol	  II	  active	  centre	  cleft	  during	  formation	  of	  the	  transcription	  initiation	  complex	  on	   promoter	   DNA	   (see	   3.3.3).	   5)	   Liberated	   Iwr1	   is	   then	   exported	   from	   the	  nucleus	   with	   the	   help	   of	   its	   NES	   (see	   3.1.1)	   by	   the	   karyopherin	   Xpo1	   (Peiro-­‐Chova	  &	  Estruch,	  2009)	  for	  another	  round	  of	  Pol	  II	  nuclear	  import.	  The	  data	  and	  model	  are	  consistent	  with	  Pol	  II	  assembly	  in	  the	  cytoplasm	  (Boulon	  et	  al,	  2010)	  and	  Pol	  II	  disassembly	  	  and	  Rpb1	  degradation	  in	  the	  nucleus	  (see	  3.5.2).	  Iwr1	  is	  specific	  for	  Pol	  II	  among	  the	  RNA	  polymerases,	  both	  in	  terms	  of	  binding	  and	  in	  its	  requirement	  for	  nuclear	  localization.	  Yet,	  similar	  mechanism	  might	  apply	   to	  Pol	   I	  and	  Pol	   III.	   In	  plants,	   Iwr1	  may	  additionally	  direct	  nuclear	  import	  of	  the	  plant-­‐specific	  Pol	  II-­‐related	  enzymes	  Pol	  IV	  and	  Pol	  V	  (Ream	  et	  al,	  2009),	  because	  Iwr1	  is	  required	  for	  Pol	  IV/V-­‐dependent	  processes	  in	  Arabidopsis	  
thaliana	  (He	  et	  al,	  2009;	  Kanno	  et	  al,	  2010).	  Further,	  Iwr1	  function	  seems	  to	  be	  conserved	  among	  all	  eukaryotes,	  including	  humans	  (see	  3.1.4).	  These	   results	   provide	   a	   starting	   point	   for	   analyzing	   the	   mechanisms	  underlying	  RNA	  polymerase	  biogenesis	  and	  subcellular	   localization,	  which	  may	  well	  constitute	  a	  mechanism	  within	  the	  recently	  suggested	  global	  transcriptional	  regulation	  (Zhurinsky	  et	  al,	  2010).	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Figure	  16	   ⋅ 	   Cyclic	  model	   for	   Iwr1-­‐directed	  Pol	  II	   nuclear	   import.	  Pol	  II	   assembles	   from	   its	  subunits	  in	  the	  cytoplasm	  (1.).	  Iwr1	  senses	  complete	  assembly	  by	  binding	  in	  the	  Pol	  II	  cleft	  (2.).	  The	  Iwr1	  NLS	  directs	  Pol	  II	  import	  through	  the	  nuclear	  pore	  complex	  (NPC,	  3.).	  Assembly	  of	  Pol	  II	  with	   initiation	   factors	   on	   promoter	   DNA	   releases	   Iwr1	   (4.).	   The	   Iwr1	   NES	   facilitates	   nuclear	  export	  of	  the	  factor,	  completing	  the	  cycle	  (5.).	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4.2 Extending	  the	  proposed	  model	  	  To	   further	  strengthen	  and	  extend	  the	  suggested	  model	   for	  Pol	  II	  nuclear	  import,	  I	  would	  like	  to	  suggest	  a	  series	  of	  experiments.	  Interestingly,	  Iwr1	  is	  not	  an	  essential	  protein	  in	  yeast.	  A	  sufficient	  amount	  of	   Pol	  II	   still	   translocates	   to	   the	   nucleus	   in	   Δiwr1	   cells	   ensuring	   viability.	  However,	  essential	  nuclear	  factors	  often	  depend	  on	  import	  routes	  that	  are	  based	  on	   non-­‐essential	   karyopherins	   (see	   1.5.2).	   This	   seems	   to	   be	   rooted	   in	   the	  inherent	  redundancy	  in	   import	  pathways.	  Firstly,	  karyopherins	  overlap	  in	  their	  specificity	   for	   cargo.	   Secondly,	   functional	   interactions	   in	   the	  nucleus,	   such	   as	   a	  GTF	   binding	   to	   polymerase,	   might	   already	   take	   place	   in	   the	   nucleus,	   thereby	  providing	  fractional	  import	  of	  a	  partner	  that	  is	  orphaned	  in	  respect	  to	  his	  proper	  import	   route.	   Good	   candidates	   that	   might	   provide	   fractional	   Pol	  II	   import	   are	  TFIIB	  and	  TFIIF	  that	  both	  have	  a	  considerable	  affinity	  to	  Pol	  II	  and	  that	  possess	  a	  proper	  NLS.	  As	   the	   expression	  of	  non-­‐functional	   Iwr1	  NLS	  mutants	   resulted	   in	  slower	   growth	   than	   absence	   of	   the	   entire	   factor,	   binding	   of	   Iwr1	   seems	   to	  interfere	  with	  one	  of	   the	  redundant	   import	  pathways.	  As	  TFIIF	  was	  co-­‐purified	  together	  with	  Iwr1	  (Krogan	  et	  al,	  2006),	  TFIIB	  for	  which	  competition	  with	  Iwr1	  was	   shown	   (see	   3.3.3)	   seems	   to	   be	   the	   most	   likely	   candidate	   for	   providing	  redundant	   Pol	  II	   import.	   Therefore,	   if	   not	   lethal	   by	   themselves,	   TFIIB	   NLS	  mutations	  in	  the	  Δiwr1	  background	  should	  be	  tested.	  In	  parallel,	  the	  accessibility	  of	   the	   TFIIB	   NLS	   for	   Kap114	   in	   a	   Pol	  II-­‐TFIIB	   complex	   should	   be	   examined	   in	  
vitro.	   Binding	   of	   Iwr1	   in	   the	   cleft	   of	   Pol	  II	   suggests	   the	   role	   of	   an	   assembly	  sensor,	   ensuring	   nuclear	   import	   of	   only	   fully	   assembled	   complexes.	   In	   this	  context,	  the	  phenotype	  of	  an	  Iwr1	  NLS	  fusion	  with	  either	  Rpb1	  or	  Rpb3	  in	  Δiwr1	  cells	  would	  be	  of	  interest.	  Additionally	  providing	  NLS	  mutant	  Iwr1	  to	  account	  for	  a	  possible	  role	  of	  Iwr1	  in	  polymerase	  biogenesis	  (see	  4.3)	  might	  provide	  further	  insights.	  In	  the	  model	  it	  is	  assumed	  that	  the	  Iwr1	  NLS	  is	  accessible	  in	  complex	  with	  Pol	  II	   and	   that	   the	  NES	   is	  not.	   In	   free	   Iwr1	   the	  NES	  should	  be	  exposed	  and	   the	  NLS	  might	  be	  masked	  by	  some	  autoinhibitory	  mechanism.	  To	  clarify	  this,	  binding	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of	  Kap60/Kap95,	  that	  recognize	  the	  classical	  bipartite	  NLS,	  and	  of	  Xpo1/RanGTP	  to	  free	  Iwr1	  and	  Pol	  II-­‐Iwr1	  should	  be	  tested	  (see	  1.5.1).	  In	  the	  case	  of	  Kap60,	  an	  N-­‐terminal	   truncation	   without	   the	   autoinhibitory	   IBB	   domain	   could	   be	   used,	  opening	   up	   the	   possibility	   to	   omit	   Kap95	   (Cook	   et	   al,	   2007).	   Concerning	  Xpo1/RanGTP,	  a	  GTPase-­‐deficient	  Ran	  mutation,	  such	  as	  Q69L	  is	  needed	  (Klebe	  et	  al,	  1995).	  To	   ultimately	   answer	   how	   Iwr1	   interacts	   with	   Pol	  II	   and	   in	   which	   way	  localisation	   signals	   are	   masked	   or	   not,	   an	   atomic	   model	   of	   the	   Pol	  II-­‐Iwr1	  complex	   is	   needed.	   As	   a	   minimal	   and	   functional	   Pol	  II	   binding	   domain	   was	  delineated	   in	   the	   course	   of	   this	   work	   (see	   3.2.2),	   co-­‐crystallization	   with	   this	  domain	  or	  soaking	  of	  pre-­‐formed	  Pol	  II	  crystals	  with	  even	  smaller	  variants	  that	  can	  still	  be	  expressed	  but	  do	  not	  bind	  with	   sufficient	  affinity	   for	   size-­‐exclusion	  chromatography	  seems	  to	  be	  the	  best	  starting	  point.	  As	  the	  Rpb4/7	  region	  in	  the	  cryo-­‐EM	   of	   the	   Pol	  II-­‐Iwr1	   complex	   is	   shifted	   relatively	   to	   the	   position	   in	   the	  crystal	   structure	  (see	  3.3.1)	  co-­‐crystallization	   trials	  with	  10-­‐subunit	  core	  Pol	  II,	  lacking	  Rpb4/7,	  might	  be	  promising.	  	  	  
4.3 Iwr1	  might	  integrate	  RNA	  polymerase	  II	  biogenesis	  
and	  nuclear	  import	  	  Recently,	  a	  role	  of	  HSP90	  in	  Pol	  II	  biogenesis	  was	  published	  (Boulon	  et	  al,	  2010).	  Interestingly,	  a	  protein	  co-­‐purified	  with	  Iwr1	  in	  vivo	  is	  Cns1	  (Krogan	  et	  al,	  2006),	  an	  essential	  HSP90	  co-­‐chaperone	  (Hainzl	  et	  al,	  2004;	  Marsh	  et	  al,	  1998;	  Tesic	   et	   al,	   2003).	   In	   preliminary	   experiments	   during	   this	   work	   binding	   of	  recombinant	   Cns1	   to	   Iwr1,	   but	   not	   to	   Pol	  II	   or	   Pol	  II-­‐Iwr1	   was	   observed	   (not	  shown).	   The	   most	   confident	   in	   vivo	   interaction	   of	   Iwr1	   that	   was	   not	   a	   Pol	  II	  subunit	  is	  the	  kinetochore	  protein	  Cbf2	  (Krogan	  et	  al,	  2006).	  Cbf2	  also	  undergoes	  interactions	  with	  HSP90	  as	  a	  member	  of	  the	  CBF3	  complex	  (Lingelbach	  &	  Kaplan,	  2004;	   Pearl	   et	   al,	   2008).	   Whatever	   might	   be	   the	   detailed	   nature	   of	   these	  interactions,	   they	   seem	   to	   establish	   a	   link	   between	   nuclear	   import	   and	  biogenesis	  of	  Pol	  II.	  A	  possible	   role	  might	   for	  example	  be	   in	   recruitment	  of	   the	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two	  largest	  subunits	  to	  HSP90	  or	  in	  picking	  up	  the	  fully	  assembled	  enzyme	  at	  the	  chaperone.	   Interestingly,	   Rpb1	   protein	   levels	   and	   half-­‐life	   are	   increased	   upon	  IWR1	  deletion	  (see	  3.5.2).	  Yet,	  according	  to	  ongoing	  experiments	  Rpb3	  levels	  are	  unchanged,	  implying	  that	  a	  second	  function	  of	  Iwr1	  should	  be	  specific	  for	  Rpb1	  and	  possibly	   for	  Rpb2.	  To	  clarify	   this,	  a	  comprehensive	  comparison	  of	  all	  Pol	  II	  subunit	  levels	  between	  Δiwr1	  and	  wild-­‐type	  cells	  should	  be	  performed.	  By	  approaching	  these	  questions,	   Iwr1	  might	  emerge	  with	  dual	  roles	  and	  as	  a	  factor	  that	  integrates	  Pol	  II	  biogenesis	  and	  Pol	  II	  nuclear	  import.	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a.	  a.	   amino	  acids	  
bp	   base	  pairs	  
C-­‐terminus	   carboxy	  terminus	  
CAPS	   N-­‐cyclohexyl-­‐3-­‐aminopropanesulfonic	  acid	  
ChIP	   chromatin	  immunoprecipitation	  
CTD	   carboxy-­‐terminal	  domain	  
CV	   column	  volumes	  
Da	   Dalton	  
DAPI	   4',6-­‐diamidino-­‐2-­‐phenylindole	  
DIC	   differential	  interference	  contrast	  
DMSO	   dimethyl	  sulfoxide	  
DNA	   deoxyribonucleic	  acid	  
DTT	   1,4-­‐dithio-­‐D,L-­‐threitol	  
EGFP	   enhanced	  green	  fluorescent	  protein	  
EM	   electron	  microscopy	  
et	  al.	   et	  alii	  (Latin	  “and	  others”)	  
g	   earth’s	  gravity	  
GFP	   green	  fluorescent	  protein	  
GTF	   general	  transcription	  factor	  
HEPES	   N-­‐2-­‐hydroxyethylpiperazine-­‐N’-­‐2-­‐ethane	  sulfonic	  acid	  
HSP	   heat	  shock	  protein	  
IMAC	   immobilized	  metal	  ion	  affinity	  chromatography	  
IPTG	   isopropyl-­‐β-­‐D-­‐thiogalactopyranoside	  
Iwr1	   Interact	  With	  RNA	  polymerase	  II	  
kDa	   kilo	  Dalton	  
LB	   Luria-­‐Bertani	  (media)	  
M	   molar	  
MOPS	   4-­‐morpholinepropanesulfonic	  acid	  
mRNA	   messenger	  ribonucleic	  acid	  
MS	   mass	  spectrometry	  
N-­‐terminus	   amino	  terminus	  
NES	   nuclear	  export	  sequence	  
NLS	   nuclear	  localization	  sequence	  
NPC	   nuclear	  pore	  complex	  
NTA	   nitrilotriacetic	  acid	  
ABBREVIATIONS	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ODX	  nm	   optical	  density	  at	  a	  wavelength	  of	  X	  nm	  
ORF	   open	  reading	  frame	  
PAGE	   polyacrylamide	  gel	  electrophoresis	  
PBS	   phosphate	  buffered	  saline	  
PCR	   polymerase	  chain	  reaction	  
PDB	   protein	  data	  bank	  
PI	   protease	  inhibitor	  
PIC	   pre-­‐initiation	  complex	  
Pol	   RNA	  polymerase	  
PVDF	   polyvinylidene	  fluoride	  
RNA	   ribonucleic	  acid	  
rpm	   rounds	  per	  minute	  
RT-­‐PCR	   reverse	  transcriptase	  PCR	  
S	   Svedberg	  (sedimentation	  coefficient	  unit)	  
SDS	   sodium	  dodecylsulfate	  
SGA	   synthetic	  genetic	  array	  
TAF	   TBP-­‐associated	  factor	  
TAP	   tandem	  affinity	  purification	  
TCA	   trichloroacetic	  acid	  
TCEP	   tris(2-­‐carboxyethyl)phosphine	  
TCR	   transcription-­‐coupled	  repair	  
TF	   transcription	  factor	  
Tris	   tris-­‐(hydroxymethyl)-­‐aminomethane	  
U	   units	  
URA	   uracil	  
UTR	   untranslated	  region	  
v/v	   volume	  per	  volume	  
w/v	   weight	  per	  volume	  
YPD	   yeast	  extract	  peptone	  dextrose	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